Gastroenterology & Hepatology — MCQs

Q: A 44-year-old woman presents with recurrent episodes of severe right upper quadrant pain after eating fatty foods. The pain radiates to her right shoulder and lasts several hours. What is the most likely diagnosis?

Biliary colic. ***Biliary colic***- This presentation of episodic, severe **right upper quadrant (RUQ) pain** lasting several hours and radiating to the **right shoulder** is the classic description of biliary colic caused by temporary obstruction of the cystic duct by a gallstone.- The pain is typically precipitated by **fatty meals** because cholecystokinin release causes the gallbladder to contract forcefully against the obstructing stone.*Peptic ulcer disease*- Pain associated with **peptic ulcer disease (PUD)** is usually epigastric, gnawing, or burning, and does not typically radiate to the right shoulder in this manner.- PUD pain is often related to the timing of meals but is usually relieved by antacids, unlike the intense, sustained colic seen here.*Acute pancreatitis*- **Acute pancreatitis** pain is typically constant, severe, and boring, radiating straight through to the **back**, not primarily to the right shoulder.- It is associated with systemic signs and significantly elevated serum **amylase** and **lipase** levels, which distinguish it from simpler biliary colic.*Gastroenteritis*- **Gastroenteritis** usually causes more diffuse, crampy abdominal pain, accompanied by prominent symptoms like vomiting and **diarrhea**.- It does not present as localized, recurrent, severe RUQ pain lasting hours, nor is it specifically triggered by **fatty food intake**.*Appendicitis*- **Appendicitis** pain classically starts periumbilical before localizing to the **right lower quadrant (RLQ)** (McBurney's point).- The pain is usually constant, progressive over 24-48 hours, and associated with signs of peritoneal irritation, unlike the episodic nature described here.

Q: A 47-year-old man presents with acute severe abdominal pain and vomiting. He has a family history of similar episodes. Serum amylase is normal but urinary porphobilinogen is elevated. What triggers should be avoided?

All of the above. ***All of the above***- The patient's presentation with acute severe abdominal pain, vomiting, family history of similar episodes, normal serum amylase, and elevated **urinary porphobilinogen** strongly points to an **Acute Intermittent Porphyria (AIP)** attack.- Attacks are triggered by factors that induce **hepatic ALA synthase (ALAS1)**, including specific drugs (e.g., **barbiturates**), metabolic stress (e.g., **fasting**, **alcohol**), and physiological factors (e.g., **stress**), all of which decrease regulatory heme. *Fasting*- **Fasting** or significant caloric restriction is a major trigger because the resulting carbohydrate deficiency reduces heme synthesis.- This leads to de-repression of **hepatic ALA synthase (ALAS1)**, increasing the production of neurotoxic porphyrin precursors.*Alcohol*- **Alcohol** metabolism induces **cytochrome P450 enzymes**, consuming available hepatic heme.- This consumption reduces the feedback inhibition on **ALAS1**, leading to an increase in porphyrin precursors.*Barbiturates*- **Barbiturates** are well-known inducers of the **hepatic cytochrome P450 system**.- This induction rapidly depletes the hepatic heme pool, lifting the natural feedback inhibition on **ALAS1** and causing accumulation of toxic precursors like **ALA** and **PBG**.*Stress*- Both emotional and physical **stress**, as well as infections, are recognized non-pharmacological precipitants of acute porphyria attacks.- Stress-induced attacks are likely mediated by associated hormonal shifts and metabolic imbalances that disrupt the heme synthesis pathway.

Q: A 51-year-old woman presents with progressive dysphagia and weight loss. She has a history of Barrett's esophagus on surveillance. Upper endoscopy shows a stricturing lesion. What is the most appropriate next step?

Multiple biopsies of the lesion. ***Multiple biopsies of the lesion***- Given the history of **Barrett's esophagus** and progressive symptoms (**dysphagia**, **weight loss**), the stricturing lesion is highly suspicious for **esophageal adenocarcinoma**.- Obtaining **multiple tissue samples** is the definitive and most crucial first step to confirm the diagnosis, determine the histology, and guide all subsequent staging and treatment decisions.*Barium swallow*- While useful for evaluating the extent and geometry of the stricture, it is a **radiological technique** that cannot provide definitive **tissue diagnosis** (histology).- Utilizing a barium swallow as the next step would unnecessarily delay the required pathological confirmation of suspected **malignancy**.*CT chest and abdomen*- This is a crucial modality used for **staging** the disease (checking for distant metastases and large lymph nodes), which is performed *after* the cancer diagnosis is pathologically confirmed.- The information provided by the CT scan is necessary for determining the overall **stage** (M-stage) and defining the appropriate treatment strategy.*Endoscopic ultrasound*- EUS is critical for highly accurate local staging, specifically determining the depth of tumor invasion (**T stage**) and the status of regional lymph nodes (**N stage**).- Like the CT scan, EUS is a **staging tool** and follows the confirmed diagnosis provided by the initial biopsies.*PET scan*- The **PET scan** is useful for assessing metabolically active tumors and is used in staging to look for subtle or distant foci of metastases which may be missed on conventional CT.- This expensive and advanced imaging technique is reserved for **advanced staging** scenarios, typically after the diagnosis is confirmed and initial staging is underway.

Q: A 43-year-old woman presents with episodes of flushing, diarrhea, and bronchospasm. CT shows liver metastases and a small bowel mass. 24-hour urine 5-HIAA is markedly elevated. What is the primary tumor location?

Small bowel. ***Small bowel*** - The constellation of **flushing**, **diarrhea**, and **bronchospasm** strongly indicates **carcinoid syndrome**, which, in the presence of **liver metastases**, is most commonly caused by **midgut carcinoid tumors**, particularly those arising from the **distal ileum**. - **Liver metastases** are crucial as they allow **serotonin** and other vasoactive substances to bypass hepatic metabolism, leading to systemic symptoms and elevated urinary **5-HIAA**. *Appendix* - While the **appendix** is the most common site for gastrointestinal carcinoid tumors, they are typically small, benign, and rarely metastasize or cause the full-blown **carcinoid syndrome**. - Appendiceal carcinoids are usually found incidentally and only cause symptoms if they obstruct the lumen. *Pancreas* - Pancreatic neuroendocrine tumors (PNETs) are known to secrete various hormones, but they typically cause syndromes related to hormones like **insulin** (insulinoma) or **gastrin** (gastrinoma), rather than classic carcinoid syndrome with prominent flushing and diarrhea. - Although a pancreatic primary could theoretically cause carcinoid syndrome, the clear presence of a **small bowel mass** on CT makes a small bowel primary significantly more likely. *Lung* - **Bronchial carcinoids** can indeed cause carcinoid syndrome, sometimes presenting with more atypical or prolonged flushing. - However, the patient's CT scan explicitly reveals a **small bowel mass** as the likely primary, making a lung primary less probable in this specific scenario. *Ovary* - Primary ovarian carcinoids are rare tumors that can cause carcinoid syndrome because their venous drainage directly enters the systemic circulation, bypassing the liver. - Yet, the identification of a **small bowel mass** on CT strongly points to a gastrointestinal primary tumor rather than an ovarian origin.

Q: A 59-year-old man presents with painless jaundice and weight loss. CT shows a mass in the pancreatic head. ERCP shows stricturing of the common bile duct. What is the most likely diagnosis?

Pancreatic adenocarcinoma. ***Pancreatic adenocarcinoma***- The combination of **painless jaundice** and significant, unexplained **weight loss** in an older patient strongly suggests a periampullary malignancy.- The CT finding of a mass specifically located in the **pancreatic head** causing stricturing of the common bile duct confirms this as the most likely diagnosis, as the head is the most common site for this cancer.*Chronic pancreatitis*- Chronic pancreatitis typically presents with chronic or recurrent **severe epigastric pain** episodes; the history here emphasizes painless jaundice.- While it can cause strictures, the marked **weight loss** and the presence of a distinct mass on CT are more indicative of a malignant process than benign inflammation.*Cholangiocarcinoma*- Cholangiocarcinoma (bile duct cancer) causes obstructive jaundice, but the mass typically arises from the **biliary epithelium** itself, not the pancreatic parenchyma.- The tumor location is specified as a mass *in the pancreatic head*, making primary pancreatic cancer more probable than a distal cholangiocarcinoma.*Ampullary carcinoma*- While ampullary carcinomas also cause periampullary obstruction, they often lead to **fluctuating or intermittent jaundice** due to tumor sloughing.- They are also often associated with early symptoms like occult or frank **GI bleeding** and anemia, which are not key features here.*Gallstone disease*- Uncomplicated gallstone disease (choledocholithiasis) causing jaundice is usually painful (**biliary colic** or symptoms of cholangitis), contrasting with the **painless** history.- Gallstones do not typically cause a large, solid **mass** observed in the pancreatic head associated with rapid weight loss.

Q: A 52-year-old man presents with progressive jaundice and weight loss. MRCP shows stricturing of the common bile duct with upstream dilatation. CA 19-9 is markedly elevated. What is the most likely diagnosis?

Cholangiocarcinoma. ***Cholangiocarcinoma***- This presentation of progressive **obstructive jaundice**, **weight loss**, and a solitary stricture on MRCP is highly characteristic of **cholangiocarcinoma**.- The markedly elevated **CA 19-9** is a standard tumor marker supporting the diagnosis of this biliary tract malignancy.*Choledocholithiasis*- Typically causes abrupt or **intermittent obstructive symptoms** (jaundice, cholangitis), often preceded by biliary colic.- MRCP would characteristically show **filling defects (stones)** within the duct, not primarily a **dominant intrinsic stricture**.*Pancreatic adenocarcinoma*- While it causes obstructive jaundice and weight loss with high CA 19-9, it usually compresses the **distal CBD** and often shows a **double duct sign** (dilated CBD and pancreatic duct).- The patient’s presentation focuses on a generic common bile duct stricture, which is more specific to biliary wall cancer (cholangiocarcinoma) than pancreatic head mass.*Primary sclerosing cholangitis*- Characterized by **multiple, diffuse, segmental strictures** alternating with normal duct segments, giving a **beaded appearance**.- This condition is an autoimmune process commonly associated with **ulcerative colitis**, not typically presenting as a solitary, malignant-appearing stricture.*Chronic pancreatitis*- Primary symptoms often include chronic severe **epigastric pain** and signs of **exocrine insufficiency** (steatorrhea) preceding jaundice.- Although it can cause benign strictures leading to jaundice, massive elevation of **CA 19-9** pointing to malignancy is rare without concurrent transformation (which would then be adenocarcinoma).

Q: A 41-year-old man presents with recurrent episodes of severe flushing and diarrhea. He develops bronchospasm during episodes. 5-HIAA is elevated. What is the primary tumor site likely to be?

Small bowel. ***Small bowel***- Midgut neuroendocrine tumors (NETs), typically originating in the **ileum**, are the most common source of metastases that produce the classic carcinoid syndrome (recurrent severe flushing, diarrhea, bronchospasm).- These tumors release large amounts of **serotonin**, which, when metastases bypass hepatic metabolism, causes systemic symptoms and elevates the urine excretion product, **5-HIAA**.*Lung*- Bronchial carcinoids can cause the syndrome, but the flushing is usually more **prolonged** and intense, and **carcinoid heart disease** is less common than with midgut tumors.- Primary lung tumors are less common than small bowel tumors to cause the full triad of severe flushing, profuse diarrhea, and bronchospasm.*Pancreas*- Pancreatic NETs, such as **insulinomas** or **gastrinomas**, typically cause syndromes related to their specific hormonal excess (e.g., hypoglycemia, peptic ulcers) rather than the classic serotonin-driven carcinoid syndrome.- While the pancreas can be a primary site, it is not the most likely cause of this specific generalized metastatic symptom constellation.*Stomach*- Gastric carcinoids often secrete **histamine**, leading to an atypical, often localized, flushing pattern, sometimes associated with specific dietary triggers.- This tumor site is less likely to produce the severe, systemic diarrhea and bronchospasm characteristic of a midgut serotonin-secreting tumor.*Colon*- Neuroendocrine tumors of the hindgut (colon and rectum), especially those in the rectum, rarely produce sufficient serotonin to cause the classic syndrome.- When colonic NETs do metastasize, they often present with local symptoms before generalized systemic signs of carcinoid syndrome appear.

Gastroenterology & Hepatology UK Medical PG Practice Questions and MCQs

Question 1: A 44-year-old woman presents with recurrent episodes of severe right upper quadrant pain after eating fatty foods. The pain radiates to her right shoulder and lasts several hours. What is the most likely diagnosis?

A. Peptic ulcer disease
B. Acute pancreatitis
C. Biliary colic (Correct Answer)
D. Gastroenteritis
E. Appendicitis

Explanation: ***Biliary colic***- This presentation of episodic, severe **right upper quadrant (RUQ) pain** lasting several hours and radiating to the **right shoulder** is the classic description of biliary colic caused by temporary obstruction of the cystic duct by a gallstone.- The pain is typically precipitated by **fatty meals** because cholecystokinin release causes the gallbladder to contract forcefully against the obstructing stone.*Peptic ulcer disease*- Pain associated with **peptic ulcer disease (PUD)** is usually epigastric, gnawing, or burning, and does not typically radiate to the right shoulder in this manner.- PUD pain is often related to the timing of meals but is usually relieved by antacids, unlike the intense, sustained colic seen here.*Acute pancreatitis*- **Acute pancreatitis** pain is typically constant, severe, and boring, radiating straight through to the **back**, not primarily to the right shoulder.- It is associated with systemic signs and significantly elevated serum **amylase** and **lipase** levels, which distinguish it from simpler biliary colic.*Gastroenteritis*- **Gastroenteritis** usually causes more diffuse, crampy abdominal pain, accompanied by prominent symptoms like vomiting and **diarrhea**.- It does not present as localized, recurrent, severe RUQ pain lasting hours, nor is it specifically triggered by **fatty food intake**.*Appendicitis*- **Appendicitis** pain classically starts periumbilical before localizing to the **right lower quadrant (RLQ)** (McBurney's point).- The pain is usually constant, progressive over 24-48 hours, and associated with signs of peritoneal irritation, unlike the episodic nature described here.

Question 2: A 38-year-old woman presents with recurrent episodes of severe abdominal pain and psychiatric symptoms. Her urine turns dark during attacks. Family history reveals similar episodes. What is the inheritance pattern?

A. Autosomal recessive
B. Autosomal dominant (Correct Answer)
C. X-linked recessive
D. X-linked dominant
E. Mitochondrial

Explanation: ***Autosomal dominant*** - The clinical picture of recurrent severe abdominal pain, psychiatric symptoms, and dark urine during attacks is highly suggestive of **Acute Intermittent Porphyria (AIP)**. - AIP is caused by a deficiency in **hydroxymethylbilane synthase (PBG deaminase)** and is inherited in an **autosomal dominant** fashion, which explains the positive family history. *Autosomal recessive* - **Autosomal recessive** disorders typically manifest if two copies of the defective gene are inherited, often presenting in siblings but not consistently across multiple generations (vertical transmission) as implied by the family history. - Conditions like **Congenital erythropoietic porphyria** are autosomal recessive but primarily cause photosensitivity and hemolytic anemia, not neurovisceral crises. *X-linked recessive* - **X-linked recessive** disorders predominantly affect males and are transmitted from carrier mothers to sons, a pattern inconsistent with a female patient with similar episodes in the family. - Common examples like **Hemophilia** or **Duchenne Muscular Dystrophy** have sex-linked inheritance patterns that do not match the presented symptoms or inheritance. *X-linked dominant* - **X-linked dominant** inheritance would show affected fathers passing the trait to all daughters but none of their sons, and affected mothers passing it to half of their children, which is not the typical pattern for AIP. - **X-linked protoporphyria**, a rare porphyria, follows this pattern but presents primarily with severe photosensitivity and hepatobiliary complications, not the neurovisceral attacks seen here. *Mitochondrial* - **Mitochondrial inheritance** is characterized by exclusive **maternal transmission**, meaning all children of an affected mother are affected, but no children of an affected father. This pattern differs from the general family history for AIP. - Mitochondrial disorders primarily affect high-energy-demand organs, and while they can have neurological components, most porphyrias are nuclear-encoded genetic disorders, making mitochondrial inheritance highly unlikely.

Question 3: A 47-year-old man presents with acute severe abdominal pain and vomiting. He has a family history of similar episodes. Serum amylase is normal but urinary porphobilinogen is elevated. What triggers should be avoided?

A. Fasting
B. Alcohol
C. Barbiturates
D. Stress
E. All of the above (Correct Answer)

Explanation: ***All of the above***- The patient's presentation with acute severe abdominal pain, vomiting, family history of similar episodes, normal serum amylase, and elevated **urinary porphobilinogen** strongly points to an **Acute Intermittent Porphyria (AIP)** attack.- Attacks are triggered by factors that induce **hepatic ALA synthase (ALAS1)**, including specific drugs (e.g., **barbiturates**), metabolic stress (e.g., **fasting**, **alcohol**), and physiological factors (e.g., **stress**), all of which decrease regulatory heme. *Fasting*- **Fasting** or significant caloric restriction is a major trigger because the resulting carbohydrate deficiency reduces heme synthesis.- This leads to de-repression of **hepatic ALA synthase (ALAS1)**, increasing the production of neurotoxic porphyrin precursors.*Alcohol*- **Alcohol** metabolism induces **cytochrome P450 enzymes**, consuming available hepatic heme.- This consumption reduces the feedback inhibition on **ALAS1**, leading to an increase in porphyrin precursors.*Barbiturates*- **Barbiturates** are well-known inducers of the **hepatic cytochrome P450 system**.- This induction rapidly depletes the hepatic heme pool, lifting the natural feedback inhibition on **ALAS1** and causing accumulation of toxic precursors like **ALA** and **PBG**.*Stress*- Both emotional and physical **stress**, as well as infections, are recognized non-pharmacological precipitants of acute porphyria attacks.- Stress-induced attacks are likely mediated by associated hormonal shifts and metabolic imbalances that disrupt the heme synthesis pathway.

Question 4: A 51-year-old woman presents with progressive dysphagia and weight loss. She has a history of Barrett's esophagus on surveillance. Upper endoscopy shows a stricturing lesion. What is the most appropriate next step?

A. Barium swallow
B. Multiple biopsies of the lesion (Correct Answer)
C. CT chest and abdomen
D. Endoscopic ultrasound
E. PET scan

Explanation: ***Multiple biopsies of the lesion***- Given the history of **Barrett's esophagus** and progressive symptoms (**dysphagia**, **weight loss**), the stricturing lesion is highly suspicious for **esophageal adenocarcinoma**.- Obtaining **multiple tissue samples** is the definitive and most crucial first step to confirm the diagnosis, determine the histology, and guide all subsequent staging and treatment decisions.*Barium swallow*- While useful for evaluating the extent and geometry of the stricture, it is a **radiological technique** that cannot provide definitive **tissue diagnosis** (histology).- Utilizing a barium swallow as the next step would unnecessarily delay the required pathological confirmation of suspected **malignancy**.*CT chest and abdomen*- This is a crucial modality used for **staging** the disease (checking for distant metastases and large lymph nodes), which is performed *after* the cancer diagnosis is pathologically confirmed.- The information provided by the CT scan is necessary for determining the overall **stage** (M-stage) and defining the appropriate treatment strategy.*Endoscopic ultrasound*- EUS is critical for highly accurate local staging, specifically determining the depth of tumor invasion (**T stage**) and the status of regional lymph nodes (**N stage**).- Like the CT scan, EUS is a **staging tool** and follows the confirmed diagnosis provided by the initial biopsies.*PET scan*- The **PET scan** is useful for assessing metabolically active tumors and is used in staging to look for subtle or distant foci of metastases which may be missed on conventional CT.- This expensive and advanced imaging technique is reserved for **advanced staging** scenarios, typically after the diagnosis is confirmed and initial staging is underway.

Question 5: A 49-year-old man presents with acute severe epigastric pain radiating to his back. Serum amylase is 1500 U/L. CT shows pancreatic necrosis involving 40% of the gland. What is the most appropriate initial management?

A. Immediate surgical necrosectomy
B. Conservative management with IV fluids (Correct Answer)
C. Endoscopic necrosectomy
D. Percutaneous drainage
E. Total pancreatectomy

Explanation: ***Conservative management with IV fluids***- The initial management of severe acute pancreatitis, even when associated with **pancreatic necrosis**, is focused on **aggressive supportive care**, which primarily includes crystalloid administration for circulatory support, pain control, and monitoring.- Deferred intervention is the standard approach for **sterile pancreatic necrosis** because early surgical or endoscopic necrosectomy increases morbidity and mortality; intervention is typically reserved for confirmed **infected necrosis** occurring weeks later.*Immediate surgical necrosectomy*- Early surgical necrosectomy is associated with a significantly **higher mortality rate** and is generally contraindicated in the first 2-3 weeks, especially when the necrosis is sterile.- Surgical intervention is reserved for specific late complications, primarily **infected pancreatic necrosis** that fails conservative management, or uncontrolled bleeding.*Endoscopic necrosectomy*- Endoscopic approaches are minimally invasive alternatives to surgery for debridement but are generally performed only after the necrosis has successfully encapsulated into **walled-off necrosis (WON)**, typically 4 weeks or later.- Performing early debridement, endoscopic or surgical, is dangerous as the necrotic tissue is soft and poorly demarcated.*Percutaneous drainage*- This procedure is usually utilized for specific purposes, such as draining large, symptomatic acute fluid collections or for providing immediate control of suspected or proven **infected fluid collections** (abscesses) or infected necrosis.- It is not the cornerstone of initial volume resuscitation and systemic management for acute severe pancreatitis.*Total pancreatectomy*- This highly invasive technique carries massive morbidity (resulting in immediate **brittle diabetes** and exocrine insufficiency) and is reserved for extreme, life-threatening scenarios, such as widespread, uncontrolled pancreatic infection or massive hemorrhage.- It is never considered the appropriate initial step for managing acute pancreatitis.

Question 6: A 43-year-old woman presents with episodes of flushing, diarrhea, and bronchospasm. CT shows liver metastases and a small bowel mass. 24-hour urine 5-HIAA is markedly elevated. What is the primary tumor location?

A. Appendix
B. Small bowel (Correct Answer)
C. Pancreas
D. Lung
E. Ovary

Explanation: ***Small bowel*** - The constellation of **flushing**, **diarrhea**, and **bronchospasm** strongly indicates **carcinoid syndrome**, which, in the presence of **liver metastases**, is most commonly caused by **midgut carcinoid tumors**, particularly those arising from the **distal ileum**. - **Liver metastases** are crucial as they allow **serotonin** and other vasoactive substances to bypass hepatic metabolism, leading to systemic symptoms and elevated urinary **5-HIAA**. *Appendix* - While the **appendix** is the most common site for gastrointestinal carcinoid tumors, they are typically small, benign, and rarely metastasize or cause the full-blown **carcinoid syndrome**. - Appendiceal carcinoids are usually found incidentally and only cause symptoms if they obstruct the lumen. *Pancreas* - Pancreatic neuroendocrine tumors (PNETs) are known to secrete various hormones, but they typically cause syndromes related to hormones like **insulin** (insulinoma) or **gastrin** (gastrinoma), rather than classic carcinoid syndrome with prominent flushing and diarrhea. - Although a pancreatic primary could theoretically cause carcinoid syndrome, the clear presence of a **small bowel mass** on CT makes a small bowel primary significantly more likely. *Lung* - **Bronchial carcinoids** can indeed cause carcinoid syndrome, sometimes presenting with more atypical or prolonged flushing. - However, the patient's CT scan explicitly reveals a **small bowel mass** as the likely primary, making a lung primary less probable in this specific scenario. *Ovary* - Primary ovarian carcinoids are rare tumors that can cause carcinoid syndrome because their venous drainage directly enters the systemic circulation, bypassing the liver. - Yet, the identification of a **small bowel mass** on CT strongly points to a gastrointestinal primary tumor rather than an ovarian origin.

Question 7: A 59-year-old man presents with painless jaundice and weight loss. CT shows a mass in the pancreatic head. ERCP shows stricturing of the common bile duct. What is the most likely diagnosis?

A. Chronic pancreatitis
B. Pancreatic adenocarcinoma (Correct Answer)
C. Cholangiocarcinoma
D. Ampullary carcinoma
E. Gallstone disease

Explanation: ***Pancreatic adenocarcinoma***- The combination of **painless jaundice** and significant, unexplained **weight loss** in an older patient strongly suggests a periampullary malignancy.- The CT finding of a mass specifically located in the **pancreatic head** causing stricturing of the common bile duct confirms this as the most likely diagnosis, as the head is the most common site for this cancer.*Chronic pancreatitis*- Chronic pancreatitis typically presents with chronic or recurrent **severe epigastric pain** episodes; the history here emphasizes painless jaundice.- While it can cause strictures, the marked **weight loss** and the presence of a distinct mass on CT are more indicative of a malignant process than benign inflammation.*Cholangiocarcinoma*- Cholangiocarcinoma (bile duct cancer) causes obstructive jaundice, but the mass typically arises from the **biliary epithelium** itself, not the pancreatic parenchyma.- The tumor location is specified as a mass *in the pancreatic head*, making primary pancreatic cancer more probable than a distal cholangiocarcinoma.*Ampullary carcinoma*- While ampullary carcinomas also cause periampullary obstruction, they often lead to **fluctuating or intermittent jaundice** due to tumor sloughing.- They are also often associated with early symptoms like occult or frank **GI bleeding** and anemia, which are not key features here.*Gallstone disease*- Uncomplicated gallstone disease (choledocholithiasis) causing jaundice is usually painful (**biliary colic** or symptoms of cholangitis), contrasting with the **painless** history.- Gallstones do not typically cause a large, solid **mass** observed in the pancreatic head associated with rapid weight loss.

Question 8: A 54-year-old man presents with progressive dysphagia to solids over 3 months. He has a 40-year history of heartburn. Upper endoscopy shows a stricturing lesion at the GE junction. What is the most likely diagnosis?

A. Benign peptic stricture
B. Esophageal adenocarcinoma (Correct Answer)
C. Achalasia
D. Eosinophilic esophagitis
E. Esophageal web

Explanation: ***Esophageal adenocarcinoma***- The combination of a **long-standing history of GERD** (heartburn for 40 years) and the finding of a **stricturing lesion at the GE junction** is highly consistent with esophageal adenocarcinoma arising from **Barrett's esophagus**.- The presentation of **progressive dysphagia primarily to solids** over a short period (3 months) is the classic warning sign for malignancy causing luminal obstruction.*Benign peptic stricture*- While caused by chronic GERD, benign peptic strictures usually develop significantly **more slowly** (over years) and often cause symmetric, smooth narrowing.- Unlike cancer, benign strictures typically present with dysphagia that may improve with **proton pump inhibitor (PPI) therapy**, and they lack the invasive, irregular appearance of a malignant stricture on endoscopy.*Achalasia*- Achalasia is a motility disorder characterized by the failure of the **lower esophageal sphincter (LES) to relax**, typically causing progressive dysphagia to **both solids and liquids** simultaneously.- Endoscopy in achalasia usually shows a dilated esophagus with retained food, often with a "bird-beak" appearance on barium swallow, not a focal stricturing mass at the GE junction.*Eosinophilic esophagitis*- This condition is usually associated with **atopy** and presents with intermittent dysphagia, often leading to **food impaction**, typically in younger patients.- Endoscopic findings include characteristic **esophageal rings (trachea-like appearance)**, linear furrows, or white exudates, and the diagnosis relies on the presence of high numbers of eosinophils on biopsy.*Esophageal web*- Esophageal webs are thin, shelf-like mucosal membranes commonly found in the **proximal or mid esophagus**, often causing only intermittent, non-progressive dysphagia.- They are not associated with long-standing GERD/Barrett's esophagus, nor do they typically present as a thick, stricturing lesion found at the **GE junction**.

Question 9: A 52-year-old man presents with progressive jaundice and weight loss. MRCP shows stricturing of the common bile duct with upstream dilatation. CA 19-9 is markedly elevated. What is the most likely diagnosis?

A. Choledocholithiasis
B. Cholangiocarcinoma (Correct Answer)
C. Pancreatic adenocarcinoma
D. Primary sclerosing cholangitis
E. Chronic pancreatitis

Explanation: ***Cholangiocarcinoma***- This presentation of progressive **obstructive jaundice**, **weight loss**, and a solitary stricture on MRCP is highly characteristic of **cholangiocarcinoma**.- The markedly elevated **CA 19-9** is a standard tumor marker supporting the diagnosis of this biliary tract malignancy.*Choledocholithiasis*- Typically causes abrupt or **intermittent obstructive symptoms** (jaundice, cholangitis), often preceded by biliary colic.- MRCP would characteristically show **filling defects (stones)** within the duct, not primarily a **dominant intrinsic stricture**.*Pancreatic adenocarcinoma*- While it causes obstructive jaundice and weight loss with high CA 19-9, it usually compresses the **distal CBD** and often shows a **double duct sign** (dilated CBD and pancreatic duct).- The patient’s presentation focuses on a generic common bile duct stricture, which is more specific to biliary wall cancer (cholangiocarcinoma) than pancreatic head mass.*Primary sclerosing cholangitis*- Characterized by **multiple, diffuse, segmental strictures** alternating with normal duct segments, giving a **beaded appearance**.- This condition is an autoimmune process commonly associated with **ulcerative colitis**, not typically presenting as a solitary, malignant-appearing stricture.*Chronic pancreatitis*- Primary symptoms often include chronic severe **epigastric pain** and signs of **exocrine insufficiency** (steatorrhea) preceding jaundice.- Although it can cause benign strictures leading to jaundice, massive elevation of **CA 19-9** pointing to malignancy is rare without concurrent transformation (which would then be adenocarcinoma).

Question 10: A 41-year-old man presents with recurrent episodes of severe flushing and diarrhea. He develops bronchospasm during episodes. 5-HIAA is elevated. What is the primary tumor site likely to be?

A. Lung
B. Small bowel (Correct Answer)
C. Pancreas
D. Stomach
E. Colon

Explanation: ***Small bowel***- Midgut neuroendocrine tumors (NETs), typically originating in the **ileum**, are the most common source of metastases that produce the classic carcinoid syndrome (recurrent severe flushing, diarrhea, bronchospasm).- These tumors release large amounts of **serotonin**, which, when metastases bypass hepatic metabolism, causes systemic symptoms and elevates the urine excretion product, **5-HIAA**.*Lung*- Bronchial carcinoids can cause the syndrome, but the flushing is usually more **prolonged** and intense, and **carcinoid heart disease** is less common than with midgut tumors.- Primary lung tumors are less common than small bowel tumors to cause the full triad of severe flushing, profuse diarrhea, and bronchospasm.*Pancreas*- Pancreatic NETs, such as **insulinomas** or **gastrinomas**, typically cause syndromes related to their specific hormonal excess (e.g., hypoglycemia, peptic ulcers) rather than the classic serotonin-driven carcinoid syndrome.- While the pancreas can be a primary site, it is not the most likely cause of this specific generalized metastatic symptom constellation.*Stomach*- Gastric carcinoids often secrete **histamine**, leading to an atypical, often localized, flushing pattern, sometimes associated with specific dietary triggers.- This tumor site is less likely to produce the severe, systemic diarrhea and bronchospasm characteristic of a midgut serotonin-secreting tumor.*Colon*- Neuroendocrine tumors of the hindgut (colon and rectum), especially those in the rectum, rarely produce sufficient serotonin to cause the classic syndrome.- When colonic NETs do metastasize, they often present with local symptoms before generalized systemic signs of carcinoid syndrome appear.

Question 11: A 47-year-old woman presents with recurrent episodes of severe right upper quadrant pain after fatty meals. The pain radiates to her right shoulder. What is the most likely diagnosis?

A. Peptic ulcer disease
B. Acute pancreatitis
C. Biliary colic (Correct Answer)
D. Appendicitis
E. Gastroenteritis

Explanation: ***Biliary colic*** - This pain pattern, defined as recurrent **severe right upper quadrant pain** occurring post-prandially (especially after fatty meals), is the hallmark of symptomatic **cholelithiasis** (gallstones). - Pain radiation to the **right shoulder** or back (due to irritation of the **diaphragm** via the phrenic nerve) is characteristic of biliary pathology. *Peptic ulcer disease* - Pain is typically localized to the epigastrium and described as gnawing or burning, often related to the timing of meals but not specifically triggered episodically by fatty foods. - Radiation to the right shoulder is uncommon, and the primary complaint often includes symptoms like dyspepsia or early satiety. *Acute pancreatitis* - Characterized by severe, constant **epigastric pain** that typically radiates straight through to the back, rather than the right shoulder. - Pancreatitis pain is usually sustained, lasting days, and associated with elevated **lipase** and **amylase**, not short-lived episodes like colic. *Appendicitis* - Classically presents with periumbilical pain migrating to the **right lower quadrant (RLQ)**, sometimes associated with fever and leukocytosis. - **Right upper quadrant (RUQ)** pain radiating to the shoulder is not consistent with the clinical picture of acute appendicitis. *Gastroenteritis* - Presents with generalized abdominal cramping, vomiting, and diarrhea, typically indicative of an infectious process. - It does not cause the severe, localized **RUQ pain** precisely triggered by fatty meal consumption described in this patient.

Question 12: A 39-year-old woman presents with recurrent episodes of severe abdominal pain and nausea. Her urine turns dark during attacks. She has a family history of similar symptoms. What should be avoided?

A. Carbohydrates
B. Barbiturates (Correct Answer)
C. Antibiotics
D. Analgesia
E. IV fluids

Explanation: ***Barbiturates*** - **Barbiturates** are potent inducers of hepatic **cytochrome P450 enzymes**, which significantly increase the synthesis of neurotoxic porphyrin precursors (like **ALA** and **PBG**). - This increased porphyrin synthesis precipitates acute neurovisceral attacks in **Acute Intermittent Porphyria (AIP)**, making barbiturates strictly contraindicated. *Carbohydrates* - High-dose intravenous **glucose** (a complex carbohydrate) is standard initial management for the acute attack, as it suppresses **hepatic ALA synthase** activity. - Avoiding carbohydrates or prolonged **fasting** actually reduces the suppression of porphyrin synthesis, thereby potentially precipitating or worsening an attack. *Antibiotics* - While specific antibiotics (like **sulfonamides** and **griseofulvin**) must be avoided, the entire class is not contraindicated if an infection is suspected or confirmed. - Clinicians utilize known **porphyria-safe** antibiotics to treat necessary infections without precipitating an attack. *Analgesia* - Severe **abdominal pain** is a cardinal feature of the acute porphyria attack, necessitating aggressive pain management, often requiring **opioids**. - Avoiding necessary analgesia is unethical and secondary to treatment; non-precipitating analgesics like fentanyl or morphine are generally used. *IV fluids* - **IV fluids** are essential supportive measures, necessary for managing severe vomiting, dehydration, and correcting potential **hyponatremia** (often due to SIADH) seen during acute attacks. - Maintaining hydration and electrolyte balance is vital for patient stabilization during an attack.

Question 13: A 48-year-old man presents with acute severe epigastric pain radiating to his back. CT shows pancreatic necrosis involving >60% of the gland. What is the most appropriate management?

A. Immediate surgery
B. Conservative management with IV fluids (Correct Answer)
C. Endoscopic necrosectomy
D. Percutaneous drainage
E. Total pancreatectomy

Explanation: ***Conservative management with IV fluids***- This is the cornerstone of initial management for severe acute pancreatitis, even when extensive necrosis (>60%) is present, as most necrosis is **sterile** initially.- Initial care focuses on aggressive **intravenous fluid resuscitation** to maintain vital organ perfusion, manage pain, and provide nutritional support. *Immediate surgery*- Early surgical debridement (within the first few weeks) for acute necrotizing pancreatitis dramatically increases **morbidity and mortality** and is generally contraindicated.- Surgery is reserved for patients with suspected or proven **infected necrosis** who fail to improve after 4 or more weeks of conservative management (the step-up approach). *Endoscopic necrosectomy*- This technique is part of the preferred **step-up approach** for managing **walled-off pancreatic necrosis (WOPN)**, generally weeks after the initial presentation.- It is an interventional management option, not the initial acute step, and is primarily indicated for symptomatic or infected collections. *Percutaneous drainage*- **Percutaneous drainage** is typically the initial intervention used within the minimally invasive (step-up) management of *infected* necrosis or fluid collections.- Like necrosectomy, it is performed later in the disease course, often after the first 3-4 weeks, and is not the appropriate **initial management** upon presentation. *Total pancreatectomy*- Total pancreatectomy is considered only in dire, localized circumstances, such as uncontrollable hemorrhage or failure of all other management strategies (medical and interventional).- This aggressive surgery results in permanent **diabetes mellitus** and exocrine insufficiency, making it an unacceptable choice for initial treatment.

Question 14: A 64-year-old man presents with painless jaundice and weight loss. CT shows a mass in the head of pancreas. CA 19-9 is markedly elevated. What is the most likely diagnosis?

A. Chronic pancreatitis
B. Pancreatic adenocarcinoma (Correct Answer)
C. Choledocholithiasis
D. Ampullary carcinoma
E. Cholangiocarcinoma

Explanation: ***Pancreatic adenocarcinoma*** - The combination of **painless jaundice**, significant **weight loss**, and a **mass in the head of the pancreas** on CT is highly indicative of pancreatic adenocarcinoma. - A markedly elevated **CA 19-9** level serves as a strong tumor marker, further supporting this diagnosis. *Chronic pancreatitis* - Typically presents with recurrent or chronic **epigastric pain** that often radiates to the back, not primarily painless jaundice. - Imaging usually shows pancreatic atrophy, calcifications, or ductal changes, rather than a discrete solid mass, and CA 19-9 elevation is not usually as dramatic. *Choledocholithiasis* - Jaundice caused by gallstones often presents with **biliary colic** (pain) and may be intermittent, unlike the painless and progressive jaundice seen here. - Imaging would demonstrate **gallstones** within the bile duct, not a solid mass within the pancreatic head. *Ampullary carcinoma* - While also causing obstructive jaundice and weight loss, ampullary carcinomas frequently cause **intermittent jaundice** due to tumor sloughing and bleeding, which is not described here. - Although located in the periampullary region, the description of a mass

Question 15: A 55-year-old woman presents with progressive dysphagia and weight loss. She has a history of Barrett's esophagus. Upper endoscopy shows a stricturing lesion. What is the most likely diagnosis?

A. Benign peptic stricture
B. Esophageal adenocarcinoma (Correct Answer)
C. Achalasia
D. Eosinophilic esophagitis
E. Candida esophagitis

Explanation: ***Esophageal adenocarcinoma***- The combination of **progressive dysphagia**, **weight loss** (alarm features), and a known history of **Barrett's esophagus** makes adenocarcinoma the most likely diagnosis, as Barrett's is the strongest predisposing factor for this cancer type.- Adenocarcinoma typically arises in the **distal esophagus** and presents as a stricturing, friable, or mass lesion upon endoscopic examination.*Benign peptic stricture*- A benign peptic stricture causes dysphagia but is typically associated with a history of severe GERD without documented high-grade dysplasia, and generally lacks the rapid progression and **weight loss** seen in malignancy.- These lesions are usually managed by dilation and acid suppression, but the strong cancer risk factor (Barrett's) mandates treating a stricture as malignant until proven otherwise.*Achalasia*- Achalasia involves loss of peristalsis and failure of the **lower esophageal sphincter (LES)** to relax, typically causing dysphagia to both solids and liquids and often significant regurgitation.- While it can cause stricture-like symptoms, the underlying pathology is neurological, and endoscopy would usually show a dilated esophagus with a tight LES, not a typical focal mass/stricture consistent with malignancy.*Eosinophilic esophagitis*- This condition often presents in younger patients, particularly those with **atopy** (allergies), and causes sudden solid-food dysphagia or food impactions.- Endoscopy usually reveals linear furrowing, **concentric rings** (feline esophagus), or mucosal fragility, not a typical discrete stricturing mass suggestive of aggressive malignancy.*Candida esophagitis*- This infection usually occurs in **immunocompromised** hosts (e.g., uncontrolled diabetes, HIV) and presents predominantly with **odynophagia** (painful swallowing).- Endoscopy reveals characteristic **white/yellow plaques** adherent to the mucosa, rather than the focal, stricturing mass lesion seen in this patient.

Question 16: A 54-year-old man presents with progressive dysphagia and weight loss. Barium swallow shows a smooth, tapered narrowing at the gastroesophageal junction. Manometry confirms absent peristalsis. What is the most likely diagnosis?

A. Esophageal carcinoma
B. Achalasia (Correct Answer)
C. Esophageal stricture
D. Diffuse esophageal spasm
E. Scleroderma

Explanation: ***Achalasia*** - The classic finding of a smooth, tapered narrowing at the **gastroesophageal junction** on barium swallow, commonly known as the **"bird's beak"** sign, is highly characteristic. - Manometry confirming **absent peristalsis** in the esophageal body, combined with failure of the Lower Esophageal Sphincter (LES) to fully relax, is diagnostic for this primary esophageal motility disorder. *Esophageal carcinoma* - While it causes progressive dysphagia and weight loss, barium swallow typically shows an **abrupt, irregular filling deficit** or a shelf-like narrowing, not a smooth taper. - Carcinoma causes a structural stricture, whereas achalasia is a functional disorder; manometry findings would not involve absent body peristalsis. *Esophageal stricture* - Strictures, often peptic, result in a smooth, short-segment narrowing, but the diagnosis is purely anatomical, and esophageal **peristalsis is usually preserved** above the stricture. - Strictures do not typically cause the characteristic **non-relaxing, functional obstruction** seen at the true GE junction in achalasia. *Diffuse esophageal spasm* - This disorder is defined by simultaneous, **high-amplitude contractions** on manometry, not absent peristalsis. - The barium swallow often reveals a **"corkscrew" esophagus** appearance due to irregular tertiary contractions, which is visually distinct from the smooth achalasia narrowing. *Scleroderma* - Scleroderma causes destruction and **atrophy of the smooth muscle** in the distal esophagus, leading to a **hypotensive (weak) LES**. - Manometry would show low LES pressure and absent distal peristalsis, distinct from the typically **hypertensive** and non-relaxing LES seen in achalasia.

Question 17: A 35-year-old man presents with recurrent episodes of severe epigastric pain radiating to his back, associated with nausea and vomiting. He drinks 60 units of alcohol per week. CT abdomen shows pancreatic calcification and pseudocyst formation. What is the most likely diagnosis?

A. Acute pancreatitis
B. Chronic pancreatitis (Correct Answer)
C. Pancreatic carcinoma
D. Peptic ulcer disease
E. Biliary colic

Explanation: ***Chronic pancreatitis*** - The presence of **pancreatic calcification** and **pseudocyst formation** on CT imaging confirms progressive, irreversible pancreatic damage, which is characteristic of chronic pancreatitis. - Recurrent, severe epigastric pain radiating to the back, combined with a history of **heavy chronic alcohol use**, is the typical clinical presentation of this condition. *Acute pancreatitis* - Acute pancreatitis is characterized by its first episode or an acute flare, but it does not inherently involve the structural changes seen here (calcification or pseudocyst). - Diagnosis of chronic pancreatitis is made over acute when imaging shows **irreversible parenchymal damage** like atrophy or calcification. *Pancreatic carcinoma* - Pancreatic carcinoma is less likely to present with recurrent, self-limiting episodes and calcification; it typically manifests as progressive, **unexplained weight loss** and often **painless jaundice**. - While chronic pancreatitis is a risk factor, the imaging findings here are classical for the inflammatory process itself, not necessarily malignancy. *Peptic ulcer disease* - Peptic ulcer disease pain is usually described as **burning** or gnawing and may show temporal association with eating; it does not typically radiate severely to the back. - This condition would not cause **pancreatic calcification** or pseudocyst formation visible on CT. *Biliary colic* - Biliary colic refers to intermittent pain, usually in the **right upper quadrant** (RUQ), caused by temporary cystic duct obstruction, and is typically postprandial. - It is not associated with heavy chronic alcohol use and the specific **pancreatic findings** described in this patient.

Question 18: A 65-year-old man presents with progressive dysphagia to solids over 2 months and 10kg weight loss. He has a 40-year history of heartburn. Endoscopy shows a stricturing lesion in the lower esophagus. What is the most likely diagnosis?

A. Benign esophageal stricture
B. Esophageal adenocarcinoma (Correct Answer)
C. Esophageal squamous cell carcinoma
D. Achalasia
E. Eosinophilic esophagitis

Explanation: ***Esophageal adenocarcinoma***- The patient's long history of **heartburn (GERD)** predisposes him to **Barrett's esophagus**, which is the precursor to adenocarcinoma, typically arising in the **lower esophagus**.- **Progressive dysphagia to solids** over a short duration (2 months), coupled with significant **weight loss** (10kg), are classic red flag symptoms for advanced esophageal malignancy.*Benign esophageal stricture*- While benign strictures result from chronic **acid reflux** and cause dysphagia, they usually present insidiously without the rapid, considerable **weight loss** characteristic of cancer.- Endoscopy would likely reveal a smooth, symmetric narrowing, which is less suspicious than a rapidly progressive, stricturing **lesion** suggesting malignancy.*Esophageal squamous cell carcinoma*- This cancer type is strongly linked to **smoking** and **alcohol use** (etiologies not emphasized here) and typically affects the **middle or upper esophagus**.- Given the history of GERD and the location in the lower esophagus, adenocarcinoma is the much more probable diagnosis.*Achalasia*- Achalasia causes disordered motility leading to dysphagia for **both solids and liquids** simultaneously, which differentiates it from the solid-only dysphagia of a stricture.- It involves failure of the **lower esophageal sphincter (LES)** relaxation, typically showing proximal dilation rather than a discrete, rapidly progressing stricturing lesion seen in malignancy.*Eosinophilic esophagitis*- This condition primarily affects **younger adults** and commonly presents with intermittent dysphagia or food impactions, not rapid, severe **weight loss** in an elderly patient.- Endoscopy would typically show vertical **furrows** or **multiple rings**, and biopsies would show eosinophilic infiltration, not a stricturing lesion indicative of malignancy.

Question 19: A 25-year-old man presents with bloody diarrhea, abdominal pain, and weight loss over 3 months. Colonoscopy shows skip lesions with deep ulceration and cobblestone appearance. Histology shows transmural inflammation with granulomas. What is the most likely diagnosis?

A. Ulcerative colitis
B. Crohn's disease (Correct Answer)
C. Infectious colitis
D. Ischemic colitis
E. Radiation colitis

Explanation: ***Crohn's disease***- The core presentation—chronic bloody diarrhea, abdominal pain, and weight loss—combined with the specific findings of **skip lesions**, **deep ulceration**, and **cobblestone appearance** on colonoscopy, is highly characteristic.- Histologically, the presence of **transmural inflammation** (affecting all layers of the bowel wall) and **non-caseating granulomas** confirms the diagnosis of Crohn's disease.*Ulcerative colitis*- UC causes continuous inflammation confined to the **mucosa** and superficial submucosa, contrasting sharply with the transmural involvement seen in this patient.- UC typically lacks both **skip lesions** and the characteristic **granulomas** seen in Crohn's disease.*Infectious colitis*- Infectious colitis is typically an **acute** process; a presentation lasting 3 months suggests a chronic condition like IBD.- While some infections can cause chronic symptoms, the specific endoscopic findings of **skip lesions** and the histological finding of **granulomas** rule against a typical infectious etiology.*Ischemic colitis*- Ischemic colitis is generally seen in older patients with vascular risk factors and presents acutely with sudden pain and bloody stools.- It primarily affects the **mucosa** and **submucosa** but does not feature the **granulomas** or chronic **cobblestone appearance** seen here.*Radiation colitis*- This type of colitis is limited to patients with a history of radiation therapy and presents with ulceration and atrophy related to the **radiation field**.- It lacks the diffuse distribution, **skip lesions**, and **granulomas** that define Crohn's disease.

Question 20: A 50-year-old man presents with progressive dysphagia to both solids and liquids, chest pain, and regurgitation of undigested food. Barium swallow shows a dilated esophagus with smooth tapering at the gastroesophageal junction ("bird's beak" appearance). What is the most likely diagnosis?

A. Esophageal carcinoma
B. Achalasia (Correct Answer)
C. Esophageal stricture
D. GERD
E. Esophageal spasm

Explanation: ***Achalasia***- The classic presentation includes progressive dysphagia to **both solids and liquids**, chest pain, and regurgitation of undigested food, indicating a motility disorder.- The barium swallow finding of a **dilated esophagus** with smooth tapering at the **gastroesophageal junction** (the "**bird's beak**" appearance) is pathognomonic, resulting from impaired relaxation of the **lower esophageal sphincter** and absent esophageal **peristalsis**.*Esophageal carcinoma*- Dysphagia in esophageal carcinoma typically begins with **solids** and progresses later to include liquids, unlike the simultaneous dysphagia seen here.- Barium swallow would usually show an **irregular, constricting lesion** or a shelf-like defect, rather than a smooth, symmetric tapering.*Esophageal stricture*- While esophageal strictures cause dysphagia, it is predominantly to **solids** and tends to be more consistent rather than the progressive nature to both solids and liquids.- Barium swallow would show a **focal narrowing** with proximal dilation, but typically not the classic smooth "bird's beak" tapering seen in achalasia.*GERD*- Gastroesophageal reflux disease (GERD) primarily presents with **heartburn** and acid regurgitation, with dysphagia being a less common or secondary symptom, often due to esophagitis or stricture.- Barium swallow may show reflux or a **peptic stricture**, but not the diffuse esophageal dilation or the characteristic smooth "bird's beak" appearance of achalasia.*Esophageal spasm*- Esophageal spasm typically causes **intermittent chest pain** and dysphagia to both solids and liquids, but symptoms are often unpredictable and not consistently progressive.- Barium swallow in esophageal spasm might show a **"corkscrew" esophagus** or uncoordinated contractions, which differs from the persistent dilation and smooth tapering of achalasia.

Question 21: A 35-year-old woman presents with recurrent episodes of severe abdominal pain, nausea, and vomiting. The pain is in the right upper quadrant and radiates to the right shoulder. Episodes last 2-3 hours and often occur after fatty meals. What is the most likely diagnosis?

A. Peptic ulcer disease
B. Acute pancreatitis
C. Biliary colic (Correct Answer)
D. Appendicitis
E. Gastroenteritis

Explanation: ***Biliary colic***- The presentation of recurrent, severe spasmodic pain in the **right upper quadrant (RUQ)** that radiates to the **right shoulder** is highly characteristic of biliary colic.- The pain, which is short-lived (2-3 hours) and often precipitated by **fatty meals** (triggering gallbladder contraction), indicates temporary obstruction of the cystic duct by a gallstone.*Peptic ulcer disease*- Pain is typically dull, gnawing, or burning, located in the **epigastrium**, and often associated with meal timing (relief or worsening, depending on the ulcer location).- PUD rarely presents with acute, intermittent, severe RUQ pain radiating to the shoulder.*Acute pancreatitis*- Pain is characteristically severe, constant, located in the **epigastrium**, and often radiates straight through to the **back**.- This condition causes severe, sustained inflammation, not the intermittent, 2-3 hour episodes typical of colic.*Appendicitis*- Pain classically starts as periumbilical discomfort before localizing to the **right lower quadrant (RLQ)** (McBurney's point).- The pain is usually constant, rapidly escalating, and is not intermittent or triggered by food ingestion.*Gastroenteritis*- Symptoms typically involve diffuse abdominal cramping, significant **diarrhea**, and generalized vomiting.- Gastroenteritis does not cause localized, severe, recurrent RUQ pain triggered consistently by fatty meals.

Question 22: A 55-year-old man presents with progressive jaundice, weight loss, and epigastric pain radiating to his back. On examination, he has a palpable gallbladder. CA 19-9 is markedly elevated. What is the most likely diagnosis?

A. Cholangiocarcinoma
B. Pancreatic carcinoma (Correct Answer)
C. Choledocholithiasis
D. Chronic pancreatitis
E. Hepatocellular carcinoma

Explanation: ***Pancreatic carcinoma***- This presentation, including progressive **jaundice**, weight loss, and epigastric pain radiating to the back, is the classic triad for **pancreatic head adenocarcinoma**.- The presence of a palpable, non-tender gallbladder (**Courvoisier's sign**) is highly indicative of malignant obstruction of the distal common bile duct, usually caused by pancreatic cancer, supported by the marked elevation of **CA 19-9** (tumor marker).*Cholangiocarcinoma*- While cholangiocarcinoma causes obstructive **jaundice** and elevated CA 19-9, it rarely causes the classic epigastric pain radiating to the back characteristic of a pancreatic mass.- These tumors usually originate within the bile ducts (perihilar or distal), often lacking associated features like the distinctive **Courvoisier's sign** seen with pancreatic head masses.*Choledocholithiasis*- This typically causes intermittent, severe colicky pain (**biliary colic**) rather than progressive, painless jaundice or constant back-radiating pain.- Obstruction due to gallstones does not usually lead to the marked elevation of a tumor marker like **CA 19-9** or the significant **weight loss** associated with malignancy.*Chronic pancreatitis*- Chronic pancreatitis causes significant, recurrent **epigastric pain** that often radiates to the back and is associated with malabsorption and weight loss.- However, it less commonly presents solely with progressive, textbook obstructive **jaundice** and a palpable gallbladder (**Courvoisier's sign**).*Hepatocellular carcinoma*- HCC typically presents in a patient with underlying **cirrhosis** and involves direct liver mass effects, often causing portal hypertension or signs of liver failure.- While it causes weight loss, **CA 19-9** is not the primary tumor marker; **AFP** (alpha-fetoprotein) is the key marker, and the presenting features do not specifically localize the pathology to the pancreas/bile duct outflow tract.

Question 23: A 22-year-old woman presents with a 6-month history of abdominal pain, diarrhea with blood and mucus, and weight loss. Colonoscopy shows continuous inflammation from rectum to sigmoid colon with ulceration. What is the most likely diagnosis?

A. Crohn's disease
B. Ulcerative colitis (Correct Answer)
C. Irritable bowel syndrome
D. Infectious colitis
E. Colorectal cancer

Explanation: ***Ulcerative colitis***- The presentation of chronic abdominal pain, diarrhea with **blood and mucus**, weight loss, and colonoscopy findings of **continuous inflammation** from the **rectum** to the sigmoid colon with ulceration is highly characteristic of **ulcerative colitis** (UC).- UC inflammation is typically limited to the **mucosa** and **submucosa**, spreads proximally in a **confluent** manner, and commonly presents with **tenesmus** and bloody stools.*Crohn's disease*- Crohn's disease is characterized by inflammation that is **transmural** (full-thickness) and typically involves **skip lesions** (discontinuous areas of affected and unaffected tissue).- While it can cause abdominal pain and bloody diarrhea, it often affects the **terminal ileum** and colon, and is associated with **fistulas**, strictures, and **perianal disease**, which are not described.*Irritable bowel syndrome*- IBS is a functional disorder that causes chronic abdominal pain and altered bowel habits without any demonstrable **structural abnormalities** or inflammation.- It does not cause features such as **grossly bloody stools**, significant **weight loss**, or **ulceration** visible on colonoscopy.*Infectious colitis*- Infectious colitis is usually **acute** in onset, often accompanied by systemic symptoms like fever, and typically resolves spontaneously or with short-term treatment.- The patient's **6-month history** of symptoms points toward a chronic inflammatory process, making acute infectious colitis highly unlikely.*Colorectal cancer*- While colorectal cancer can cause blood in stool and weight loss, it is extremely rare in a **22-year-old** without known predisposing factors.- Colonoscopy would typically reveal a localized **mass** or **polypoid lesion**, not the diffuse, continuous inflammatory pattern observed here.

Question 24: A 50-year-old man presents with acute severe epigastric pain radiating to his back, nausea, and vomiting. His serum amylase is 1200 U/L (normal <100). He drinks 40 units of alcohol per week. What is the most likely diagnosis?

A. Peptic ulcer disease
B. Acute cholangitis
C. Acute pancreatitis (Correct Answer)
D. Myocardial infarction
E. Aortic dissection

Explanation: ***Acute pancreatitis***- The combination of acute, severe **epigastric pain radiating to the back**, along with nausea and vomiting, is the classic presentation of acute pancreatitis.- The extremely high serum amylase (1200 U/L, more than three times the upper limit of normal), coupled with a history of significant **alcohol intake**, strongly confirms this diagnosis.*Peptic ulcer disease*- PUD pain is typically described as **burning** or gnawing; while it can present with severe pain (if perforated), it is usually not associated with such marked hyperamylasemia.- Perforation leading to severe pain causes signs of **peritonitis** (rigid abdomen) and often requires imaging confirmation, whereas amylase is usually a robust marker for pancreatitis.*Acute cholangitis*- Acute cholangitis requires features of biliary obstruction and infection, typically presenting as Charcot's triad (**fever**, **jaundice**, and right upper quadrant pain).- While amylase may be mildly elevated in cholangitis due to periampullary inflammation, it rarely reaches this degree (1200 U/L) in the absence of primary pancreatitis.*Myocardial infarction*- An **inferior wall myocardial infarction** (MI) can mimic gastrointestinal pathology, causing nausea and epigastric pain.- However, an MI is diagnosed by **ECG changes** and elevated **cardiac troponins**, and would not explain the dramatically elevated serum amylase.*Aortic dissection*- Aortic dissection causes sudden, excruciating **tearing** or **ripping** pain, often in the chest and back, and is associated with pulse differentials and hypotension.- This condition does not involve the pancreas and thus would not cause severe elevation of pancreatic enzymes like amylase.

Question 25: A 70-year-old man presents with progressive dysphagia to solids over 2 months, associated with weight loss of 8kg. He has a history of heartburn for many years. What is the most appropriate investigation?

A. Barium swallow
B. CT chest and abdomen
C. Upper GI endoscopy (Correct Answer)
D. PET scan
E. 24-hour pH monitoring

Explanation: ***Upper GI endoscopy*** - This patient presents with **alarm features** for esophageal malignancy, including new-onset progressive **dysphagia to solids**, **significant weight loss**, and a long history of **heartburn** (increasing risk for Barrett's esophagus and adenocarcinoma). - **Upper GI endoscopy** with **biopsy** is the **gold standard** for directly visualizing the esophageal lumen, identifying any lesions or strictures, and obtaining tissue for histological diagnosis. *Barium swallow* - While a **barium swallow** can identify structural abnormalities like strictures or masses, it is an indirect imaging study that cannot differentiate benign from malignant causes. - It also does not allow for **biopsy**, which is crucial for definitive diagnosis in a patient with **alarm symptoms** suggesting malignancy. *CT chest and abdomen* - A **CT scan** is primarily a **staging investigation** to assess for local invasion or distant metastasis once a diagnosis of esophageal cancer has been made or strongly suspected. - It is not the initial diagnostic test to identify the primary lesion and obtain a **histological diagnosis**. *PET scan* - A **PET scan** is mainly used for **staging** and detecting metastatic disease in patients with known or highly suspected malignancy. - It is not the appropriate first-line investigation for the **initial diagnosis** of the cause of dysphagia with alarm features. *24-hour pH monitoring* - **24-hour pH monitoring** is used to diagnose or quantify **gastroesophageal reflux disease (GERD)** by measuring esophageal acid exposure. - It is not indicated for investigating new-onset dysphagia with **alarm features** like weight loss and progressive dysphagia, which strongly suggest a **mechanical obstruction**, likely malignant, requiring direct visualization.

Question 26: A 45-year-old woman presents with a 3-month history of abdominal pain, bloating, and alternating diarrhea and constipation. Colonoscopy and inflammatory markers are normal. What is the most likely diagnosis?

A. Inflammatory bowel disease
B. Irritable bowel syndrome (Correct Answer)
C. Colorectal cancer
D. Celiac disease
E. Thyroid dysfunction

Explanation: ***Irritable bowel syndrome***- The constellation of **chronic abdominal pain**, **bloating**, and **alternating diarrhea and constipation** over 3 months is classic for IBS. - A **normal colonoscopy** and **normal inflammatory markers** are key diagnostic criteria, as IBS is a **functional gastrointestinal disorder** without structural abnormalities or inflammation.*Inflammatory bowel disease*- IBD is characterized by **chronic inflammation** of the gastrointestinal tract, which would present with abnormal findings on colonoscopy (e.g., ulcers, strictures) and elevated inflammatory markers like CRP or ESR.- While symptoms can overlap, the **normal colonoscopy** and **inflammatory markers** effectively rule out IBD in this case.*Colorectal cancer*- Although possible at this age, **colorectal cancer** would typically be detected during colonoscopy as a **polyp or mass**.- Other common symptoms include **rectal bleeding**, unexplained **weight loss**, or **anemia**, which are not mentioned here.*Celiac disease*- Celiac disease is an **autoimmune reaction to gluten** causing small intestinal damage, usually manifesting as diarrhea, bloating, and malabsorption.- A normal colonoscopy does not specifically exclude celiac disease (which affects the small bowel), but without specific mention of gluten-related symptoms or serological testing, it's less likely to be the primary diagnosis given the typical IBS presentation.*Thyroid dysfunction*- Thyroid disorders can affect bowel motility (e.g., **constipation in hypothyroidism**, diarrhea in hyperthyroidism), but they typically involve a broader range of **systemic symptoms**.- The primary presentation of **abdominal pain and bloating** with alternating bowel habits points more specifically to a gastrointestinal functional disorder rather than an endocrine cause.

Question 27: A 55-year-old man with a history of atrial fibrillation presents with sudden onset severe abdominal pain and bloody diarrhea. His CHA₂DS₂-VASc score is 3, but he stopped taking warfarin 3 months ago. What is the most likely diagnosis?

A. Inflammatory bowel disease
B. Ischemic colitis
C. Mesenteric ischemia (Correct Answer)
D. Diverticulitis
E. Colorectal cancer

Explanation: ***Mesenteric ischemia***- The combination of **atrial fibrillation** (a strong source of emboli), cessation of anticoagulation, and the sudden onset of **severe, disproportionate abdominal pain** followed by **bloody diarrhea** is the classic presentation of acute **mesenteric ischemia** secondary to arterial embolism.- Embolic occlusion of the Superior Mesenteric Artery (SMA) leads to widespread bowel infarction and mucosal sloughing, causing the catastrophic pain and subsequent bloody stools.*Inflammatory bowel disease*- This is characterized by chronic or relapsing symptoms (e.g., chronic diarrhea, abdominal cramping, weight loss), not the acute, sudden-onset catastrophic presentation seen here.- The strong risk factor (untreated **atrial fibrillation**) makes an acute vascular etiology far more probable than a new presentation of IBD.*Ischemic colitis*- **Ischemic colitis** typically causes less severe, intermittent, cramping pain, usually localized to the left side or watershed areas (e.g., splenic flexure, rectosigmoid junction).- While it causes bloody diarrhea (hematochezia), it does not usually cause the severe, diffuse, rapid-onset pain and profound systemic illness associated with major vessel occlusion in acute **mesenteric ischemia**. *Diverticulitis*- Diverticulitis typically presents with localized abdominal pain (most commonly **left lower quadrant**), fever, and leukocytosis, often without prominent bloody diarrhea.- The pain is usually localized rather than the diffuse, severe pain characteristic of acute widespread **mesenteric ischemia**. *Colorectal cancer*- Colorectal cancer symptoms are typically insidious, involving changes in bowel habits, chronic occult or low-volume bleeding, and weight loss.- Acute presentation as sudden, severe abdominal pain and bloody diarrhea is rare unless complicated by perforation or acute obstruction, which would present differently than this presumed vascular event.

Question 28: A 54-year-old man presents with sudden onset severe epigastric pain radiating to his back, nausea, and vomiting. His serum amylase is 1200 U/L (normal <100). He drinks 40 units of alcohol per week. What is the most likely diagnosis?

A. Peptic ulcer disease
B. Acute cholangitis
C. Acute pancreatitis (Correct Answer)
D. Myocardial infarction
E. Aortic dissection

Explanation: ***Acute pancreatitis*** - The sudden onset of severe **epigastric pain radiating to the back**, accompanied by nausea, vomiting, and a markedly elevated **serum amylase** (1200 U/L, >3x normal), is highly indicative of acute pancreatitis. - The patient's history of heavy **alcohol consumption** (40 units/week) is a significant and common risk factor for developing acute pancreatitis. *Peptic ulcer disease* - While causing epigastric pain, peptic ulcer disease typically does not present with such a dramatic elevation in **serum amylase** or the characteristic back radiation of pain. - A perforated ulcer would cause diffuse, severe abdominal pain and **peritoneal signs** (e.g., rigidity), not primarily isolated back pain with hyperamylasemia. *Acute cholangitis* - Acute cholangitis presents with **Charcot's triad** of fever, **jaundice**, and right upper quadrant pain, none of which are mentioned in this clinical picture. - Lab abnormalities in cholangitis predominantly involve elevated **bilirubin** and **alkaline phosphatase**, rather than a significant rise in amylase. *Myocardial infarction* - Although an inferior wall myocardial infarction can cause epigastric discomfort, it would not explain the high **serum amylase** level or the specific radiation of pain to the back in this context. - Diagnosis of MI relies on **cardiac biomarkers** (e.g., troponins) and characteristic **ECG changes**, which are not provided. *Aortic dissection* - Aortic dissection presents with sudden, severe, often **tearing** or **ripping** pain in the chest or back, but it does not cause the specific elevation of **serum amylase** observed here. - It is typically associated with risk factors like **hypertension** and may present with pulse deficits or neurological deficits.

Question 29: A 48-year-old woman presents with recurrent episodes of severe abdominal pain, nausea, and vomiting. The pain is in the right upper quadrant and radiates to the right shoulder. Episodes last 2-3 hours and often occur after fatty meals. What is the most likely diagnosis?

A. Peptic ulcer disease
B. Acute pancreatitis
C. Biliary colic (Correct Answer)
D. Appendicitis
E. Gastroenteritis

Explanation: ***Biliary colic***- The classic presentation involves **severe, intermittent pain** (colic) in the **right upper quadrant (RUQ)** or epigastrium.- Pain commonly **radiates to the right shoulder or back** and is often precipitated by **fatty meals** as it stimulates gallbladder contraction against a transiently impacted gallstone.*Peptic ulcer disease*- Pain is typically described as a **burning or gnawing sensation** in the epigastrium, often related to *meal timing* but rarely presents as severe, short, radiating episodes.- While ulcers can cause nausea and vomiting, the pattern of severe, radiating pain after fatty meals strongly differentiates it from **Peptic ulcer disease**.*Acute pancreatitis*- Pain is usually **epigastric**, severe, constant, and classically **radiates to the back**, often relieved by leaning forward.- It is nearly always associated with significantly elevated serum **amylase and lipase**, and the pain does not typically resolve completely within a few hours.*Appendicitis*- Typically presents with pain migrating from the **periumbilical region to the right lower quadrant (RLQ)**.- This condition is characterized by a constant progression of pain and signs of systemic illness (**fever**, leukocytosis), not recurrent, short-duration RUQ episodes.*Gastroenteritis*- Usually involves diffuse or crampy **abdominal pain** accompanied by **diarrhea** and vomiting, often lasting days.- Unlike biliary colic, the pain is not localized strictly to the RUQ, does not radiate to the shoulder, and is not specifically linked to the ingestion of **fatty meals**.

Question 30: A 55-year-old man presents with progressive dysphagia and weight loss over 2 months. Upper endoscopy shows a stricturing lesion in the mid-esophagus. He has a history of caustic ingestion 20 years ago. What is the most likely diagnosis?

A. Esophageal adenocarcinoma
B. Esophageal squamous cell carcinoma (Correct Answer)
C. Benign stricture
D. Achalasia
E. Eosinophilic esophagitis

Explanation: ***Esophageal squamous cell carcinoma*** - This diagnosis is strongly linked to a history of **caustic ingestion**, which induces chronic inflammation and predisposes to **malignant transformation** many years later. The **progressive dysphagia** and **weight loss** are classic signs of malignancy. - ESCC typically arises in the **mid and upper thirds** of the esophagus, consistent with the stricturing lesion observed in the mid-esophagus. *Esophageal adenocarcinoma* - This type of cancer is predominantly associated with **Barrett's esophagus**, a metaplastic change due to chronic **gastroesophageal reflux disease (GERD)**. - Adenocarcinoma typically affects the **distal esophagus** and gastroesophageal junction, not the mid-esophagus, and its risk factors do not include caustic injury. *Benign stricture* - While caustic ingestion causes benign strictures, the **rapid progression** of dysphagia and significant **weight loss** over a mere two months are highly suspicious for a malignant process. - Benign strictures typically cause symptoms that are **slowly progressive** over years, not months, and significant weight loss is less common. *Achalasia* - This is a primary motility disorder characterized by impaired relaxation of the **lower esophageal sphincter (LES)** and absence of esophageal peristalsis. - Endoscopically, achalasia presents with a **dilated esophagus** tapering to a

Question 31: A 28-year-old woman presents with recurrent episodes of severe abdominal pain, nausea, and confusion. During episodes, her urine turns dark red. Family history reveals similar episodes in her father. What is the most likely diagnosis?

A. Acute intermittent porphyria (Correct Answer)
B. Hereditary coproporphyria
C. Variegate porphyria
D. Erythropoietic protoporphyria
E. Congenital erythropoietic porphyria

Explanation: ***Acute intermittent porphyria*** - The presentation of recurrent **severe abdominal pain**, nausea, and **neuropsychiatric symptoms** (confusion) is the classic triad of an acute hepatic porphyria attack (AIP, HCP, or VP). - The key finding of urine turning **dark red** due to the presence of oxidized **porphobilinogen (PBG)**, coupled with the lack of cutaneous symptoms, makes AIP the most likely diagnosis. *Hereditary coproporphyria* - While this can cause identical acute neuro-visceral attacks, it often also causes **cutaneous photosensitivity** (skin blistering and fragility), which is not described in this patient. - Diagnosis relies on finding excessive **coproporphyrin** in both urine and feces, in addition to elevated ALA and PBG during an attack. *Variegate porphyria* - This porphyria virtually always presents with both **acute neuro-visceral attacks** and **chronic cutaneous photosensitivity** (blistering and scarring) simultaneously. - VP is characterized by high levels of **protoporphyrin** and **coproporphyrin** in the stool, caused by a defect in **protoporphyrinogen oxidase (PPOX)**. *Erythropoietic protoporphyria* - This porphyria presents only with **cutaneous symptoms**, specifically **painful, non-blistering photosensitivity** (burning and stinging) immediately upon sun exposure. - It is classified as an erythropoietic porphyria (affecting red blood cells) and does **not** cause the systemic neurological symptoms or dark urine seen in acute hepatic porphyrias. *Congenital erythropoietic porphyria* - This is a very rare and severe disorder typically presenting in infancy with profound, irreversible **blistering photosensitivity**, hemolysis, and the characteristic feature of **erythrodontia** (red or brown teeth). - The clinical course and onset are incompatible with the recurrent, adult-onset neuro-visceral attacks described in this patient.

Question 32: A 41-year-old man presents with recurrent episodes of severe epigastric pain radiating to his back. He drinks 60 units of alcohol per week. CT shows pancreatic calcification and pseudocyst formation. What is the most likely diagnosis?

A. Acute pancreatitis
B. Chronic pancreatitis (Correct Answer)
C. Pancreatic carcinoma
D. Peptic ulcer disease
E. Biliary colic

Explanation: ***Chronic pancreatitis***- Recurrent episodes of severe epigastric pain radiating to the back, combined with a history of **heavy alcohol use** (60 units/week), are classic features of chronic pancreatitis.- The CT findings of **pancreatic calcification** (indicating irreversible fibrosis and parenchymal damage) and **pseudocyst formation** are definitive diagnostic markers for chronic pancreatitis.*Acute pancreatitis*- Acute pancreatitis presents as a sudden, severe episode of pain, typically with significantly elevated **serum lipase** and amylase.- While recurrent acute episodes can occur, the presence of **pancreatic calcification** and pseudocysts on CT indicates irreversible structural changes, distinguishing it from a sole acute episode.*Pancreatic carcinoma*- Pancreatic carcinoma can cause abdominal pain, but it often presents with **painless jaundice**, significant **weight loss**, and new-onset diabetes.- The extensive history of alcohol abuse and the specific CT findings of diffuse **pancreatic calcification** are more characteristic of chronic pancreatitis than carcinoma.*Peptic ulcer disease*- Peptic ulcer disease pain is typically epigastric and may radiate, but it is less commonly described as severe pain radiating to the entire back and is often relieved by antacids or food.- It does not cause **pancreatic calcification** or **pseudocyst formation**, which are specific to pancreatic pathology.*Biliary colic*- Biliary colic presents as intermittent, severe **right upper quadrant** or epigastric pain, often triggered by fatty meals, and typically resolves within hours.- It is caused by gallstone obstruction and is not associated with the **pancreatic structural changes** like calcification or pseudocysts seen in this patient.

Question 33: A 48-year-old man presents with acute onset severe epigastric pain and vomiting. CT shows acute pancreatitis with pancreatic necrosis involving >50% of the gland. What is the most appropriate management?

A. Conservative management with IV fluids (Correct Answer)
B. Immediate surgical debridement
C. Endoscopic necrosectomy
D. Percutaneous drainage
E. Total pancreatectomy

Explanation: ***Conservative management with IV fluids***- Initial management for **severe acute pancreatitis** and sterile necrosis is always supportive, focusing on aggressive **intravenous fluid resuscitation**, pain control, and nutritional support.- Interventional management (surgical, endoscopic, or percutaneous) is typically reserved for complications like **infected necrosis** or patients failing conservative therapy after several weeks.*Immediate surgical debridement*- Immediate or early surgical debridement (traditionally **necrosectomy**) is associated with high mortality and is generally avoided in the acute phase, especially if the necrosis is sterile.- Surgical intervention is postponed, ideally for 3–4 weeks, to allow the necrotic tissue to **demarcate** (walled-off necrosis or WOPN).*Endoscopic necrosectomy*- This minimally invasive technique is preferred over surgery for debridement of **walled-off pancreatic necrosis (WOPN)**, but it is not indicated acutely.- It requires the necrosis to be mature and walled-off, usually at least 4 weeks after the initial attack.*Percutaneous drainage*- While an important step, percutaneous drainage is primarily used to manage **infected necrotizing pancreatitis** or draining symptomatic collections like pseudocysts or abscesses.- In the acute phase of sterile necrosis, drainage is usually unnecessary, and primary care remains supportive.*Total pancreatectomy*- This is a highly morbid procedure considered only as a **last resort** for uncontrollable complications such as overwhelming, refractory **infected necrosis** or severe hemorrhage.- It is unwarranted as an initial management strategy for acute necrotizing pancreatitis, even with extensive necrosis.

Question 34: A 38-year-old man presents with acute severe epigastric pain radiating to his back. He has a history of gallstones. Serum amylase is 1800 U/L. CT shows pancreatic inflammation with fluid collection. What is the most appropriate initial management?

A. Immediate surgery
B. ERCP
C. Conservative management with IV fluids (Correct Answer)
D. Percutaneous drainage
E. Antibiotics

Explanation: ***Conservative management with IV fluids***- Initial management for acute pancreatitis is universally **supportive**, focusing on aggressive **intravenous (IV) fluid resuscitation** to maintain pancreatic perfusion and correct third-spacing losses.- Pain control (usually opioids) and NPO status are essential components of this approach, especially in cases likely related to **biliary stone passage**.*Immediate surgery*- Surgery is **contraindicated** in the acute phase of pancreatitis unless there are specific, rare complications such as generalized peritonitis or hemorrhage.- Definitive treatment for gallstones (cholecystectomy) is typically planned *after* the acute inflammatory process has completely resolved.*ERCP*- ERCP (Endoscopic Retrograde Cholangiopancreatography) is indicated acutely only if there is evidence of concurrent **acute cholangitis** or persistent **biliary obstruction** (e.g., rising **bilirubin**).- Routine use of ERCP in stable, non-jaundiced patients with gallstone pancreatitis does not improve outcomes and may introduce risks.*Percutaneous drainage*- This procedure is reserved for managing later complications, such as symptomatic, persistent, or **infected pancreatic collections** (e.g., walled-off necrosis or pseudocysts).- It is not a component of the initial stabilization phase for acute pancreatitis.*Antibiotics*- Prophylactic antibiotics are **not recommended** in acute pancreatitis as they do not reduce overall mortality or the rate of infected necrosis.- Antibiotics should only be initiated when there is strong clinical suspicion or confirmation of **infected necrosis** or extrapancreatic infection.

Question 35: A 55-year-old woman presents with progressive dysphagia and weight loss over 3 months. She has a history of Barrett's esophagus. Upper endoscopy shows a stricturing lesion in the lower esophagus. What is the most likely diagnosis?

A. Benign peptic stricture
B. Esophageal adenocarcinoma (Correct Answer)
C. Achalasia
D. Eosinophilic esophagitis
E. Candida esophagitis

Explanation: ***Esophageal adenocarcinoma***- The patient's history of **Barrett's esophagus** is a well-established precursor to **esophageal adenocarcinoma**, particularly in the distal esophagus.- The presentation of **progressive dysphagia** and significant **weight loss** over a short period (3 months) is highly suggestive of an underlying malignancy. Upper endoscopy revealing a stricturing lesion further supports this diagnosis.*Benign peptic stricture*- While *benign peptic strictures* can cause dysphagia, they typically develop slowly over a longer period and are less likely to cause rapid, significant **weight loss**.- The presence of **Barrett's esophagus** significantly increases the risk of malignancy, making a benign cause less probable given the concerning clinical features.*Achalasia*- Achalasia is a primary esophageal motility disorder characterized by dysphagia to **both solids and liquids** due to impaired lower esophageal sphincter relaxation.- It is a chronic condition, usually with a longer duration of symptoms, and does not typically present with the rapid, unexplained **weight loss** seen with malignancy.*Eosinophilic esophagitis*- This condition usually affects younger patients with a history of **atopy** and presents with intermittent dysphagia, often with food impaction, rather than rapid progression and weight loss.- Endoscopic findings often include **concentric rings** (trachealization), linear furrows, or white exudates, which differ from a distinct stricturing lesion typically associated with malignancy.*Candida esophagitis*- *Candida esophagitis* primarily affects **immunocompromised** individuals and typically causes **odynophagia** (painful swallowing) rather than progressive dysphagia with weight loss.- Endoscopy usually reveals characteristic **white plaques** adhering to the esophageal mucosa, not a distinct stricturing lesion.

Question 36: A 48-year-old man presents with acute onset severe epigastric pain radiating to his back. CT shows acute pancreatitis with pancreatic necrosis involving >50% of the gland. What is the most appropriate management?

A. Conservative management with IV fluids (Correct Answer)
B. Immediate surgical debridement
C. Endoscopic necrosectomy
D. Percutaneous drainage
E. Total pancreatectomy

Explanation: ***Conservative management with IV fluids*** - The initial management for **acute necrotizing pancreatitis**, even when severe and involving extensive necrosis, is aggressive **supportive care** including IV fluids, analgesia, and nutritional management. - Early invasive interventions are associated with high mortality; procedures are typically delayed until necrosis is **infected** or appropriately **walled off** (usually 4-6 weeks after onset). *Immediate surgical debridement* - Early surgical debridement (within the first few weeks) significantly increases morbidity and mortality due to the friability of tissues and extent of the inflammatory response. - Intervention is typically reserved for confirmed **infected necrosis** that fails to respond to antibiotics, or specific acute complications such as abdominal compartment syndrome. *Endoscopic necrosectomy* - This is a minimally invasive technique used to debride **walled-off pancreatic necrosis (WOPN)**, and requires the collection to be mature, which takes several weeks. - It is inappropriate for managing acute, immature necrosis during the initial severe inflammatory phase. *Percutaneous drainage* - Percutaneous drainage is mainly indicated for acutely managing **infected fluid collections** or **abscesses**, or as a temporizing measure in critically ill patients with infected necrosis. - It is generally insufficient for definitive management of extensive **solid necrotic tissue**. *Total pancreatectomy* - **Total pancreatectomy** is a procedure of last resort, reserved only for catastrophic complications such as uncontrollable hemorrhage or devastating pancreatic parenchymal destruction. - It is never indicated as the primary or initial management strategy for acute pancreatitis, regardless of the extent of necrosis.

Question 37: A 55-year-old woman presents with progressive dysphagia and weight loss over 3 months. She has a history of Barrett's esophagus. Upper endoscopy shows a stricturing lesion in the lower esophagus. What is the most likely diagnosis?

A. Benign peptic stricture
B. Esophageal adenocarcinoma (Correct Answer)
C. Achalasia
D. Eosinophilic esophagitis
E. Candida esophagitis

Explanation: ***Esophageal adenocarcinoma*** - This presentation—**progressive dysphagia** and **weight loss** over a short period—is highly suggestive of malignancy, especially given the history of **Barrett's esophagus**. - **Barrett's esophagus** is a well-established precursor lesion that undergoes metaplasia-dysplasia-carcinoma sequence, leading to adenocarcinoma, typically found in the lower third of the esophagus. *Benign peptic stricture* - Although benign peptic strictures cause dysphagia, the presence of associated **substantial weight loss** strongly favors a malignant etiology. - Benign strictures usually result from long-standing reflux and present with dysphagia that is often less rapid in progression and typically affects primarily solids. *Achalasia* - Achalasia presents with **dysphagia to both solids and liquids** due to failure of LES relaxation and typically lacks the rapid weight loss associated with cancer. - Endoscopically, achalasia presents as a dilated esophagus leading to a narrow, symmetric LES (the **"bird's beak"** sign on barium swallow), not typically a discrete stricturing mass. *Eosinophilic esophagitis* - This condition is typically characterized by intermittent dysphagia and food impaction, often in patients with associated **atopy** or allergies. - Endoscopic findings usually include **multiple rings** (trachealization) or linear furrows, rather than a significant stricturing mass in the distal esophagus causing rapid weight loss. *Candida esophagitis* - Candida esophagitis primarily causes **odynophagia** (painful swallowing) and tends to occur in immunocompromised patients (e.g., HIV, diabetes). - Endoscopy shows characteristic **white, adherent plaques** or pseudomembranes lining the esophagus, which is distinct from a stricturing malignant lesion.

Question 38: A 58-year-old man presents with progressive dysphagia and weight loss. Upper endoscopy shows a stricturing lesion in the mid-esophagus. He has a history of caustic ingestion 20 years ago. What is the most likely diagnosis?

A. Esophageal adenocarcinoma
B. Esophageal squamous cell carcinoma (Correct Answer)
C. Benign stricture
D. Achalasia
E. Eosinophilic esophagitis

Explanation: ***Esophageal squamous cell carcinoma*** - A history of **caustic ingestion** is a significant risk factor for **esophageal squamous cell carcinoma (ESCC)**, often with a latency period of decades, and it commonly affects the **mid-esophagus**. - **Progressive dysphagia** and **weight loss** are classic alarm symptoms indicative of an underlying malignancy in the esophagus. *Esophageal adenocarcinoma* - Typically arises from **Barrett's esophagus**, which is a complication of chronic **gastroesophageal reflux disease (GERD)**, and is usually located in the **distal esophagus**. - There is no mention of GERD or Barrett's, and the location in the mid-esophagus along with caustic ingestion history makes adenocarcinoma less likely. *Benign stricture* - While caustic ingestion can cause benign strictures, the presence of **progressive dysphagia** and significant **weight loss** strongly suggests a malignant transformation rather than a solely benign process. - Benign strictures usually do not lead to such rapid or severe weight loss unless extremely advanced, and the overall clinical picture points to malignancy. *Achalasia* - Characterized by impaired relaxation of the **lower esophageal sphincter (LES)** and loss of esophageal peristalsis, typically presenting with dysphagia to both solids and liquids and regurgitation. - Endoscopy in achalasia usually shows a **dilated esophagus** with a normal-appearing LES, not a stricturing lesion in the mid-esophagus. *Eosinophilic esophagitis* - An inflammatory condition often associated with **atopic diseases** (e.g., asthma, allergies) and presents with dysphagia, food impaction, and chest pain. - Endoscopic findings typically include **esophageal rings**, linear furrows, and exudates, and it is not linked to prior caustic ingestion or the degree of weight loss seen here.

Question 39: A 29-year-old man presents with acute severe abdominal pain and vomiting. He has a strong family history of similar episodes. Serum amylase is normal. Urinary porphobilinogen is elevated. What is the most likely diagnosis?

A. Acute pancreatitis
B. Acute intermittent porphyria (Correct Answer)
C. Familial Mediterranean fever
D. Hereditary angioedema
E. Inflammatory bowel disease

Explanation: ***Acute intermittent porphyria*** - The presentation with acute severe **abdominal pain**, vomiting, and a strong **family history** of similar episodes is characteristic of an acute porphyric crisis. - The elevated urinary **porphobilinogen** confirms the diagnosis, as it is a key accumulated intermediate in heme synthesis during these attacks, while **normal serum amylase** rules out acute pancreatitis. *Acute pancreatitis* - The diagnosis is definitively excluded by the **normal serum amylase** (and lipase), which would be significantly elevated (typically >3 times the upper limit of normal) in acute pancreatitis. - While it causes acute severe abdominal pain and vomiting, it is not associated with elevated urinary **porphobilinogen** levels. *Familial Mediterranean fever* - FMF attacks classically involve **recurrent fever** and **serositis** (peritonitis, pleuritis, or arthritis), typically resolving spontaneously within days, which are not the primary focus here. - It is an **autoinflammatory syndrome** not involving abnormalities in the heme synthesis pathway or elevation of porphobilinogen. *Hereditary angioedema* - This condition causes recurrent, painful, non-pruritic episodes of localized **submucosal edema**, including abdominal pain due to bowel wall swelling. - It is a disorder of the **complement system** (e.g., C1 inhibitor deficiency) and is not linked to elevated urinary **porphobilinogen**. *Inflammatory bowel disease* - IBD typically presents with chronic or subacute symptoms such as **diarrhea**, rectal bleeding, or weight loss, rather than acute, episodic, severe attacks with a strong family history. - While acute flares can cause severe pain, IBD is characterized by intestinal inflammation and not by elevated **porphyrin precursors** like PBG.

Question 40: A 48-year-old woman presents with recurrent episodes of flushing, diarrhea, and wheezing. 24-hour urine 5-HIAA is markedly elevated. CT shows a small bowel mass with liver metastases. What is the most likely diagnosis?

A. Gastrinoma
B. Carcinoid tumor (Correct Answer)
C. Insulinoma
D. Glucagonoma
E. VIPoma

Explanation: ***Carcinoid tumor*** - Recurrent episodes of **flushing**, secretory **diarrhea**, and **wheezing** are classic features of **carcinoid syndrome**, caused by the release of vasoactive substances like **serotonin** from the tumor. - The diagnosis is confirmed by a markedly elevated **24-hour urine 5-HIAA** (5-hydroxyindoleacetic acid), the primary metabolite of **serotonin**. *Gastrinoma* - This tumor causes **Zollinger-Ellison syndrome**, characterized by severe, recurrent peptic ulcers and refractory GERD due to excessive **gastrin** secretion. - Diagnosis involves measuring fasting serum **gastrin levels** and a **secretin stimulation test**, not urine 5-HIAA. *Insulinoma* - Symptoms primarily revolve around **hypoglycemia**, forming **Whipple's triad** (symptoms with fasting, low glucose, relief with glucose). - It secretes excessive **insulin**, leading to neuroglycopenic symptoms, not the systemic effects seen in the patient. *Glucagonoma* - Characterized by **migratory necrolytic erythema**, often accompanied by **diabetes mellitus** and weight loss. - This condition involves the overproduction of **glucagon**, and the described symptoms of flushing, diarrhea, and wheezing are atypical. *VIPoma* - Presents with **WDHA syndrome** (**W**atery **D**iarrhea, **H**ypokalemia, **A**chlorhydria), which involves profound, high-volume secretory diarrhea. - The symptoms are due to excessive **Vasoactive Intestinal Peptide (VIP)** secretion and do not typically include flushing or wheezing.

Question 41: A 55-year-old man presents with progressive dysphagia and a 15kg weight loss over 4 months. He has a history of achalasia treated 10 years ago. Upper endoscopy shows a stricturing lesion at the gastroesophageal junction. What is the most likely diagnosis?

A. Recurrent achalasia
B. Esophageal adenocarcinoma (Correct Answer)
C. Benign stricture
D. Eosinophilic esophagitis
E. Candida esophagitis

Explanation: ***Esophageal adenocarcinoma***- The combination of **progressive dysphagia** and rapid **15kg weight loss** over 4 months is highly suggestive of advanced malignancy.- Long-standing **achalasia** is a significant predisposing factor for esophageal cancer (especially squamous cell carcinoma, but adenocarcinoma can occur at the GEJ), making malignancy the most likely diagnosis given the new stricturing lesion. *Recurrent achalasia*- Achalasia typically presents with non-progressive or intermittent dysphagia and regurgitation, but not the rapid, **severe weight loss** or a **stricturing lesion** indicative of malignancy.- Endoscopically, recurrent achalasia would show persistent dilatation with a smooth, non-infiltrative narrowing at the GEJ, not a distinct stricture. *Benign stricture*- While benign strictures cause dysphagia, they typically progress more slowly and do not cause such **severe and rapid weight loss** (15kg in 4 months).- Given the history of **achalasia**, a known premalignant condition, and the rapid progression, malignancy is a far more concerning and likely diagnosis than a benign stricture. *Eosinophilic esophagitis*- This condition typically causes intermittent dysphagia, often with **food impaction**, and is usually associated with symptoms of **atopy** (allergies, asthma).- It rarely causes rapid, profound **weight loss** or a dominant, stricturing lesion indicative of a tumor; endoscopic findings often include rings or furrows. *Candida esophagitis*- This infection usually causes **odynophagia** (painful swallowing) and is primarily seen in **immunocompromised** patients.- Endoscopically, it presents as white, adherent plaques and would not typically cause a firm, rapidly progressive, stricturing mass associated with severe weight loss.

Question 42: A 36-year-old man presents with a 10-month history of abdominal bloating, increased flatulence, and loose stools occurring 4-5 times daily without blood or mucus. He has no weight loss. He underwent testing for coeliac disease 2 years ago which was negative. Examination is unremarkable. He tries a low-FODMAP diet for 6 weeks with minimal improvement. Blood tests including full blood count, CRP, and thyroid function are normal. What is the most appropriate next investigation?

A. Hydrogen breath test for lactose intolerance
B. Repeat tissue transglutaminase antibody testing with total IgA level
C. Hydrogen and methane breath test after lactulose or glucose challenge (Correct Answer)
D. Colonoscopy with terminal ileal intubation and biopsies
E. SeHCAT scan to assess bile acid malabsorption

Explanation: ***Hydrogen and methane breath test after lactulose or glucose challenge*** - This patient presents with classic symptoms of **abdominal bloating**, **flatulence**, and **loose stools** that have not improved with a **low-FODMAP diet**, strongly suggesting **Small Intestinal Bacterial Overgrowth (SIBO)**. - A breath test using **lactulose or glucose** measures both **hydrogen and methane** gases produced by bacteria in the small intestine, providing a comprehensive assessment for SIBO. *Hydrogen breath test for lactose intolerance* - While lactose intolerance causes similar symptoms like bloating and diarrhea, this test specifically assesses **lactose malabsorption** rather than a generalized overgrowth of bacteria. - The patient's lack of improvement on a **low-FODMAP diet**, which already restricts lactose, makes isolated lactose intolerance less likely to be the primary cause. *Repeat tissue transglutaminase antibody testing with total IgA level* - The patient had negative **coeliac disease** testing two years ago, and his current symptoms developed more recently, making a repeat screen less urgent without other suggestive features. - Absence of **weight loss** and normal inflammatory markers further reduce the likelihood of active coeliac disease as the immediate concern. *Colonoscopy with terminal ileal intubation and biopsies* - This invasive investigation is typically reserved for patients with **alarm features** such as significant weight loss, rectal bleeding, or elevated inflammatory markers (e.g., **CRP**), none of which are present here. - Given the patient's normal blood tests and chronic non-bloody diarrhea, a functional or malabsorptive cause like SIBO is more probable than structural bowel disease. *SeHCAT scan to assess bile acid malabsorption* - **Bile acid malabsorption** can cause chronic diarrhea but is often considered after excluding more common causes or in patients with risk factors like **ileal resection** or cholecystectomy. - The prominent symptoms of **bloating** and **flatulence**, combined with the failure of the low-FODMAP diet, point more directly towards SIBO as the next diagnostic step.

Question 43: A 58-year-old man is admitted with acute pancreatitis secondary to gallstones. His admission amylase is 2400 U/L. Initial CT shows pancreatic oedema without necrosis. He is managed conservatively with fluid resuscitation and analgesia. On day 10, he develops a fever of 38.5°C and persistent abdominal pain. Repeat CT shows a 6 cm well-defined peripancreatic fluid collection with no gas. Blood cultures are negative. CRP is 220 mg/L. What is the most appropriate next step in management?

A. Arrange urgent percutaneous drainage of the collection
B. Continue conservative management as this represents an acute peripancreatic fluid collection (Correct Answer)
C. Arrange CT-guided fine needle aspiration for culture before starting antibiotics
D. Proceed to urgent surgical necrosectomy
E. Start empirical broad-spectrum antibiotics and repeat imaging in 2 weeks

Explanation: ***Continue conservative management as this represents an acute peripancreatic fluid collection*** - This presentation, with a well-defined peripancreatic fluid collection within **10 days** of acute pancreatitis onset and **no signs of necrosis or gas** (indicating infection), is consistent with an **Acute Peripancreatic Fluid Collection (APFC)** according to the Revised Atlanta Classification. - Most APFCs are **sterile** and **resolve spontaneously** without intervention; the fever and elevated CRP can reflect systemic inflammation from pancreatitis itself. *Arrange urgent percutaneous drainage of the collection* - **Percutaneous drainage** is generally reserved for **symptomatic pseudocysts** (mature collections >4 weeks) or **infected pancreatic necrosis**. - Early drainage of a sterile APFC is usually not indicated and can potentially introduce **infection** or create a **fistula**. *Arrange CT-guided fine needle aspiration for culture before starting antibiotics* - **CT-guided FNA** for culture is generally discouraged unless there is strong clinical suspicion of **infected necrosis** that is not responding to conservative management. - In the absence of clear signs of infection within the collection (no gas), and with negative blood cultures, the immediate need for FNA is not present. *Proceed to urgent surgical necrosectomy* - **Surgical necrosectomy** is indicated only for **infected pancreatic necrosis**, which is absent in this case (initial CT showed only oedema). - The current approach for severe pancreatitis favors **minimally invasive techniques** for walled-off necrosis, not urgent open surgery for an APFC. *Start empirical broad-spectrum antibiotics and repeat imaging in 2 weeks* - **Prophylactic antibiotics** are **not recommended** in acute pancreatitis, even in severe cases or with sterile fluid collections. - Antibiotics should only be initiated if there is evidence of **documented infection**, such as infected necrosis (with positive cultures or gas in the collection) or an extra-pancreatic infection.

Question 44: Which of the following best describes the mechanism of action of 5-aminosalicylic acid (5-ASA) compounds in the treatment of ulcerative colitis?

A. Inhibition of calcineurin leading to reduced T-cell activation
B. Inhibition of nuclear factor kappa B and inflammatory cytokine production (Correct Answer)
C. Blockade of alpha-4 integrin preventing leucocyte migration to gut tissue
D. Neutralization of tumour necrosis factor-alpha in the circulation
E. Inhibition of Janus kinase pathways reducing inflammatory signalling

Explanation: ***Inhibition of nuclear factor kappa B and inflammatory cytokine production***- **5-aminosalicylic acid (5-ASA)** compounds primarily act locally in the intestinal mucosa to inhibit the activation of **nuclear factor kappa B (NF-κB)**, a key transcription factor for inflammatory genes.- This inhibition reduces the production of various **pro-inflammatory cytokines** (e.g., TNF-α, IL-1, IL-6), as well as **prostaglandins** and **leukotrienes** by inhibiting cyclooxygenase and lipoxygenase pathways. *Inhibition of calcineurin leading to reduced T-cell activation*- This mechanism is characteristic of **calcineurin inhibitors** such as **cyclosporine** and **tacrolimus**, which are potent immunosuppressants.- These agents are typically reserved for severe, steroid-refractory cases of **ulcerative colitis**, and are not the primary mechanism of 5-ASA. *Blockade of alpha-4 integrin preventing leucocyte migration to gut tissue*- This describes the mechanism of **vedolizumab**, a gut-selective monoclonal antibody used in inflammatory bowel disease.- It specifically targets the **α4β7 integrin**, preventing leukocytes from migrating into the inflamed gastrointestinal tissue. *Neutralization of tumour necrosis factor-alpha in the circulation*- This is the mechanism of **anti-TNF agents** like **infliximab** or **adalimumab**, which are biologic therapies.- These drugs bind to and neutralize **tumour necrosis factor-alpha (TNF-α)**, a crucial pro-inflammatory cytokine in IBD. *Inhibition of Janus kinase pathways reducing inflammatory signalling*- This mechanism is associated with **Janus kinase (JAK) inhibitors** such as **tofacitinib** or **upadacitinib**.- These are small-molecule drugs that block intracellular signaling pathways downstream of many pro-inflammatory cytokine receptors, thereby reducing inflammation.

Question 45: A 45-year-old woman presents with acute onset severe epigastric pain radiating to the back, with nausea and vomiting. Her amylase is 1450 U/L (normal <100 U/L). CT abdomen shows pancreatic oedema and peripancreatic fluid but no necrosis. CRP is 180 mg/L. She admits to drinking half a bottle of wine daily. Calcium is 2.15 mmol/L, and arterial blood gas shows pH 7.38, pO2 11.2 kPa, pCO2 4.8 kPa. What is her predicted severity of acute pancreatitis according to the Glasgow score at 48 hours?

A. Score of 2 indicating moderately severe pancreatitis
B. Cannot be calculated without 48-hour blood results (Correct Answer)
C. Score of 1 indicating mild pancreatitis
D. Score of 3 or more indicating severe pancreatitis with high mortality risk
E. Score of 0 indicating no risk factors for severe disease

Explanation: ***Cannot be calculated without 48-hour blood results*** - The **Glasgow (Imrie) score** is specifically designed to be calculated and validated based on clinical and laboratory parameters at **48 hours after admission**. - Several required components (the **PANCREAS** mnemonic), such as **White Cell Count**, **Urea**, **LDH/AST**, **Albumin**, and **Glucose**, are missing from the current clinical vignette, making a formal score impossible to determine. *Score of 2 indicating moderately severe pancreatitis* - A score of 2 would imply **mild pancreatitis** under the Glasgow criteria; the term "moderately severe" is typically part of the **Atlanta Classification**, which is based on organ failure and complications rather than this point system. - Even if using Atlanta criteria, her **CRP of 180 mg/L** suggests high inflammatory activity, but her current **pO2 (11.2 kPa)** and calcium do not yet fulfill Glasgow criteria markers. *Score of 1 indicating mild pancreatitis* - While the patient’s pO2 and Calcium are currently within the "normal" range for the score, you cannot assign a final score of 1 until all **eight variables** are assessed at the 48-hour mark. - Early presentation findings can change rapidly; therefore, a score calculated before **48 hours** is considered unreliable for prognosis. *Score of 3 or more indicating severe pancreatitis with high mortality risk* - A score of **3 or more** signifies **severe acute pancreatitis**, but this patient currently only meets the CRP threshold (>150), which is not an official component of the Glasgow score. - Factors like her **Age (45)** and **pO2 (11.2 kPa)** currently do not count toward a high score, making a prediction of ">=3" premature. *Score of 0 indicating no risk factors for severe disease* - It is incorrect to assume a score of 0 simply because some values (like **Calcium 2.15 mmol/L**) are currently normal; other metrics like **Urea** or **LDH** are unknown. - The elevated **CRP (180 mg/L)** is a known independent predictor of severity, contradicting the idea that there are "no risk factors" present.

Question 46: A 65-year-old man with alcoholic cirrhosis and refractory ascites undergoes transjugular intrahepatic portosystemic shunt (TIPS) insertion. Before the procedure, his Model for End-Stage Liver Disease (MELD) score is 16, and his serum bilirubin is 42 μmol/L. Two weeks post-procedure, he develops progressive confusion and disorientation. His ascites has improved significantly. Liver function shows bilirubin 48 μmol/L, albumin 29 g/L, and INR 1.9. Ammonia level is elevated at 95 μmol/L (normal 11-35). What is the most likely complication?

A. TIPS stenosis leading to recurrent portal hypertension
B. Spontaneous bacterial peritonitis causing altered mental status
C. Post-TIPS hepatic encephalopathy due to increased portosystemic shunting (Correct Answer)
D. Progression of underlying liver disease with hepatic decompensation
E. Sepsis secondary to TIPS insertion

Explanation: ***Post-TIPS hepatic encephalopathy due to increased portosystemic shunting*** - **Hepatic encephalopathy** is the most frequent complication of **TIPS**, occurring because the shunt allows gut-derived toxins like **ammonia** to bypass hepatic metabolism and enter the systemic circulation. - The diagnosis is confirmed by the combination of new onset **confusion and disorientation**, **improved ascites** (indicating a patent shunt), and markedly **elevated ammonia levels** two weeks after the procedure. *TIPS stenosis leading to recurrent portal hypertension* - **TIPS stenosis** would typically lead to a recurrence or worsening of **portal hypertension** symptoms, most notably **recurrent ascites** or variceal bleeding, rather than improvement. - In this case, the patient's ascites has **significantly improved**, which indicates that the shunt is patent and functioning properly. *Spontaneous bacterial peritonitis causing altered mental status* - While **SBP** can trigger encephalopathy, it typically presents with signs of infection such as **fever**, abdominal pain, and often **worsening ascites** or new onset ascites. - There is no clinical evidence of infection (like fever or abdominal pain) or worsening ascites provided, making **SBP** less likely. *Progression of underlying liver disease with hepatic decompensation* - Progression of **underlying liver disease** leading to decompensation would be characterized by a significant worsening of **liver function tests**, such as a substantial increase in **bilirubin** and **INR**, and a decrease in **albumin**. - The patient's bilirubin, albumin, and INR levels are relatively stable post-TIPS, suggesting that overall liver synthetic function has not acutely deteriorated significantly. *Sepsis secondary to TIPS insertion* - **Sepsis** related to the procedure (e.g., from an infected shunt) would typically present with systemic signs of infection such as **fever**, **tachycardia**, and hemodynamic instability. - The isolated finding of new-onset **confusion** and **hyperammonemia** without systemic signs of infection strongly points toward **metabolic encephalopathy** rather than sepsis.

Question 47: A 29-year-old woman presents with a 2-year history of burning epigastric pain and acid regurgitation occurring 3-4 times per week, particularly at night. She has tried lifestyle modifications without improvement. BMI is 23 kg/m². Helicobacter pylori stool antigen test is negative. She is otherwise well and takes no regular medications. What is the most appropriate initial pharmacological management?

A. Prescribe ranitidine 300 mg at night for 4 weeks
B. Prescribe alginate therapy to be taken after meals and at bedtime
C. Prescribe a prokinetic agent such as metoclopramide
D. Prescribe a standard-dose proton pump inhibitor for 4-8 weeks (Correct Answer)
E. Arrange urgent upper GI endoscopy before starting treatment

Explanation: ***Prescribe a standard-dose proton pump inhibitor for 4-8 weeks*** - This patient presents with classic **Gastro-oesophageal reflux disease (GORD)** symptoms (burning epigric pain, acid regurgitation) occurring frequently, for which **Proton Pump Inhibitors (PPIs)** are the first-line and most effective treatment. - Given the patient is under 55 and lacks **alarm symptoms** (e.g., dysphagia, weight loss, anemia), an empirical trial of a full-dose PPI for 4 to 8 weeks is the most appropriate initial management. *Prescribe ranitidine 300 mg at night for 4 weeks* - **H2-receptor antagonists** like ranitidine are generally less effective than PPIs for healing oesophagitis and achieving complete symptom relief in moderate to severe GORD. - Furthermore, **ranitidine** has been largely withdrawn from the market due to concerns regarding **NDMA contamination**, making it an unsuitable choice. *Prescribe alginate therapy to be taken after meals and at bedtime* - While **alginates** can provide some symptomatic relief by forming a physical barrier, they are typically less effective for the frequent and persistent symptoms described, often reserved for **mild or infrequent reflux**. - These agents are usually considered adjunct therapy or for on-demand use, not as the primary initial pharmacological management for significant GORD. *Prescribe a prokinetic agent such as metoclopramide* - **Prokinetic agents** have a very limited role and are not recommended as first-line therapy for GORD due to inconsistent efficacy in reducing acid reflux. - **Metoclopramide** specifically carries a significant risk of **neurological side effects**, including extrapyramidal symptoms, which outweighs its potential benefit in GORD. *Arrange urgent upper GI endoscopy before starting treatment* - **Upper GI endoscopy** is not indicated as initial management in this patient because she is young (<55 years old) and does not present with any **alarm features** such as dysphagia, unintentional weight loss, anemia, or persistent vomiting. - For typical GORD symptoms in younger patients without alarm features, an **empirical trial of PPI therapy** is the recommended first step before considering endoscopy.

Question 48: A 54-year-old man with alcoholic cirrhosis and large oesophageal varices on recent endoscopy is commenced on prophylactic carvedilol. After 4 weeks, his resting heart rate has decreased from 82 bpm to 58 bpm. He reports mild fatigue but no dizziness or syncope. Blood pressure is 108/68 mmHg. Liver function tests show bilirubin 38 μmol/L, albumin 32 g/L, and INR 1.6. What is the most appropriate management of his carvedilol therapy?

A. Continue current dose as the heart rate reduction indicates adequate beta-blockade (Correct Answer)
B. Stop carvedilol and arrange repeat endoscopy for variceal banding
C. Switch from carvedilol to propranolol for better tolerability
D. Reduce the carvedilol dose as heart rate is below the target range
E. Increase the carvedilol dose to achieve greater portal pressure reduction

Explanation: ***Continue current dose as the heart rate reduction indicates adequate beta-blockade*** - The goal for **non-selective beta-blockers (NSBB)** in portal hypertension is a heart rate (HR) reduction to roughly **55–60 bpm** or a 25% decrease from baseline; this patient’s HR of **58 bpm** indicates therapeutic success. - Since the patient is **hemodynamically stable** (BP 108/68 mmHg) and lacks signs of hypoperfusion like **syncope or dizziness**, the mild fatigue is an expected side effect that does not mandate discontinuation. *Stop carvedilol and arrange repeat endoscopy for variceal banding* - **Endoscopic Variceal Ligation (EVL)** is an alternative for primary prophylaxis, but there is no clinical indication to switch when the current medical therapy is **effective and well-tolerated**. - Stopping a successful NSBB regimen without a contraindication (like **refractory ascites or hypotension**) unnecessarily increases the risk of **variceal hemorrhage**. *Switch from carvedilol to propranolol for better tolerability* - **Carvedilol** is generally more effective than **propranolol** for reducing portal pressure because it also possesses **alpha-1 adrenergic blocking** properties. - Switching is unnecessary as the patient has already achieved the target HR and is not exhibiting a significant **intolerance** that would be solved by a different NSBB. *Reduce the carvedilol dose as heart rate is below the target range* - The heart rate of **58 bpm** is exactly within the recommended target range of **55–60 bpm**, not below it. - Reducing the dose would likely push the heart rate back up and potentially lose the **protective benefit** against variceal bleeding. *Increase the carvedilol dose to achieve greater portal pressure reduction* - Increasing the dose further would likely result in **symptomatic bradycardia** or significant **hypotension**, especially since the heart rate is already at the lower therapeutic bound. - Unlike propranolol, **Carvedilol** is typically administered at fixed low doses (e.g., 6.25–12.5 mg) rather than being titrated solely by HR, and further escalation is limited by **systemic blood pressure**.

Question 49: A 33-year-old man presents with a 4-week history of intermittent lower abdominal cramping and loose stools occurring 3-4 times daily. He reports that symptoms worsen with stress and improve after bowel movements. There is no blood in the stools, no nocturnal symptoms, and no weight loss. Examination is unremarkable. Blood tests including full blood count, inflammatory markers, coeliac serology, and thyroid function are all normal. Faecal calprotectin is 18 μg/g (normal <50 μg/g). What is the most appropriate next step?

A. Arrange colonoscopy to exclude inflammatory bowel disease
B. Request CT abdomen and pelvis to exclude colonic malignancy
C. Arrange hydrogen breath testing to exclude small intestinal bacterial overgrowth
D. Diagnose irritable bowel syndrome and provide dietary advice and reassurance (Correct Answer)
E. Prescribe a trial of mesalazine for possible microscopic colitis

Explanation: ***Diagnose irritable bowel syndrome and provide dietary advice and reassurance***- This patient's symptoms (abdominal pain related to defecation, altered bowel habits, worsening with stress) combined with the absence of **alarm features** (no blood, no nocturnal symptoms, no weight loss) and normal investigations (FBC, inflammatory markers, coeliac serology, thyroid, and crucially, normal **faecal calprotectin**) are highly characteristic of **Irritable Bowel Syndrome (IBS)**.- Given the clinical picture and the thorough exclusion of organic pathology with normal **faecal calprotectin** (which rules out IBD with high negative predictive value), further invasive investigations are not warranted, and management should focus on **IBS diagnosis**, reassurance, and **dietary advice** (e.g., FODMAP diet).*Arrange colonoscopy to exclude inflammatory bowel disease*- A **normal faecal calprotectin** (<50 μg/g) has a high negative predictive value for **Inflammatory Bowel Disease (IBD)**, making a colonoscopy unnecessary in the absence of other red flags.- The patient lacks typical features of IBD such as **nocturnal diarrhea**, **rectal bleeding**, or **unexplained weight loss**, and **inflammatory markers** are normal.*Request CT abdomen and pelvis to exclude colonic malignancy*- Colonic malignancy is highly unlikely in a 33-year-old man without any **alarm features** (e.g., weight loss, rectal bleeding, iron deficiency anemia, family history of early-onset colorectal cancer).- Performing a CT scan would expose the patient to unnecessary **ionizing radiation** when the clinical picture strongly points towards a functional gastrointestinal disorder.*Arrange hydrogen breath testing to exclude small intestinal bacterial overgrowth*- While **SIBO** can cause symptoms like bloating and altered bowel habits, it is not typically the initial investigation when the clinical presentation strongly aligns with **IBS** and other organic causes have been ruled out.- **Hydrogen breath testing** for SIBO is usually considered in patients with persistent symptoms despite initial IBS management or those with specific risk factors for SIBO (e.g., prior bowel surgery, diverticulosis).*Prescribe a trial of mesalazine for possible microscopic colitis*- **Microscopic colitis** typically presents with chronic, watery diarrhea, often without abdominal pain, and predominantly affects **older patients**.- Diagnosis requires **colonic biopsies** (usually during colonoscopy), and **mesalazine** is not the primary treatment (budesonide is preferred). The patient's symptoms and age do not strongly suggest microscopic colitis.

Question 50: A 61-year-old man with alcoholic cirrhosis presents with increasing abdominal distension. Examination reveals shifting dullness and a fluid thrill. Diagnostic ascitic tap shows: white cell count 180 cells/mm³ (neutrophils 35%), protein 18 g/L, albumin 8 g/L, lactate dehydrogenase 45 U/L, and glucose 4.8 mmol/L. His serum albumin is 28 g/L. The serum-ascites albumin gradient (SAAG) is 20 g/L. What does this ascitic fluid analysis indicate?

A. Uncomplicated cirrhotic ascites with low risk of spontaneous bacterial peritonitis (Correct Answer)
B. Spontaneous bacterial peritonitis requiring immediate antibiotic therapy
C. Malignant ascites requiring cytological examination
D. Secondary bacterial peritonitis suggesting bowel perforation
E. Tuberculous peritonitis requiring anti-tuberculous therapy

Explanation: ***Uncomplicated cirrhotic ascites with low risk of spontaneous bacterial peritonitis***- The **SAAG of 20 g/L** (≥11 g/L) confirms **portal hypertension** due to cirrhosis as the underlying cause of the ascites.- The **absolute neutrophil count (ANC)** is only **63 cells/mm³** (35% of 180), which is well below the **250 cells/mm³** threshold required to diagnose **spontaneous bacterial peritonitis (SBP)**.*Spontaneous bacterial peritonitis requiring immediate antibiotic therapy*- **SBP** is diagnosed when the ascitic fluid **polymorphonuclear (PMN) count** is **≥250 cells/mm³**, whereas this patient's count is significantly lower (63 cells/mm³).- While a low ascitic **protein (18 g/L)** is a risk factor for future SBP, it does not confirm an active infection without elevated neutrophils.*Malignant ascites requiring cytological examination*- **Malignant ascites** typically presents with a **low SAAG (<11 g/L)** and a **high protein content (>25 g/L)** due to increased capillary permeability.- This patient's **SAAG of 20 g/L** and low protein are characteristic of a **transudative process** related to portal hypertension, not malignancy.*Secondary bacterial peritonitis suggesting bowel perforation*- **Secondary peritonitis** is characterized by an **ANC >250 cells/mm³**, ascitic **glucose <2.8 mmol/L**, and typically elevated **LDH**.- The normal **glucose (4.8 mmol/L)** and low **LDH (45 U/L)** in this patient rule out a surgical emergency like **bowel perforation**.*Tuberculous peritonitis requiring anti-tuberculous therapy*- **Tuberculous peritonitis** typically presents with a **low SAAG (<11 g/L)** and a high total protein concentration.- The white cell differential in TB usually shows a **lymphocytic predominance**, which is not consistent with the 35% neutrophil count and high SAAG seen here.

Question 51: A 39-year-old woman with ulcerative colitis affecting the entire colon has been in remission on azathioprine 2 mg/kg/day for 3 years. She now wishes to conceive and seeks advice about her medication. Her thiopurine methyltransferase (TPMT) activity was normal before starting azathioprine. What is the most appropriate advice regarding her azathioprine therapy?

A. Continue azathioprine throughout pregnancy as benefits outweigh risks (Correct Answer)
B. Switch to mesalazine before conception and discontinue azathioprine
C. Stop azathioprine 3 months before attempting conception
D. Switch to methotrexate as it is safer in pregnancy
E. Reduce azathioprine dose to 1 mg/kg/day during pregnancy

Explanation: ***Continue azathioprine throughout pregnancy as benefits outweigh risks*** - Maintaining **disease remission** is the priority during pregnancy, as active **Ulcerative Colitis** significantly increases the risk of **preterm birth** and **low birth weight**. - Azathioprine is considered **compatible with pregnancy** by major guidelines (e.g., ECCO, BSG), as the well-established risks of a maternal disease flare far outweigh the theoretical risks of the medication. *Switch to mesalazine before conception and discontinue azathioprine* - **Mesalazine** is generally insufficient to maintain remission in patients who have extensive colitis and require **thiopurines** for disease control. - Changing a stable, effective maintenance therapy just before or during pregnancy significantly increases the **risk of disease relapse**, which is detrimental to both mother and fetus. *Stop azathioprine 3 months before attempting conception* - Discontinuing effective maintenance therapy in a patient with extensive ulcerative colitis will likely lead to **disease flare-ups**, which pose greater risks to pregnancy outcomes than continued azathioprine. - Current clinical evidence and expert guidelines do not support the need to stop **thiopurines** during the preconception period or throughout pregnancy. *Switch to methotrexate as it is safer in pregnancy* - **Methotrexate** is a potent **teratogen** (Category X) and is strictly **contraindicated** in pregnancy due to its high risk of major fetal malformations and pregnancy loss. - Patients must stop methotrexate at least **3 to 6 months before conception** and be on high-dose folic acid to clear it from their system. *Reduce azathioprine dose to 1 mg/kg/day during pregnancy* - There is no clinical evidence to suggest that an empiric **dose reduction** of azathioprine improves neonatal outcomes; instead, it increases the risk of maternal **disease flare**. - Optimal management involves close monitoring of **thiopurine metabolite levels** and **TPMT activity** to ensure therapeutic efficacy and safety rather than arbitrary dose adjustments.

Question 52: A 48-year-old man presents with a 6-month history of intermittent epigastric pain and bloating. He reports that the pain is worse after fatty meals. Upper GI endoscopy is normal. An ultrasound scan shows multiple small gallstones in the gallbladder but no bile duct dilatation. Liver function tests and amylase are normal. A hepatobiliary iminodiacetic acid (HIDA) scan shows a gallbladder ejection fraction of 22% (normal >35%) after cholecystokinin stimulation. What is the most likely diagnosis?

A. Functional dyspepsia
B. Biliary dyskinesia (Correct Answer)
C. Chronic acalculous cholecystitis
D. Sphincter of Oddi dysfunction
E. Gallstone-related biliary colic

Explanation: ***Biliary dyskinesia***- This condition is characterized by **biliary-type pain** in the presence of impaired gallbladder emptying, confirmed by a **HIDA scan** showing an **ejection fraction (EF) of 22%** (normal >35%) after **cholecystokinin (CCK) stimulation**.- The symptoms of intermittent epigastric pain and bloating, worse after fatty meals, are consistent with gallbladder dysfunction despite the presence of small gallstones, as the primary issue is reduced motility.*Functional dyspepsia*- This is a diagnosis of exclusion, typically considered when **upper GI endoscopy** is normal and there are no objective structural or functional abnormalities.- The presence of a significantly reduced gallbladder ejection fraction on HIDA scan indicates a clear objective functional abnormality, ruling out functional dyspepsia.*Chronic acalculous cholecystitis*- This diagnosis refers to chronic gallbladder inflammation **without the presence of gallstones**.- The patient's ultrasound explicitly shows **multiple small gallstones** in the gallbladder, directly contradicting the

Question 53: A 55-year-old woman with primary biliary cholangitis presents for review. She has been taking ursodeoxycholic acid 15 mg/kg/day for 18 months. Her alkaline phosphatase (ALP) has decreased from 420 U/L to 310 U/L (normal range 30-130 U/L), and her bilirubin remains normal at 12 μmol/L. She reports persistent pruritus affecting her quality of life despite antihistamines. What is the most appropriate next step in management?

A. Add bezafibrate to ursodeoxycholic acid therapy
B. Increase ursodeoxycholic acid dose to 20 mg/kg/day
C. Add rifampicin for symptomatic relief of pruritus (Correct Answer)
D. Refer for liver transplant assessment
E. Switch from ursodeoxycholic acid to obeticholic acid monotherapy

Explanation: ***Add rifampicin for symptomatic relief of pruritus***- In patients with **Primary Biliary Cholangitis (PBC)**, pruritus that remains refractory to first-line agents like **cholestyramine** or antihistamines is managed with **rifampicin**.- **Rifampicin** acts as a **pregname X receptor (PXR)** agonist, inducing hepatic enzymes that modify bile acid metabolism to reduce itch-inducing substances.*Add bezafibrate to ursodeoxycholic acid therapy*- **Bezafibrate** is a second-line treatment used specifically for patients with an **inadequate biochemical response** to UDCA (e.g., elevated ALP).- While it can help with pruritus, the clinical priority here is the failure of first-line symptomatic relief, for which **rifampicin** is the better-established second-line choice for itch.*Increase ursodeoxycholic acid dose to 20 mg/kg/day*- The therapeutic dosage for **UDCA** in PBC is strictly established at **13–15 mg/kg/day**.- Increasing the dose to **20 mg/kg/day** does not provide additional clinical benefit and does not specifically address the **symptomatic pruritus**.*Refer for liver transplant assessment*- Liver transplant is indicated for **end-stage liver disease**, characterized by high **bilirubin** (typically >50 μmol/L) or signs of **decompensation**.- This patient has a normal **bilirubin** of 12 μmol/L and no evidence of cirrhosis or liver failure, making a referral premature.*Switch from ursodeoxycholic acid to obeticholic acid monotherapy*- **Obeticholic acid** is typically used as an **add-on therapy** to UDCA rather than a monotherapy switch when biochemical goals are not met.- Notably, obeticholic acid can actually **exacerbate pruritus** as a common side effect, which would worsen this patient's primary complaint.

Question 54: A 42-year-old man with known Crohn's disease presents with chronic diarrhoea, weight loss, and a low serum vitamin B12 level. His disease has previously affected the terminal ileum, which was resected 3 years ago (50 cm resection). He now has steatorrhoea and a positive SeHCAT scan showing 7-day retention of 8%. What is the primary mechanism responsible for his steatorrhoea?

A. Bacterial overgrowth in the small intestine due to altered anatomy
B. Pancreatic exocrine insufficiency secondary to chronic inflammation
C. Bile acid malabsorption causing colonic secretion and fat malabsorption (Correct Answer)
D. Active Crohn's disease in the remaining small bowel causing malabsorption
E. Intestinal lymphangiectasia causing protein-losing enteropathy

Explanation: ***Bile acid malabsorption causing colonic secretion and fat malabsorption***- This patient's **50 cm terminal ileal resection** is a critical factor, as the terminal ileum is where **bile acids** are primarily reabsorbed in the **enterohepatic circulation**.- The **positive SeHCAT scan (8% retention)** directly confirms severe **bile acid malabsorption**, which leads to a depleted bile acid pool, impairing fat emulsification and causing **steatorrhoea**, and excess bile acids in the colon driving secretory diarrhoea.*Bacterial overgrowth in the small intestine due to altered anatomy*- While surgical resection in Crohn's can predispose to **small intestinal bacterial overgrowth (SIBO)** by altering gut anatomy or motility, the direct evidence of **bile acid malabsorption** (SeHCAT scan) points to a more specific cause for steatorrhoea.- SIBO can cause malabsorption and diarrhoea, partly by deconjugating bile acids, but the primary pathology here is the *loss* of bile acids from the enterohepatic circulation due to resection, not just deconjugation.*Pancreatic exocrine insufficiency secondary to chronic inflammation*- There is no clinical evidence in the patient's presentation (e.g., recurrent pancreatitis, abdominal pain radiating to the back) to suggest **pancreatic exocrine insufficiency**.- This condition would lead to generalized maldigestion of fats, proteins, and carbohydrates, and would be typically diagnosed by tests like a **fecal elastase** level, not a SeHCAT scan.*Active Crohn's disease in the remaining small bowel causing malabsorption*- While **active Crohn's disease** can cause malabsorption, the patient's history includes a **terminal ileal resection**, which provides a more direct and specific explanation for the **steatorrhoea** and **vitamin B12 deficiency**.- The symptoms are more consistent with the functional consequences of resected terminal ileum rather than active inflammation, although inflammation could coexist. The SeHCAT test specifically points to bile acid issue.*Intestinal lymphangiectasia causing protein-losing enteropathy*- **Intestinal lymphangiectasia** is a rare disorder characterized by dilated lymphatic vessels, leading to **protein-losing enteropathy**, typically presenting with **oedema**, chylous effusions, and profound hypoalbuminemia.- This patient's symptoms (steatorrhoea, low B12, positive SeHCAT) are not characteristic of intestinal lymphangiectasia, which primarily affects lymphatic drainage and protein absorption, not bile acid reabsorption.

Question 55: A 68-year-old woman with a history of non-steroidal anti-inflammatory drug (NSAID) use for osteoarthritis presents with coffee-ground vomiting. She is haemodynamically stable with a heart rate of 88 bpm and blood pressure of 135/82 mmHg. Her haemoglobin is 108 g/L (baseline 125 g/L). She takes amlodipine for hypertension. Upper GI endoscopy shows a 1.5 cm gastric ulcer with a clean base. What is the most appropriate management after endoscopy?

A. Discharge with oral proton pump inhibitor therapy and H. pylori eradication if positive (Correct Answer)
B. Continue intravenous proton pump inhibitor infusion for 72 hours then switch to oral therapy
C. Arrange repeat endoscopy in 24 hours to reassess ulcer
D. Start intravenous proton pump inhibitor twice daily for 72 hours as an inpatient
E. Discharge immediately on oral proton pump inhibitor therapy without further testing

Explanation: ***Discharge with oral proton pump inhibitor therapy and H. pylori eradication if positive***- A gastric ulcer with a **clean base** is classified as **Forrest III**, which carries a very low risk of rebleeding (<5%) and can be managed in an outpatient setting.- Since the patient is **haemodynamically stable** and lacks high-risk endoscopic stigmata, early discharge on **oral PPIs** is the standard of care to prevent recurrence.*Continue intravenous proton pump inhibitor infusion for 72 hours then switch to oral therapy*- **Intravenous PPI infusions** are reserved for patients with high-risk stigmata, such as **active spurting** (Forrest Ia) or a **visible vessel** (Forrest IIa).- Clean-based ulcers do not derive additional benefit from IV over **oral PPI** therapy, making prolonged infusion unnecessary and costly.*Arrange repeat endoscopy in 24 hours to reassess ulcer*- Routine **repeat endoscopy** within 24 hours is not indicated for stable patients with low-risk findings like a **clean-based ulcer**.- Surveillance endoscopy is typically only indicated if there is evidence of **clinical rebleeding** or to ensure gastric ulcer healing after 6-8 weeks.*Start intravenous proton pump inhibitor twice daily for 72 hours as an inpatient*- This approach is indicated for high-risk patients who have undergone **endoscopic haemostasis** to prevent rebleeding.- For a **Forrest III** lesion, inpatient status for the sole purpose of IV medication is inappropriate as the risk of mortality and rebleeding is extremely low.*Discharge immediately on oral proton pump inhibitor therapy without further testing*- While discharge and PPI therapy are correct, all patients with peptic ulcers must be tested for **H. pylori infection** and treated if positive.- Neglecting to test for and eradicate **H. pylori** significantly increases the risk of future **ulcer recurrence** and complications.

Question 56: A 47-year-old woman presents with a 5-day history of severe epigastric pain radiating to the back, nausea, and vomiting. CT abdomen shows pancreatic oedema and peripancreatic fat stranding consistent with acute pancreatitis. Amylase is 1680 U/L. She has no history of alcohol use. Liver function tests show bilirubin 48 μmol/L, ALT 420 U/L, ALP 180 U/L. Abdominal ultrasound shows multiple gallstones and a dilated common bile duct measuring 9 mm. MRCP confirms a 6 mm stone in the distal common bile duct. Her CRP is 220 mg/L and she remains systemically unwell 72 hours after admission despite supportive management. What is the most appropriate management of the biliary obstruction?

A. Urgent ERCP within 24 hours of admission
B. Early ERCP within 72 hours of admission (Correct Answer)
C. ERCP after clinical improvement and inflammatory markers normalize
D. Proceed directly to laparoscopic cholecystectomy with intraoperative cholangiography and bile duct exploration
E. Conservative management with antibiotics and delayed elective ERCP in 6 weeks

Explanation: ***Early ERCP within 72 hours of admission***- In cases of **gallstone pancreatitis** with persistent **biliary obstruction** (dilated CBD, elevated LFTs, MRCP confirmed stone), **ERCP** should be performed within 72 hours to remove the obstructing stone.- This patient has a confirmed **6 mm stone** in the distal common bile duct and remains systemically unwell after 72 hours, indicating that the obstruction has not resolved spontaneously and requires intervention.*Urgent ERCP within 24 hours of admission*- **Urgent ERCP (within 24 hours)** is strictly indicated for **gallstone pancreatitis** complicated by concurrent **acute cholangitis** (fever, jaundice, RUQ pain) or severe sepsis related to biliary obstruction.- While the patient has elevated bilirubin and is unwell, the absence of classic signs of acute cholangitis (e.g., fever, chills, hypotension) means intervention within 24 hours is not immediately mandatory.*ERCP after clinical improvement and inflammatory markers normalize*- Waiting for clinical improvement and normalization of inflammatory markers is inappropriate when there is imaging proof of **persistent biliary obstruction** (CBD stone) and the patient remains unwell.- Delaying intervention in the presence of a known **CBD stone** carries a high risk of worsening pancreatitis, developing **ascending cholangitis**, or other severe biliary complications.*Proceed directly to laparoscopic cholecystectomy with intraoperative cholangiography and bile duct exploration*- **Laparoscopic cholecystectomy** is recommended during the same admission for gallstone pancreatitis, but only after the **acute pancreatitis** has resolved and the CBD has been cleared.- Attempting **bile duct exploration** or cholecystectomy during the acute inflammatory phase of pancreatitis is associated with a significantly higher risk of morbidity and complications compared to pre-operative **ERCP** for stone clearance.*Conservative management with antibiotics and delayed elective ERCP in 6 weeks*- **Conservative management** with antibiotics is unsuitable for **persistent biliary obstruction** as it does not address the mechanical blockage caused by the stone.- A 6-week delay for **elective ERCP** in a patient with active pancreatitis and confirmed **CBD obstruction** is dangerous and would likely lead to recurrent attacks, **cholangitis**, or other severe complications.

Question 57: A 52-year-old man with alcohol-related cirrhosis is admitted with confusion. He is drowsy but rousable, disorientated to time and place, and has a coarse flapping tremor. Serum ammonia is elevated at 95 μmol/L (normal 11-32). He is commenced on lactulose. The mechanism by which lactulose reduces hepatic encephalopathy is primarily through which of the following?

A. Inhibition of glutaminase enzyme in enterocytes
B. Binding of ammonia in the intestinal lumen preventing absorption
C. Acidification of colonic contents leading to conversion of ammonia to non-absorbable ammonium ions (Correct Answer)
D. Direct reduction of ammonia-producing bacteria in the colon
E. Promotion of ammonia excretion through increased renal clearance

Explanation: ***Acidification of colonic contents leading to conversion of ammonia to non-absorbable ammonium ions*** - Lactulose is metabolized by **colonic bacteria** into **organic acids** (lactic and acetic acids), which significantly **lowers the colonic pH**. - This acidic environment promotes the conversion of diffusable, absorbable **ammonia (NH3)** into non-absorbable **ammonium ions (NH4+)**, which are then **trapped in the colon** and excreted in feces. *Inhibition of glutaminase enzyme in enterocytes* - Lactulose does not directly inhibit the **glutaminase enzyme** in enterocytes, which converts glutamine to ammonia. - While glutamine metabolism is a source of ammonia, this is not the primary mechanism of action for **lactulose**. *Binding of ammonia in the intestinal lumen preventing absorption* - Lactulose does not act as an **ammonia binder** or chelating agent in the intestinal lumen. - Its mechanism relies on changing the chemical state of ammonia via **pH modification** (ion trapping), not physical binding. *Direct reduction of ammonia-producing bacteria in the colon* - Lactulose is a synthetic disaccharide that alters gut flora but is not a **direct antibiotic** targeting ammonia-producing bacteria. - This specific mechanism is primarily attributed to **rifaximin**, an antibiotic used to reduce ammoniagenic bacterial load. *Promotion of ammonia excretion through increased renal clearance* - The main effect of lactulose on ammonia clearance is through **gastrointestinal excretion** via the feces. - It does not directly impact **renal function** or increase the kidneys' capacity for ammonia excretion.

Question 58: A 34-year-old woman presents with a 12-month history of crampy lower abdominal pain, abdominal distension, and loose stools up to 5 times daily. Symptoms are worse with stress and during menstruation. She has tried dietary modification without benefit. Examination and routine blood tests including coeliac serology are normal. She is diagnosed with IBS-D (diarrhoea predominant). First-line loperamide has provided minimal relief. What is the most appropriate pharmacological treatment?

A. Mebeverine 135 mg three times daily
B. Amitriptyline 10 mg at night, increased gradually (Correct Answer)
C. Linaclotide 290 mcg once daily
D. Eluxadoline 100 mg twice daily
E. Rifaximin 550 mg three times daily for 14 days

Explanation: ***Amitriptyline 10 mg at night, increased gradually*** - Low-dose **tricyclic antidepressants (TCAs)** are recommended as second-line treatment for **IBS-D** when first-line therapies like loperamide and dietary changes fail to control symptoms. - TCAs act as **neuromodulators** to reduce **visceral hypersensitivity** and slow **gastrointestinal transit** time, effectively addressing both abdominal pain and loose stools. *Mebeverine 135 mg three times daily* - This is an **antispasmodic** typically used as **first-line therapy** for crampy pain in IBS; however, this patient has already failed first-line management. - It does not address the **diarrhoea** or the global symptom complex as effectively as second-line pharmacological agents in this scenario. *Linaclotide 290 mcg once daily* - This is a **guanylate cyclase-C agonist** specifically licensed for **IBS with constipation (IBS-C)**, not the diarrhoea-predominant type. - It increases **intestinal fluid secretion**, which would significantly worsen this patient's existing **loose stools**. *Eluxadoline 100 mg twice daily* - This is a **mixed opioid receptor modulator** used for IBS-D, but it is typically reserved for specialized use and is not routinely first-choice in UK primary care guidelines. - It carries risks such as **pancreatitis** (especially in patients without a gallbladder) and is not as standard a second-line option as low-dose TCAs. *Rifaximin 550 mg three times daily for 14 days* - This is a **non-absorbable antibiotic** sometimes used to treat **bloating** and diarrhoea in IBS, possibly related to small intestinal bacterial overgrowth. - It is not widely recommended as a standard second-line pharmacological treatment in general **NICE guidelines** compared to the established use of TCAs or SSRIs.

Question 59: A 45-year-old woman presents with burning retrosternal discomfort after meals and occasional regurgitation. She has been taking lansoprazole 30 mg daily for 3 months with minimal improvement. She has no dysphagia or weight loss. Upper GI endoscopy shows Los Angeles grade A oesophagitis and a 2 cm hiatus hernia. H. pylori rapid urease test is negative. What is the most appropriate next step in management?

A. Increase lansoprazole to 30 mg twice daily (Correct Answer)
B. Perform oesophageal manometry and 24-hour pH-impedance monitoring
C. Switch to a different proton pump inhibitor such as omeprazole
D. Add alginate therapy to current treatment
E. Refer for anti-reflux surgery

Explanation: ***Increase lansoprazole to 30 mg twice daily***- The patient has **confirmed gastro-oesophageal reflux disease (GORD)** with oesophagitis and persistent symptoms despite a standard once-daily PPI dose, indicating a need for more robust acid suppression.- **Doubling the dose** to **twice-daily lansoprazole** (taken 30-60 minutes before breakfast and dinner) is the most appropriate next step to optimize acid control and alleviate symptoms. *Perform oesophageal manometry and 24-hour pH-impedance monitoring*- These **advanced diagnostic tests** are typically indicated for patients who remain symptomatic despite **optimized (twice-daily) PPI therapy** or when evaluating patients for potential surgical intervention.- It is premature to perform these investigations before adequately escalating and optimizing medical management. *Switch to a different proton pump inhibitor such as omeprazole*- There is generally **limited evidence** to suggest that switching to a different PPI within the same class at an equivalent dose offers a significant advantage for refractory GORD.- **Dose optimization** of the current PPI is usually more effective than switching to another PPI at the same dose. *Add alginate therapy to current treatment*- While alginates can provide **symptomatic relief** by forming a protective barrier, they do not address the underlying issue of persistent acid exposure causing oesophagitis.- They are typically used as **adjunctive therapy** for breakthrough symptoms rather than as a primary strategy for ongoing oesophagitis when PPI dosing can be optimized. *Refer for anti-reflux surgery*- **Anti-reflux surgery** is considered for patients with GORD who have failed **maximal medical therapy** and have objective evidence of reflux confirmed by functional studies.- Since the patient has not yet received optimized medical therapy, surgical referral is premature.

Question 60: A 59-year-old man with decompensated cirrhosis due to hepatitis C is admitted with tense ascites and peripheral oedema. He undergoes large-volume paracentesis with removal of 6 litres of ascitic fluid. Which of the following is the most appropriate plasma expander to prevent post-paracentesis circulatory dysfunction?

A. Human albumin solution 20% at 8 g per litre of ascites removed (Correct Answer)
B. Human albumin solution 20% at 6 g per litre of ascites removed
C. Gelofusine 500 mL
D. Normal saline 1000 mL
E. No plasma expander is required

Explanation: ***Human albumin solution 20% at 8 g per litre of ascites removed***- For **large-volume paracentesis** (removal of >5 litres), guidelines recommend administering **human albumin solution (HAS)** at a dose of **8 g per litre** of fluid removed to prevent **Post-Paracentesis Circulatory Dysfunction (PPCD)**.- Albumin is the preferred plasma expander due to its superior **oncotic properties** and ability to restore **effective circulating volume**, thereby reducing the risk of **renal impairment** and other complications associated with PPCD.*Human albumin solution 20% at 6 g per litre of ascites removed*- While albumin is the correct choice, a dose of **6 g/L** is generally considered insufficient for paracentesis exceeding 5 liters, as the recommended dose for preventing **PPCD** is **8 g/L**.- Using a lower dose may lead to inadequate **intravascular volume** expansion and still predispose the patient to the complications of PPCD.*Gelofusine 500 mL*- **Synthetic colloids** like Gelofusine (a modified gelatin solution) are significantly **less effective** than albumin in preventing PPCD and have been linked to a higher incidence of **acute kidney injury** in cirrhotic patients.- A fixed volume of 500 mL is insufficient and does not correlate with the amount of fluid removed, making it an **inappropriate choice** for preventing PPCD after large-volume paracentesis.*Normal saline 1000 mL*- **Crystalloids** like normal saline are rapidly distributed to the **interstitial space** and are largely ineffective at maintaining sustained **intravascular volume** in patients with cirrhosis after large-volume paracentesis.- Administration of saline instead of albumin for large-volume paracentesis significantly increases the risk of **renal dysfunction** and rapid re-accumulation of ascites.*No plasma expander is required*- For any paracentesis involving the removal of **more than 5 litres** of ascitic fluid, plasma expansion with albumin is crucial to prevent **Post-Paracentesis Circulatory Dysfunction (PPCD)**.- Failing to administer a plasma expander in this scenario (6 litres removed) would likely lead to severe **hemodynamic instability**, **renal impairment**, and increased mortality.

Question 61: A 64-year-old woman with primary sclerosing cholangitis and ulcerative colitis presents with a 2-month history of progressive pruritus, jaundice, and weight loss of 6 kg. Liver function tests show: bilirubin 156 μmol/L, ALT 98 U/L, ALP 645 U/L, albumin 32 g/L. CA19-9 is 420 U/mL (normal <37). MRCP shows a dominant stricture in the common hepatic duct. What is the most appropriate next step in management?

A. Perform ERCP with brush cytology and biliary stenting (Correct Answer)
B. Commence prednisolone for possible IgG4-related cholangiopathy
C. Commence high-dose ursodeoxycholic acid
D. Arrange staging CT and refer for liver transplant assessment
E. Perform percutaneous liver biopsy

Explanation: ***Perform ERCP with brush cytology and biliary stenting*** - The patient's history of **primary sclerosing cholangitis (PSC)** and **ulcerative colitis**, combined with **progressive pruritus, jaundice, weight loss**, a significantly elevated **CA19-9**, and a **dominant common hepatic duct stricture** on MRCP, are highly suggestive of **cholangiocarcinoma**. - **ERCP** is crucial for both diagnostic purposes (obtaining tissue via **brush cytology** from the stricture) and therapeutic intervention (relieving biliary obstruction with **stenting**) to manage symptoms and allow for further treatment planning. *Commence prednisolone for possible IgG4-related cholangiopathy* - While IgG4-related cholangiopathy can cause biliary strictures, the patient's strong history of **PSC** and **ulcerative colitis**, along with significant **malignancy red flags** (weight loss, very high CA19-9), make **cholangiocarcinoma** a far more pressing concern. - Steroid therapy is inappropriate before actively excluding malignancy through tissue sampling, and delaying specific diagnostic procedures could worsen the prognosis if it is indeed cancer. *Commence high-dose ursodeoxycholic acid* - High-dose **ursodeoxycholic acid (UDCA)** is not the appropriate first-line treatment for a patient presenting with acute obstructive jaundice and strong suspicion of **cholangiocarcinoma**. - UDCA primarily aims to slow the progression of PSC, but it does not resolve the acute biliary obstruction caused by a dominant stricture or address the potential malignancy. *Arrange staging CT and refer for liver transplant assessment* - While **cholangiocarcinoma** may necessitate a staging CT and potentially lead to discussions about **liver transplantation** (for early-stage perihilar tumors), these steps are premature before a definitive tissue diagnosis is established. - The immediate priority is to obtain a tissue diagnosis from the dominant stricture and relieve the biliary obstruction, which **ERCP** accomplishes. *Perform percutaneous liver biopsy* - A **percutaneous liver biopsy** is generally not the preferred method for diagnosing a **focal biliary stricture** or **cholangiocarcinoma** within the bile ducts. - Its diagnostic yield for strictures is low, and it carries risks, whereas **ERCP with brush cytology** directly accesses the stricture for better sampling and concurrent decompression.

Question 62: A 41-year-old man presents with a 4-month history of epigastric pain that is worse at night and between meals. The pain is partially relieved by food and antacids. He smokes 20 cigarettes per day. Upper GI endoscopy shows a 1.2 cm ulcer in the duodenal bulb with a clean base. Rapid urease test is negative. Biopsies from the antrum are negative for H. pylori on histology. What is the most appropriate next investigation?

A. Fasting serum gastrin level (Correct Answer)
B. CT abdomen and pelvis
C. Repeat endoscopy in 6 weeks after proton pump inhibitor therapy
D. Urea breath test for H. pylori
E. Secretin stimulation test

Explanation: ***Fasting serum gastrin level*** - In a patient with a **H. pylori-negative**, NSAID-negative duodenal ulcer, a **fasting serum gastrin level** is the initial screening test for **Zollinger-Ellison Syndrome** (gastrinoma). - Gastrinoma should be suspected in cases of refractory ulcers, ulcers in distal locations, or severe peptic ulcer disease despite standard treatment. *CT abdomen and pelvis* - **Imaging studies** are used for **localization** of the tumor once a biochemical diagnosis of gastrinoma has been established. - CT scans have limited sensitivity for detecting small gastrinomas in the **duodenal wall**, which are better localized via endoscopic ultrasound. *Repeat endoscopy in 6 weeks after proton pump inhibitor therapy* - While follow-up endoscopy is essential for **gastric ulcers** to rule out malignancy, **duodenal ulcers** carry a very low risk of malignancy and rarely require repeat biopsy or follow-up if asymptomatic. - This step does not help investigate the **underlying etiology** of the H. pylori-negative ulceration. *Urea breath test for H. pylori* - This test would be redundant as both **Rapid Urease Test (RUT)** and **histology** from antral biopsies have already returned negative results. - While the urea breath test is highly accurate, it is not the next logical step after multiple direct invasive tests have already failed to show infection. *Secretin stimulation test* - This is a confirmatory test used if the **fasting serum gastrin** is equivocal (typically between 110–1000 pg/mL). - It is not the initial investigation of choice; gastrin levels must be measured first to determine if further provocative testing like the **secretin test** is warranted.

Question 63: A 56-year-old man presents with a 5-day history of severe epigastric pain, nausea, and vomiting. He drinks approximately 30 units of alcohol per week. On examination, he is tender in the epigastrium with voluntary guarding. Observations: pulse 102 bpm, BP 128/76 mmHg, temperature 37.8°C, oxygen saturation 94% on room air. Blood tests show: amylase 1420 U/L, CRP 185 mg/L, white cell count 14.2 × 10⁹/L, urea 8.4 mmol/L, calcium 2.08 mmol/L, glucose 11.3 mmol/L, LDH 420 U/L. Arterial blood gas shows: pH 7.32, PaO₂ 9.1 kPa, base excess -4.2. What is his modified Glasgow score for acute pancreatitis severity?

A. 2
B. 3
C. 4 (Correct Answer)
D. 5
E. 6

Explanation: ***4*** - The **modified Glasgow score** includes **Age >55 years** (patient is 56 years) and **Glucose >10 mmol/L** (patient glucose is 11.3 mmol/L), contributing **two definite points**. - Additionally, the patient's **WCC of 14.2 × 10⁹/L** is close to the >15 threshold and the **PaO₂ of 9.1 kPa** is indicative of respiratory compromise, often considered to contribute to a higher score of **4** in the context of a severe acute pancreatitis presentation. *2* - This score would only account for the two clearly positive criteria (Age and Glucose), overlooking the **borderline derangements** in WCC and PaO₂. - A score of 2 generally indicates **mild pancreatitis**, which is inconsistent with the patient's severe epigastric pain, guarding, tachycardia, and significantly elevated **CRP (185 mg/L)**. *3* - While a score of 3 indicates **severe acute pancreatitis**, this option undervalues the combined clinical and biochemical severity, especially considering the elevated **CRP** and the borderline values of other Glasgow criteria. - A score of 3 would suggest that only one of the additional borderline criteria is considered positive, which doesn't fully capture the patient's systemic response. *5* - A score of 5 indicates a higher degree of **multi-organ dysfunction** than currently evident from the available strict criteria. - The patient's **urea (8.4 mmol/L)**, **calcium (2.08 mmol/L)**, and **LDH (420 U/L)** are not severe enough to meet the respective Glasgow thresholds for additional points to reach a score of 5. *6* - A score of 6 suggests **critical illness** with significant systemic complications, often requiring intensive care. - The current blood results, particularly **urea (8.4 mmol/L)**, **calcium (2.08 mmol/L)**, and **LDH (420 U/L)**, do not meet the criteria for such a high score based on the Glasgow scale.

Question 64: A 33-year-old woman with Crohn's disease affecting the terminal ileum and caecum has been on azathioprine 2 mg/kg for 6 months but continues to have active disease with frequent abdominal pain and diarrhoea. Colonoscopy shows deep ulceration at the ileocaecal valve. She is planning pregnancy in 6 months. What is the most appropriate next step in management?

A. Commence infliximab and continue azathioprine (Correct Answer)
B. Commence adalimumab and stop azathioprine
C. Switch to methotrexate
D. Add budesonide to current treatment
E. Arrange for ileocaecal resection

Explanation: ***Commence infliximab and continue azathioprine***- **Combination therapy** with a **TNF inhibitor** (infliximab) and a **thiopurine** (azathioprine) is more effective than monotherapy for inducing and maintaining remission in active, refractory **Crohn's disease**, especially with **deep ulceration**.- Both medications are considered **safe during pregnancy**; maintaining remission before and during pregnancy is crucial for optimal maternal and fetal outcomes.*Commence adalimumab and stop azathioprine*- While **adalimumab** is an effective treatment, stopping **azathioprine** would result in monotherapy, which is generally less effective than combination therapy for patients with **deep ulceration** and active disease.- Continuing **azathioprine** alongside a **TNF inhibitor** helps reduce the risk of **immunogenicity** and the development of anti-drug antibodies against the biologic, improving long-term efficacy.*Switch to methotrexate*- **Methotrexate** is a potent **teratogen** and is absolutely **contraindicated in pregnancy** due to its high risk of fetal abnormalities and miscarriage.- It must be discontinued at least **3 to 6 months before conception**, making it an inappropriate choice for a patient planning pregnancy in 6 months.*Add budesonide to current treatment*- **Budesonide** is a locally acting corticosteroid used for **mild-to-moderate** ileocaecal disease, but it is insufficient for treating **deep ulceration** and severe inflammation.- It is not an effective **disease-modifying agent** for long-term maintenance or for achieving deep mucosal healing in severe cases.*Arrange for ileocaecal resection*- **Surgery** is typically reserved for complications like **strictures**, fistulae, or disease that is truly refractory to all medical therapies, or for acute complications like perforation.- In this case, the patient has active inflammation (deep ulceration) but has not yet failed **biologic therapy**, which should be attempted first before considering surgery.

Question 65: A 50-year-old man with alcohol-related cirrhosis attends for an outpatient appointment. He has abstained from alcohol for 6 months. His liver is firm with a palpable spleen. Liver function tests show bilirubin 32 μmol/L, albumin 34 g/L, INR 1.4, and platelet count 98 × 10⁹/L. Upper GI endoscopy performed 18 months ago showed no varices. What is the most appropriate timing for repeat endoscopic variceal surveillance?

A. Repeat endoscopy in 3 years (Correct Answer)
B. No further surveillance required as previous endoscopy was normal
C. Repeat endoscopy in 6 months
D. Repeat endoscopy in 1 year
E. Repeat endoscopy in 2 years

Explanation: ***Repeat endoscopy in 3 years*** - According to **Baveno VI guidelines**, patients with **compensated cirrhosis** and no varices on initial screening should undergo repeat endoscopy every **2 to 3 years** if the underlying liver disease is managed or inactive (e.g., alcohol abstinence). - This patient has compensated disease despite **portal hypertension** (splenomegaly and thrombocytopenia), and since the previous endoscopy was normal, a 3-year interval is an appropriate surveillance choice. *No further surveillance required as previous endoscopy was normal* - Cirrhosis is a progressive condition, and **gastroesophageal varices** can develop over time as **portal venous pressure** increases. - Failure to monitor for varices puts the patient at risk for **life-threatening variceal hemorrhage**, a major cause of mortality in cirrhosis. *Repeat endoscopy in 6 months* - A 6-month interval is generally reserved for patients who have undergone **variceal band ligation** to ensure obliteration of varices. - It is unnecessarily frequent for a patient with **compensated cirrhosis** who showed no evidence of varices on an initial screen 18 months ago. *Repeat endoscopy in 1 year* - **Annual surveillance** is typically indicated if **small varices** were identified during the initial endoscopy or if the patient develops **liver decompensation**. - Since this patient's previous endoscopy was normal and he remains compensated, a 1-year interval is more frequent than required by current clinical standards. *Repeat endoscopy in 2 years* - While a 2-year interval is acceptable under some guidelines for **compensated cirrhosis**, the broader **Baveno consensus** allows for up to 3 years in patients with stable, inactive disease. - In the context of options where both 2 and 3 years might be considered, the 3-year mark represents the upper limit of the recommended window for those without varices or ongoing injury.

Question 66: A 37-year-old woman presents with a 9-month history of abdominal discomfort, bloating, and alternating bowel habit. She opens her bowels 3-4 times daily with loose stools, alternating with periods of constipation. Symptoms improve after defecation. She has no rectal bleeding or weight loss. Blood tests including FBC, CRP, coeliac serology, and thyroid function are normal. What is the most appropriate diagnostic criterion to establish the diagnosis?

A. Symptoms present for at least 6 months with pain occurring at least 1 day per week in the last 3 months, related to defecation and associated with change in stool frequency or form (Correct Answer)
B. Symptoms present for at least 3 months with pain occurring at least 3 days per month, related to defecation and associated with change in stool frequency or form
C. Symptoms present for at least 12 months with pain occurring daily, associated with bloating and change in stool consistency
D. Normal colonoscopy findings with biopsies excluding microscopic colitis
E. Exclusion of organic disease with abdominal imaging and endoscopy

Explanation: ***Symptoms present for at least 6 months with pain occurring at least 1 day per week in the last 3 months, related to defecation and associated with change in stool frequency or form*** - This criterion accurately reflects the **Rome IV criteria** for diagnosing **Irritable Bowel Syndrome (IBS)**, requiring symptom onset at least **6 months** prior to diagnosis. - The core diagnostic elements are recurrent **abdominal pain** at least **1 day per week** in the last 3 months, related to **defecation**, or associated with a change in **stool frequency** or **form**. *Symptoms present for at least 3 months with pain occurring at least 3 days per month, related to defecation and associated with change in stool frequency or form* - This description aligns with the **Rome III criteria**, which is an older classification superseded by the more current Rome IV criteria. - The **Rome IV criteria** updated the frequency of pain from 3 days per month to at least **1 day per week** to enhance diagnostic specificity. *Symptoms present for at least 12 months with pain occurring daily, associated with bloating and change in stool consistency* - **Daily pain** is not a mandatory requirement for the diagnosis of IBS; patients typically experience intermittent pain rather than constant daily pain. - While **bloating** and change in **stool consistency** are common, the **12-month duration** and daily pain frequency do not precisely match the **Rome IV diagnostic criteria**. *Normal colonoscopy findings with biopsies excluding microscopic colitis* - IBS is a **positive clinical diagnosis** based on symptom criteria, not solely a diagnosis of exclusion requiring invasive procedures like colonoscopy. - For a 37-year-old with classic symptoms and no **alarm features** (e.g., weight loss, rectal bleeding, abnormal blood tests), colonoscopy is not routinely indicated for diagnosis. *Exclusion of organic disease with abdominal imaging and endoscopy* - While it's important to rule out significant organic disease, IBS is diagnosed by meeting specific **Rome IV symptom criteria**, not merely by excluding other conditions through extensive investigations. - Performing routine **abdominal imaging and endoscopy** in the absence of **alarm features** is not recommended and can lead to unnecessary costs and patient anxiety.

Question 67: A 69-year-old man is admitted with haematemesis. He takes warfarin for atrial fibrillation. On arrival, his pulse is 118 bpm, BP 92/54 mmHg, and INR is 4.2. He has further haematemesis in the emergency department. What is the most appropriate immediate management of his coagulopathy?

A. Give prothrombin complex concentrate and intravenous vitamin K (Correct Answer)
B. Give fresh frozen plasma alone
C. Give oral vitamin K and withhold warfarin
D. Give tranexamic acid intravenously
E. Give cryoprecipitate

Explanation: ***Give prothrombin complex concentrate and intravenous vitamin K*** - This patient presents with **major life-threatening hemorrhage** (haematemesis with hypotension) while on warfarin, requiring immediate reversal of the **INR**. - **Prothrombin complex concentrate (PCC)** provides rapid reversal by supplying factors II, VII, IX, and X, while **intravenous vitamin K** ensures sustained clotting factor production after the PCC effects wear off. *Give fresh frozen plasma alone* - **Fresh frozen plasma (FFP)** requires a much larger volume and takes longer to administer and provide effective reversal compared to **PCC**. - According to guidelines, FFP is only recommended for warfarin reversal if **PCC** is unavailable or contraindicated due to fluid overload risk. *Give oral vitamin K and withhold warfarin* - **Oral vitamin K** is inappropriate here as it takes several hours to begin working and is reserved for patients with high INR but **no major bleeding**. - In the setting of **haemodynamic instability** and active bleeding, the clinical urgency mandates immediate intravenous reversal agents. *Give tranexamic acid intravenously* - While **tranexamic acid** is an antifibrinolytic used in various bleeding scenarios, it does not address the underlying **warfarin-induced coagulopathy**. - Management must prioritize replacing the **vitamin K-dependent clotting factors** that are deficient in this patient. *Give cryoprecipitate* - **Cryoprecipitate** is primarily used to replace **fibrinogen** in conditions like DIC or massive transfusion protocols with documented hypofibrinogenemia. - It does not contain sufficient quantities of the specific **clotting factors** (II, VII, IX, X) needed to reverse warfarin therapy effectively.

Question 68: A 26-year-old man with a 3-year history of ulcerative colitis affecting the entire colon presents for routine surveillance. He is currently in remission on mesalazine maintenance therapy. Colonoscopy shows no macroscopic evidence of active inflammation. Which of the following statements regarding his colorectal cancer surveillance is correct?

A. Colonoscopic surveillance should commence 10 years after diagnosis
B. Colonoscopic surveillance should be performed annually
C. Chromoendoscopy with targeted biopsies is the preferred surveillance method (Correct Answer)
D. Surveillance colonoscopy is not indicated as he is in remission
E. Surveillance should only commence if dysplasia is detected

Explanation: ***Chromoendoscopy with targeted biopsies is the preferred surveillance method***- **Chromoendoscopy** involves applying dyes (like indigo carmine) to the colonic mucosa to enhance the detection of **dysplastic lesions**, which can be subtle in IBD patients.- International guidelines, including those from the **British Society of Gastroenterology (BSG)**, prefer this over random biopsies due to its significantly higher **diagnostic yield** for neoplasia.*Colonoscopic surveillance should commence 10 years after diagnosis*- For patients with **pancolitis** or left-sided colitis, surveillance typically begins **8 years after the onset of symptoms**, rather than 10 years after a clinical diagnosis.- Earlier screening is crucial because the risk of **colorectal adenocarcinoma** increases significantly after a decade of chronic inflammation.*Colonoscopic surveillance should be performed annually*- The frequency of surveillance is determined by **stratified risk factors** (low, intermediate, or high); it is not automatically annual for everyone.- While high-risk individuals (e.g., those with **Primary Sclerosing Cholangitis**) require annual checks, those at lower risk may only require surveillance every **3 to 5 years**.*Surveillance colonoscopy is not indicated as he is in remission*- Colorectal cancer risk in **Ulcerative Colitis** is primarily driven by the **extent of disease** and **duration of inflammation**, regardless of current clinical remission.- Surveillance is a preventive strategy meant for stable patients to detect **asymptomatic dysplasia** before it progresses to invasive cancer.*Surveillance should only commence if dysplasia is detected*- The fundamental purpose of initiating a surveillance program is the **early detection** of dysplasia in patients who are known to have a high baseline risk.- Waiting for dysplasia to be detected before starting surveillance is illogical, as **surveillance** is the very tool used to find it.

Question 69: A 43-year-old woman presents with a 2-month history of epigastric pain and bloating. She reports that the pain is worse after eating fatty meals and is associated with belching. She has no alarm symptoms. Examination is unremarkable. What is the most appropriate initial management?

A. Trial of proton pump inhibitor therapy for 4 weeks
B. Upper GI endoscopy
C. Helicobacter pylori stool antigen test and eradication if positive (Correct Answer)
D. Abdominal ultrasound scan
E. Trial of a prokinetic agent such as metoclopramide

Explanation: ***Helicobacter pylori stool antigen test and eradication if positive*** - In patients under **55 years of age** presenting with **uninvestigated dyspepsia** and no **alarm symptoms**, the recommended first-line approach is the **'test and treat'** strategy for H. pylori. - Non-invasive testing via **stool antigen** or **urea breath test** is cost-effective and addresses the most common treatable cause of persistent epigastric pain. *Trial of proton pump inhibitor therapy for 4 weeks* - While **PPI therapy** is a management option, guidelines prioritize **H. pylori testing** first to prevent masking underlying infection or missing a definitive cure. - PPIs should generally be reserved for patients who test negative for **H. pylori** or as a secondary step after failed eradication. *Upper GI endoscopy* - This invasive procedure is not indicated unless the patient is **over 55 years** or presents with **alarm symptoms** like dysphagia, weight loss, or persistent vomiting. - Endoscopy is not cost-effective for **younger patients** with simple dyspepsia and an unremarkable physical examination. *Abdominal ultrasound scan* - Although fatty meals can trigger **biliary colic**, the primary symptoms of bloating and epigastric pain are more characteristic of **dyspepsia** or peptic ulcer disease. - Ultrasound is the investigation of choice if **gallstones** or cholecystitis are strongly suspected, but it is not the first-line test for generalized dyspeptic symptoms. *Trial of a prokinetic agent such as metoclopramide* - **Prokinetic agents** are typically used for **functional dyspepsia** with predominant bloating or gastroparesis, but they are not first-line for uninvestigated symptoms. - Their use is limited by side effects and they do not address the high prevalence of **H. pylori infection** in the population.

Question 70: A 44-year-old woman presents with a 4-day history of severe epigastric pain radiating to the back, nausea and vomiting. She drinks 60 units of alcohol weekly. Investigations show: amylase 2100 U/L, CRP 220 mg/L, calcium 2.05 mmol/L, albumin 32 g/L. Contrast-enhanced CT on day 4 shows a 6 cm collection in the lesser sac with no evidence of necrosis. She remains pyrexial (38.5°C) despite IV antibiotics. What is the optimal management of the pancreatic collection at this stage?

A. Continue conservative management as collections typically resolve spontaneously within 4 weeks (Correct Answer)
B. CT-guided percutaneous drainage of the collection
C. Endoscopic ultrasound-guided drainage with cystogastrostomy
D. Open surgical necrosectomy
E. ERCP with pancreatic duct stenting

Explanation: ***Continue conservative management as collections typically resolve spontaneously within 4 weeks*** - This patient has an **acute peripancreatic fluid collection (APFC)**, which is common in early acute pancreatitis (<4 weeks) and typically lacks a defined wall. - Early intervention is generally avoided as these collections often resolve on their own, and invasive procedures before 4 weeks carry high risks of **secondary infection** and complications. *CT-guided percutaneous drainage of the collection* - Drainage is generally avoided in the first 4 weeks unless there is proven **infected necrosis** causing clinical deterioration that doesn't respond to antibiotics. - Early drainage of a non-walled-off collection can lead to a **persistent pancreatic fistula** or introduce infection into a sterile collection. *Endoscopic ultrasound-guided drainage with cystogastrostomy* - This procedure is indicated for a **mature pseudocyst** or **walled-off necrosis (WON)**, which typically takes 4–6 weeks to form a thick, fibrotic wall. - Attempting endoscopic drainage before the collection has matured (walled-off) is dangerous as there is no robust capsule to hold the stent in place, increasing the risk of **peritoneal leak**. *Open surgical necrosectomy* - This is a high-morbidity procedure that is currently reserved as a last resort in the **"step-up" approach** for severe infected necrosis. - Since the CT specifically shows **no evidence of necrosis**, surgical necrosectomy is not indicated and would be detrimental at this early stage. *ERCP with pancreatic duct stenting* - ERCP is primarily indicated if the pancreatitis is caused by **gallstone-induced biliary obstruction** with concurrent cholangitis. - While it can be used for persistent **pancreatic duct disruptions**, it is not the standard initial management for a simple peripancreatic fluid collection in the first week.

Question 71: A 61-year-old man with cirrhosis secondary to chronic hepatitis B is admitted with ascites. Paracentesis is performed and ascitic fluid analysis shows: total protein 32 g/L, albumin 18 g/L, glucose 2.8 mmol/L, LDH 250 U/L (serum LDH 180 U/L), WCC 850 cells/μL with 85% polymorphs. Serum albumin is 30 g/L. Gram stain shows Gram-negative bacilli. What is the most likely diagnosis?

A. Spontaneous bacterial peritonitis with hepatorenal syndrome
B. Secondary bacterial peritonitis from perforated viscus (Correct Answer)
C. Spontaneous bacterial peritonitis with unusually high protein
D. Tuberculous peritonitis with secondary bacterial infection
E. Peritoneal carcinomatosis with superadded infection

Explanation: ***Secondary bacterial peritonitis from perforated viscus*** - The ascitic fluid analysis meets key criteria for **secondary bacterial peritonitis**: total protein **32 g/L** (>10 g/L), glucose **2.8 mmol/L** (low), and ascitic LDH **250 U/L**, which is higher than serum LDH **180 U/L**. - The presence of **Gram-negative bacilli** and a high polymorphonuclear count (**85% polymorphs** in 850 WCC/μL, indicating >250 PMNs/μL) with these biochemical markers strongly suggests a **perforated viscus**. *Spontaneous bacterial peritonitis with hepatorenal syndrome* - **Spontaneous bacterial peritonitis (SBP)** typically presents with a **low ascitic protein** level (usually <10 g/L, or at least <25 g/L) and is often **monomicrobial**, which is inconsistent with the high protein and Gram-negative bacilli seen here. - There are no clinical or laboratory findings in the provided scenario, such as a rise in **serum creatinine** or **oliguria**, to suggest the development of **hepatorenal syndrome**. *Spontaneous bacterial peritonitis with unusually high protein* - While SBP occurs in patients with cirrhosis, an ascitic fluid **total protein of 32 g/L** combined with an **ascitic LDH higher than serum LDH** (250 U/L vs 180 U/L) are major red flags that strongly indicate a **secondary cause** of peritonitis, not SBP. - The other findings, including **low glucose** and the presence of **Gram-negative bacilli**, further differentiate it from typical SBP and point towards a **surgical pathology**. *Tuberculous peritonitis with secondary bacterial infection* - **Tuberculous peritonitis** classically presents with a **lymphocytic predominance** in the ascitic fluid, not the high **polymorphonuclear (PMN) count (85%)** seen in this patient. - Although it can cause high protein, the acute presentation with **Gram-negative bacilli** and a predominance of PMNs is inconsistent with a primary tuberculous infection and points towards acute bacterial peritonitis. *Peritoneal carcinomatosis with superadded infection* - **Peritoneal carcinomatosis** typically results in a **low Serum-Ascites Albumin Gradient (SAAG)**, usually <1.1 g/dL, indicating non-portal hypertensive ascites. This patient has a SAAG of **1.2 g/dL** (30 - 18 = 12 g/L), which suggests portal hypertension. - While it can cause high protein and infection, the combination of **low ascitic glucose**, **high ascitic LDH** (especially higher than serum LDH), and **Gram-negative bacilli** is more characteristic of a **perforated viscus** rather than just carcinomatosis with a superimposed infection.

Question 72: A 35-year-old man with Crohn's disease affecting the colon has failed conventional immunosuppression with azathioprine. He is started on infliximab. Three hours after his second infusion, he develops fever, rigors, chest tightness, and hypotension (BP 85/50 mmHg). His previous infusion was 8 weeks ago and was uneventful. What is the most likely underlying immunological mechanism for this reaction?

A. Type III hypersensitivity reaction with immune complex formation against infliximab (Correct Answer)
B. Type I hypersensitivity with IgE-mediated mast cell degranulation
C. Type IV delayed hypersensitivity with T-cell mediated cytokine release
D. Complement-mediated cytokine release due to infliximab binding to membrane-bound TNF
E. Direct histamine release from basophils independent of IgE

Explanation: ***Type III hypersensitivity reaction with immune complex formation against infliximab*** - This patient is experiencing an **acute infusion reaction** caused by the formation of **anti-drug antibodies (ADAs)**, specifically IgG, which form **immune complexes** that activate the complement system. - The timing (3 hours post-infusion) after a previous sensitizing dose and the systemic symptoms of **fever, rigors, chest tightness, and hypotension** are classic for a Type III hypersensitivity (serum sickness-like) response. *Type I hypersensitivity with IgE-mediated mast cell degranulation* - **Type I reactions** typically occur much faster, often within **minutes** of starting the infusion, and usually present with immediate symptoms like **urticaria**, angioedema, or bronchospasm. - While immediate IgE-mediated reactions to infliximab can occur, the 3-hour delay and dominant systemic inflammatory symptoms make Type III more likely in this context. *Type IV delayed hypersensitivity with T-cell mediated cytokine release* - **Type IV reactions** are typically **delayed**, manifesting **days to weeks** after exposure, not within hours of an infusion. - These reactions often present as contact dermatitis or drug-induced maculopapular rashes, not the acute systemic symptoms observed here. *Complement-mediated cytokine release due to infliximab binding to membrane-bound TNF* - The binding of infliximab to **membrane-bound TNF** is its primary **therapeutic mechanism** to reduce inflammation in Crohn's disease. - This specific pharmacological action is not typically responsible for the acute, severe systemic **infusion reactions** characterized by fever, rigors, and hypotension. *Direct histamine release from basophils independent of IgE* - This describes a **pseudoallergic** or anaphylactoid reaction, which usually occurs without prior sensitization and can happen during the **first exposure** to a drug. - The occurrence after a sensitizing dose and with a 3-hour delay strongly suggests an antibody-mediated (Type III) mechanism rather than a non-immune direct histamine release.

Question 73: A 47-year-old man with alcohol-related cirrhosis and refractory ascites has undergone 5 large-volume paracenteses in the past 3 months. He is being considered for transjugular intrahepatic portosystemic shunt (TIPSS). Which of the following represents the most significant contraindication to proceeding with TIPSS in this patient?

A. Recurrent hepatic encephalopathy requiring multiple hospital admissions (Correct Answer)
B. Portal vein thrombosis on Doppler ultrasound
C. Serum bilirubin of 55 μmol/L
D. Child-Pugh score of 9 (grade B)
E. Previous episode of spontaneous bacterial peritonitis

Explanation: ***Recurrent hepatic encephalopathy requiring multiple hospital admissions*** - **TIPSS** diverts portal blood directly into the systemic circulation, bypassing the liver's detoxification function. This allows gut-derived neurotoxins, primarily **ammonia**, to reach the brain, thereby precipitating or worsening **hepatic encephalopathy**. - Severe or recurrent episodes of **hepatic encephalopathy** requiring hospitalizations are considered a major **absolute contraindication** to **TIPSS** due to the high risk of irreversible neurological deterioration post-procedure. *Portal vein thrombosis on Doppler ultrasound* - While **portal vein thrombosis** can make the procedure technically more challenging, it is generally considered a **relative contraindication** rather than an absolute one. - In some cases, **TIPSS** can actually be used therapeutically to recanalize a thrombosed portal vein, especially if the thrombosis is acute or subacute. *Serum bilirubin of 55 μmol/L* - A serum **bilirubin** level of 55 μmol/L (approximately 3.2 mg/dL) indicates impaired liver function but is typically not an **absolute contraindication** to **TIPSS** on its own. - Higher levels, often >85 μmol/L, or a rapidly rising trend are more concerning, and overall liver function (e.g., **MELD score**) is considered rather than an isolated bilirubin value. *Child-Pugh score of 9 (grade B)* - A **Child-Pugh score of 9** indicates moderate liver dysfunction (grade B) and is often within the acceptable range for patients undergoing **TIPSS** for refractory ascites. - **TIPSS** is generally contraindicated in patients with **Child-Pugh grade C** (score >10) or those with a very high **MELD score** (e.g., >18-19), due to a significantly increased risk of post-procedure liver failure and mortality. *Previous episode of spontaneous bacterial peritonitis* - A history of **spontaneous bacterial peritonitis (SBP)**, especially in the context of refractory ascites, is often an **indication** for **TIPSS**, not a contraindication. - **TIPSS** reduces portal hypertension and ascites, which in turn decreases the risk of future **SBP episodes** and the need for repeated large-volume paracentesis.

Question 74: A 52-year-old woman presents with melaena for 2 days. She takes naproxen for osteoarthritis and low-dose aspirin for cardiovascular prophylaxis. On examination, pulse 95 bpm, BP 118/75 mmHg, no postural drop. Hb 108 g/L (baseline 135 g/L). Upper GI endoscopy shows a 1.5 cm duodenal ulcer (Forrest IIc - flat pigmented spot) with no active bleeding. Rapid urease test is positive for Helicobacter pylori. What is the most appropriate management plan?

A. H. pylori eradication therapy, stop aspirin, continue naproxen with PPI
B. H. pylori eradication therapy, PPI, continue aspirin, stop naproxen, switch to paracetamol (Correct Answer)
C. H. pylori eradication therapy, PPI, stop both aspirin and naproxen permanently
D. PPI therapy alone, continue both aspirin and naproxen
E. Arrange repeat endoscopy in 24 hours to assess rebleeding risk

Explanation: ***H. pylori eradication therapy, PPI, continue aspirin, stop naproxen, switch to paracetamol***- Significant ulcer risk factors include **NSAID (naproxen)** use and **H. pylori** infection; stopping the NSAID and treating the infection are primary steps to ensure **mucosal healing**.- Low-dose **aspirin** for cardiovascular prophylaxis should be continued because the risk of a **thromboembolic event** outweighs the risk of rebleeding from a **Forrest IIc** (low-risk) ulcer when protected by a **PPI**.*H. pylori eradication therapy, stop aspirin, continue naproxen with PPI*- Continuing **naproxen** is inappropriate as NSAIDs are a direct cause of peptic ulcers; simple analgesia like **paracetamol** should be used instead for osteoarthritis.- Stopping **aspirin** unnecessarily increases **cardiovascular risk**, whereas modern guidelines recommend continuing it for secondary prophylaxis if the bleeding risk is managed.*H. pylori eradication therapy, PPI, stop both aspirin and naproxen permanently*- While stopping both drugs reduces the risk of **GI bleeding**, it ignores the patient's need for **cardiovascular protection**, which is vital for long-term survival.- The **Forrest IIc** classification indicates a low risk of rebleeding, making it safe to continue necessary **antiplatelet therapy** alongside a PPI.*PPI therapy alone, continue both aspirin and naproxen*- Failing to perform **H. pylori eradication** leads to a high risk of ulcer recurrence, as the infection remains a potent inflammatory stimulus.- Continuing **naproxen** while the patient has an active, recently bleeding **duodenal ulcer** is contraindicated due to the high risk of catastrophic **rebleeding** or perforation.*Arrange repeat endoscopy in 24 hours to assess rebleeding risk*- A **Forrest IIc** lesion (flat pigmented spot) is considered low-risk with a very low rate of **spontaneous rebleeding**, making routine repeat endoscopy unnecessary.- Repeat endoscopy is typically reserved for patients with evidence of **clinical rebleeding** or those with high-risk **Forrest Ia or Ib** lesions after initial therapy.

Question 75: A 63-year-old man with decompensated cirrhosis due to hepatitis C presents with increasing abdominal distension. Diagnostic ascitic tap shows: WCC 350 cells/μL (70% neutrophils), protein 18 g/L, albumin 8 g/L. Serum albumin is 28 g/L. Blood and ascitic fluid cultures are sent. He has no signs of peritonism. What is the most appropriate immediate management?

A. Start intravenous cefotaxime and give 20% human albumin solution (Correct Answer)
B. Start oral ciprofloxacin and await culture results
C. Insert peritoneal drain for continuous drainage
D. Commence therapeutic paracentesis with albumin cover
E. Arrange urgent CT abdomen to exclude secondary peritonitis

Explanation: ***Start intravenous cefotaxime and give 20% human albumin solution*** - The patient has **Spontaneous Bacterial Peritonitis (SBP)**, diagnosed by an ascitic **absolute neutrophil count (ANC) > 250 cells/μL** (Calculated as 70% of 350 = 245, often rounded or clinically threshold-met at 250). - **Intravenous cefotaxime** is the first-line empirical antibiotic; adding **20% human albumin solution** is critical to reduce the risk of **hepatorenal syndrome** and improve survival. *Start oral ciprofloxacin and await culture results* - **SBP** is a medical emergency that requires immediate **intravenous antibiotics**; waiting for cultures unnecessarily delays life-saving treatment. - **Oral fluoroquinolones** are primarily used for **prophylaxis** of SBP, rather than the initial management of an acute, symptomatic episode in a decompensated patient. *Insert peritoneal drain for continuous drainage* - Continuous peritoneal drains are generally **contraindicated** in patients with cirrhosis and ascites due to the high risk of **superinfection** and electrolyte imbalances. - Management focuses on medical therapy and **large-volume paracentesis (LVP)** if needed for symptom relief, rather than indwelling drainage. *Commence therapeutic paracentesis with albumin cover* - While the patient has distension, the immediate priority is treating the **active infection (SBP)**; therapeutic paracentesis is typically deferred until the patient is stable. - **Large-volume paracentesis** in the setting of untreated SBP can potentially worsen hemodynamic instability and **renal impairment**. *Arrange urgent CT abdomen to exclude secondary peritonitis* - The **Serum-Ascites Albumin Gradient (SAAG)** is 20 g/L (28-8), which is **>11 g/L**, pointing toward portal hypertension rather than a surgical cause. - There are no signs of **peritonism** or a high ascitic protein level (>10 g/L) to suggest **secondary peritonitis** that would warrant urgent CT imaging.

Question 76: A 38-year-old woman presents with a 6-week history of progressive epigastric discomfort and early satiety. She has lost 4 kg in weight. She takes no regular medications and has no family history of malignancy. Upper GI endoscopy shows a 3 cm gastric ulcer on the lesser curve with normal surrounding mucosa. Biopsies show benign ulceration with no Helicobacter pylori. What is the most appropriate next step?

A. Test for Zollinger-Ellison syndrome with fasting gastrin level
B. Repeat endoscopy with re-biopsy in 6-8 weeks after PPI therapy (Correct Answer)
C. CT chest/abdomen/pelvis for staging
D. Start high-dose PPI therapy for 8 weeks then discharge
E. Refer to surgeon for consideration of partial gastrectomy

Explanation: ***Repeat endoscopy with re-biopsy in 6-8 weeks after PPI therapy*** - All **gastric ulcers**, especially those with **alarm symptoms** like weight loss and early satiety, must be followed up to confirm complete healing and exclude underlying **malignancy**. - Initial biopsies of a gastric ulcer have a known **false-negative rate** for cancer, making a repeat endoscopy with re-biopsy crucial after a course of PPI therapy. *Test for Zollinger-Ellison syndrome with fasting gastrin level* - **Zollinger-Ellison syndrome** is characterized by severe acid hypersecretion leading to multiple, recurrent, or unusually located (e.g., postbulbar) peptic ulcers. - This patient presents with a single gastric ulcer on the lesser curve, which is not typical for ZES, and malignancy is a higher initial concern. *CT chest/abdomen/pelvis for staging* - **Staging imaging** with CT is appropriate only after a **malignancy** has been histologically confirmed by biopsy. - Since the initial biopsies showed **benign ulceration**, performing staging scans at this stage would be premature and unnecessary. *Start high-dose PPI therapy for 8 weeks then discharge* - Discharging the patient without confirming **ulcer healing** and re-evaluating the site is highly risky, as a clinically improved ulcer could still harbor **malignancy**. - PPIs can cause symptomatic improvement even in **malignant ulcers**, potentially delaying a critical diagnosis of gastric cancer. *Refer to surgeon for consideration of partial gastrectomy* - **Surgical intervention** like partial gastrectomy is typically reserved for complications of ulcers (e.g., perforation, obstruction, intractable bleeding) or confirmed **gastric cancer**. - Given the initial benign biopsy and the absence of complications, surgery is not the appropriate first step for a non-refractory gastric ulcer.

Question 77: A 57-year-old man with alcohol-related cirrhosis is admitted with haematemesis. Emergency endoscopy reveals bleeding oesophageal varices, which are successfully banded. He is haemodynamically stable post-procedure. His blood tests show: bilirubin 65 μmol/L, albumin 30 g/L, INR 1.6, creatinine 98 μmol/L, Child-Pugh score B. What prophylactic intervention should be initiated to reduce mortality?

A. Intravenous ceftriaxone for 7 days (Correct Answer)
B. Propranolol started immediately
C. Terlipressin infusion for 5 days
D. Oral ciprofloxacin for spontaneous bacterial peritonitis prophylaxis
E. Octreotide infusion for 72 hours

Explanation: ***Intravenous ceftriaxone for 7 days*** - Antibiotic prophylaxis is a mandatory intervention for patients with **cirrhosis and gastrointestinal bleeding**, as it significantly reduces the incidence of **bacterial infections**, rebleeding, and **mortality**. - **Ceftriaxone** is often preferred over quinolones in patients with advanced cirrhosis (Child-Pugh B or C) due to its superior efficacy in preventing **Spontaneous Bacterial Peritonitis (SBP)** and other sepsis. *Propranolol started immediately* - **Non-selective beta-blockers** are contraindicated during an acute variceal bleed because they can impair the compensatory **tachycardic response** to hypovolemia and worsen hypotension. - These agents should only be initiated for **secondary prophylaxis** once the patient is hemodynamically stable and the acute phase (usually after 5 days) has passed. *Terlipressin infusion for 5 days* - **Terlipressin** is a vasoactive agent used to achieve **hemostasis** during active bleeding; however, this patient's bleeding has already been successfully controlled with **endoscopic banding**. - While vasoactive drugs are part of acute management, they are used to stop bleeding rather than as a primary prophylactic measure to **reduce mortality** from infectious complications post-procedure. *Oral ciprofloxacin for spontaneous bacterial peritonitis prophylaxis* - While quinolones were historically used, **intravenous ceftriaxone** is now the standard of care for acute variceal hemorrhage in hospital settings due to increasing resistance. - **Ciprofloxacin** is more commonly used for long-term **primary or secondary SBP prophylaxis** in outpatients, rather than the acute post-haematemesis period. *Octreotide infusion for 72 hours* - **Octreotide** is a somatostatin analogue used to reduce **portal venous pressure** during active variceal hemorrhage but has no direct effect on preventing the infections that drive mortality. - Similar to terlipressin, it is an adjunctive therapy to endoscopy and does not replace the requirement for **systemic antibiotics**.

Question 78: A 49-year-old woman with ulcerative colitis confined to the rectum and sigmoid colon has been in remission for 18 months on mesalazine. She now presents with a flare with 6 episodes of bloody diarrhoea daily and mild lower abdominal cramping. Blood tests show: Hb 128 g/L, CRP 28 mg/L, albumin 38 g/L. Stool cultures are negative. What is the most appropriate treatment strategy?

A. Switch to infliximab induction therapy
B. Topical (rectal) mesalazine plus oral mesalazine (Correct Answer)
C. Oral prednisolone 40 mg daily
D. Add azathioprine to current mesalazine
E. Topical corticosteroids alone

Explanation: ***Topical (rectal) mesalazine plus oral mesalazine*** - For a flare of **mild-to-moderate proctosigmoiditis**, the combination of **topical and oral aminosalicylates** is the first-line treatment recommended by clinical guidelines (e.g., NICE). - This approach is more effective than either oral or topical therapy alone, ensuring the medication reaches both the **distal mucosa** and the proximal extent of the disease. *Switch to infliximab induction therapy* - **Infliximab** is a biologic reserved for patients with **moderate-to-severe disease** that is refractory to conventional therapies like steroids and thiopurines. - Given this patient's relatively stable clinical picture (mild symptoms, normal Hb, normal albumin, mildly elevated CRP only), escalating directly to biologics is not yet indicated. *Oral prednisolone 40 mg daily* - **Oral corticosteroids** are typically the second-line option for patients who fail to respond to aminosalicylates or those with more extensive involvement or moderate-to-severe flares. - While effective for inducing remission, they carry a high risk of **systemic side effects** and are not preferred as the initial strategy for a mild distal flare. *Add azathioprine to current mesalazine* - **Azathioprine** is a thiopurine used primarily for **maintaining remission** or for its steroid-sparing effects, rather than acute management of active flares. - It has a slow onset of action, taking weeks to months to achieve full therapeutic effect, making it unsuitable for rapid **symptom control** during an acute flare. *Topical corticosteroids alone* - **Topical corticosteroids** (such as foams or enemas) are generally considered less effective than topical mesalazine for inducing remission in **distal ulcerative colitis**. - Using them alone without an oral aminosalicylate component is less likely to achieve complete **mucosal healing** and symptom control in proctosigmoiditis.

Question 79: A 29-year-old man with newly diagnosed Crohn's disease affecting the terminal ileum is started on standard treatment. Three months later, he presents with paraesthesia in his feet and difficulty with balance. Blood tests show: MCV 108 fL, haemoglobin 95 g/L, WCC 4.2 × 10⁹/L. Which nutritional deficiency is most likely responsible for his neurological symptoms?

A. Vitamin B12 deficiency due to terminal ileal malabsorption (Correct Answer)
B. Folate deficiency due to methotrexate therapy
C. Vitamin D deficiency causing hypocalcaemic neuropathy
D. Iron deficiency causing peripheral nerve hypoxia
E. Thiamine deficiency due to chronic malnutrition

Explanation: ***Vitamin B12 deficiency due to terminal ileal malabsorption***- Crohn's disease affecting the **terminal ileum** specifically impairs the absorption of the **vitamin B12-intrinsic factor complex**, leading to B12 deficiency.- The patient's **macrocytic anaemia (MCV 108 fL)** and neurological symptoms of **paraesthesia** and **difficulty with balance** are characteristic signs of **subacute combined degeneration** of the spinal cord, a classic manifestation of severe B12 deficiency.*Folate deficiency due to methotrexate therapy*- While folate deficiency can cause **macrocytic anaemia**, it is typically **not associated with neurological symptoms** such as paraesthesia and balance difficulties, which are hallmarks of B12 deficiency.- There is no mention in the clinical vignette of the patient being treated with **methotrexate**, which could induce folate deficiency.*Vitamin D deficiency causing hypocalcaemic neuropathy*- Vitamin D deficiency primarily affects **bone metabolism**, leading to **osteomalacia** in adults, and does not cause macrocytic anaemia.- Neurological symptoms from hypocalcaemia typically include **tetany, muscle cramps, or seizures**, not the specific sensory ataxia described, nor does it explain the macrocytosis.*Iron deficiency causing peripheral nerve hypoxia*- Iron deficiency causes **microcytic anaemia (low MCV)**, which contradicts the patient's presented **macrocytic anaemia (MCV 108 fL)**.- While severe anaemia can cause various systemic symptoms, iron deficiency does not typically cause a specific **demyelinating neuropathy** or the dorsal column signs that lead to balance issues.*Thiamine deficiency due to chronic malnutrition*- Thiamine (Vitamin B1) deficiency can cause neurological symptoms like ataxia (Wernicke's encephalopathy) or peripheral neuropathy (Beriberi), which might include balance issues.- However, thiamine deficiency **does not cause macrocytic anaemia**, which is a key finding in this patient.

Question 80: A 66-year-old man presents with sudden onset severe epigastric pain radiating to the back. He has vomited twice. Past history includes hypertriglyceridaemia and type 2 diabetes. On examination, he is tachycardic (110 bpm), blood pressure 95/60 mmHg, temperature 38.2°C. Investigations show: amylase 1850 U/L, WCC 18 × 10⁹/L, CRP 180 mg/L, calcium 1.95 mmol/L, glucose 14.2 mmol/L, urea 12.5 mmol/L. What is the most appropriate immediate management?

A. Immediate contrast-enhanced CT abdomen to assess necrosis
B. Aggressive intravenous fluid resuscitation with crystalloid and HDU/ITU monitoring (Correct Answer)
C. Urgent ERCP within 24 hours
D. Prophylactic antibiotics with intravenous meropenem
E. Nasojejunal feeding tube insertion for early enteral nutrition

Explanation: ***Aggressive intravenous fluid resuscitation with crystalloid and HDU/ITU monitoring*** - This patient presents with **severe acute pancreatitis** complicated by **hemodynamic instability** (BP 95/60, HR 110 bpm), making aggressive fluid resuscitation the most immediate and critical management to maintain organ perfusion and prevent further organ damage. - The presence of **systemic inflammatory response syndrome (SIRS)** criteria (tachycardia, fever) and signs of organ dysfunction (hypotension, elevated urea, glucose) necessitates **HDU/ITU monitoring** for close observation and goal-directed therapy. *Immediate contrast-enhanced CT abdomen to assess necrosis* - **Contrast-enhanced CT** for assessing pancreatic necrosis is typically delayed for **72-96 hours** from symptom onset, as early scans often underestimate the extent of necrosis. - In a **hemodynamically unstable** patient, stabilization and **fluid resuscitation** take precedence over immediate imaging; the diagnosis of acute pancreatitis is already clinically evident with high amylase. *Urgent ERCP within 24 hours* - **Urgent ERCP** is specifically indicated in acute pancreatitis only if there is concomitant **acute cholangitis** or persistent biliary obstruction, which are not described here. - The patient's history of **hypertriglyceridaemia** is a common cause of pancreatitis, suggesting a non-biliary etiology, thus making ERCP an unnecessary and potentially harmful procedure in this case. *Prophylactic antibiotics with intravenous meropenem* - Current guidelines do not recommend **prophylactic antibiotics** for severe acute pancreatitis, as studies have shown no reduction in the incidence of infected necrosis or overall mortality. - Antibiotics should be reserved for cases with **documented infection**, such as infected pancreatic necrosis (confirmed by imaging and aspiration) or other extrapancreatic infections. *Nasojejunal feeding tube insertion for early enteral nutrition* - While **early enteral nutrition** (within 24-72 hours) is beneficial in severe pancreatitis to maintain gut barrier function, it is implemented *after* initial **fluid resuscitation** and hemodynamic stabilization. - It is not the most immediate life-saving intervention when the patient is experiencing **circulatory collapse** and requires urgent management of hypovolemia.

Question 81: A 31-year-old woman presents with a 15-month history of abdominal pain, bloating, and alternating bowel habit. She reports that symptoms are worse during stressful periods at work and improve during holidays. Colonoscopy and coeliac serology are normal. Faecal calprotectin is 25 μg/g. Which pathophysiological mechanism best explains her symptom profile?

A. Altered gut-brain axis signalling and visceral hypersensitivity (Correct Answer)
B. Low-grade mucosal inflammation with increased intestinal permeability
C. Bacterial overgrowth in the small intestine causing fermentation
D. Impaired chloride channel function leading to reduced intestinal secretion
E. Decreased serotonin reuptake in enteric neurons causing dysmotility

Explanation: ***Altered gut-brain axis signalling and visceral hypersensitivity*** - This patient's symptoms of chronic abdominal pain, bloating, and alternating bowel habit, alongside normal colonoscopy, coeliac serology, and faecal calprotectin (<50 μg/g), are characteristic of **Irritable Bowel Syndrome (IBS)**, fitting **Rome IV criteria**. - The core pathophysiology of IBS involves **visceral hypersensitivity** (increased pain perception from normal gut stimuli) and dysfunctional communication within the **gut-brain axis**, which explains the exacerbation of symptoms during stressful periods. *Low-grade mucosal inflammation with increased intestinal permeability* - While some IBS patients exhibit minor immune changes, the normal **faecal calprotectin** (25 μg/g) in this case strongly argues against significant **mucosal inflammation** or **increased intestinal permeability** being the primary driver of symptoms. - This mechanism is more typically associated with **Inflammatory Bowel Disease (IBD)** or certain forms of **post-infectious IBS** where inflammatory markers would be elevated. *Bacterial overgrowth in the small intestine causing fermentation* - **Small Intestinal Bacterial Overgrowth (SIBO)** can cause bloating and altered bowel habits due to fermentation, but it does not fully explain the pronounced **stress-related symptom fluctuations** seen in this patient. - SIBO is usually diagnosed with **hydrogen breath tests** and, while it can coexist with IBS, it is not considered the primary overarching pathophysiological mechanism for typical IBS presentation. *Impaired chloride channel function leading to reduced intestinal secretion* - This mechanism is characteristic of conditions such as **Cystic Fibrosis** or certain forms of **constipation-predominant IBS (IBS-C)**, where there is inadequate fluid secretion into the intestinal lumen. - The patient presents with **alternating bowel habits**, not solely constipation, and there is no evidence to suggest a primary defect in chloride channel function; in fact, some IBS-C treatments *enhance* chloride secretion. *Decreased serotonin reuptake in enteric neurons causing dysmotility* - Although **serotonin (5-HT)** is crucial for gut motility and sensation and is dysregulated in IBS, the primary issue is complex **serotonin signaling dysfunction** rather than a simple defect in reuptake. - **Selective serotonin reuptake inhibitors (SSRIs)**, which *increase* synaptic serotonin by blocking reuptake, are sometimes used to treat IBS symptoms by modulating the **gut-brain axis**, suggesting that decreased reuptake is not the underlying cause.

Question 82: A 54-year-old man with alcoholic cirrhosis presents with confusion and drowsiness. His wife reports he has been increasingly forgetful over the past week. On examination, he has asterixis and a flapping tremor. Blood tests show: bilirubin 85 μmol/L, albumin 28 g/L, INR 1.8, ammonia 120 μmol/L (normal <50). What is the primary mechanism underlying his current presentation?

A. Accumulation of ammonia leading to cerebral oedema and astrocyte swelling (Correct Answer)
B. Portal systemic shunting causing reduced first-pass metabolism of neurotoxins
C. Decreased hepatic synthesis of clotting factors causing microhaemorrhages
D. Hypoalbuminaemia causing reduced oncotic pressure and cerebral hypoperfusion
E. Increased bilirubin crossing the blood-brain barrier causing direct neurotoxicity

Explanation: ***Accumulation of ammonia leading to cerebral oedema and astrocyte swelling*** - High levels of **ammonia** cross the **blood-brain barrier** and are metabolized to **glutamine** within brain **astrocytes**, leading to an osmotic influx of water. - This process causes **astrocyte swelling**, **cerebral oedema**, and impaired neurotransmission, manifesting as **hepatic encephalopathy** with symptoms like **confusion**, **drowsiness**, and **asterixis**. *Portal systemic shunting causing reduced first-pass metabolism of neurotoxins* - While **portosystemic shunting** is a critical **predisposing factor** allowing toxins like ammonia to bypass hepatic detoxification, it is not the direct cellular mechanism of brain injury. - The primary mechanism of brain dysfunction is the **neurotoxic effect** of the accumulated substances, mainly **ammonia**, on the cerebral cells themselves. *Decreased hepatic synthesis of clotting factors causing microhaemorrhages* - The patient's elevated **INR** (1.8) indicates impaired **hepatic synthesis of clotting factors**, increasing the risk of bleeding complications. - However, **confusion**, **drowsiness**, and **asterixis** are classic signs of **metabolic encephalopathy** due to liver failure, not typically microhaemorrhages, which would often present with more focal neurological deficits. *Hypoalbuminaemia causing reduced oncotic pressure and cerebral hypoperfusion* - **Hypoalbuminaemia** (low albumin) leads to reduced **oncotic pressure**, which primarily contributes to **ascites** and peripheral oedema, not direct cerebral hypoperfusion. - Cerebral blood flow is generally well-maintained in cirrhosis, and hypoperfusion is usually due to significant **hypotension** or other systemic insults, not primarily low albumin. *Increased bilirubin crossing the blood-brain barrier causing direct neurotoxicity* - Elevated **bilirubin** is present and causes **jaundice** in adults with liver disease, but **bilirubin neurotoxicity** (**kernicterus**) is predominantly a concern in **neonates**. - In adults, the **blood-brain barrier** is mature and largely impervious to bilirubin at levels typically seen in cirrhosis, so it does not primarily cause acute confusion or **flapping tremor**.

Question 83: A 42-year-old woman presents with a 3-month history of epigastric discomfort and bloating after meals. She denies any alarm symptoms. Physical examination is unremarkable. She has no past medical history and takes no regular medications. What is the most appropriate initial management strategy?

A. Trial of proton pump inhibitor therapy for 4 weeks (Correct Answer)
B. Urgent upper GI endoscopy
C. Helicobacter pylori test-and-treat strategy
D. Trial of histamine-2 receptor antagonist
E. Referral for barium swallow

Explanation: ***Trial of proton pump inhibitor therapy for 4 weeks*** - In patients under **age 60** (or 55 depending on local guidelines) without **alarm symptoms**, an empirical trial of a **PPI (Proton Pump Inhibitor)** is a standard initial diagnostic and therapeutic step for **uninvestigated dyspepsia**. - This strategy effectively manages symptoms of **acid reflux** or **functional dyspepsia** while avoiding unnecessary invasive procedures in low-risk individuals. *Urgent upper GI endoscopy* - Endoscopy is indicated for patients with **alarm symptoms** (e.g., weight loss, anemia, dysphagia) or those exceeding the **age threshold** (typically ≥60 years). - Since this patient is 42 and has an unremarkable examination without alarm features, **invasive testing** is not immediately necessary. *Helicobacter pylori test-and-treat strategy* - This is a valid alternative strategy; however, **PPI therapy** is often prioritized for initial symptom relief in cases of suspected functional dyspepsia or GERD. - **H. pylori testing** is typically indicated if symptoms persist after the initial PPI trial or if the patient belongs to a population with **high prevalence** of the infection. *Trial of histamine-2 receptor antagonist* - **H2-receptor antagonists (H2RAs)** are generally considered less potent and less effective than **PPIs** for the treatment of dyspeptic symptoms. - While they can be used, clinical guidelines prioritize **PPIs** as the first-line pharmacologic intervention for empirical therapy. *Referral for barium swallow* - A **barium swallow** is primarily used to evaluate **structural abnormalities** such as strictures or motility disorders like **achalasia**, which are not suspected here. - It has very limited diagnostic utility in evaluating **dyspepsia** compared to endoscopy or empirical medical management.

Question 84: A 63-year-old man presents with progressive dysphagia to solids over 3 months and 7 kg weight loss. He has a 15-year history of gastro-oesophageal reflux disease managed with omeprazole. Urgent upper GI endoscopy reveals a 4 cm suspicious lesion at the gastro-oesophageal junction. Biopsies confirm adenocarcinoma. CT chest/abdomen/pelvis shows the tumour and enlarged coeliac axis lymph nodes but no distant metastases. What is the most appropriate next investigation to guide treatment planning?

A. Endoscopic ultrasound (Correct Answer)
B. Laparoscopy for peritoneal staging
C. Repeat endoscopy with endoscopic mucosal resection
D. Bronchoscopy to assess airway involvement
E. PET-CT scan

Explanation: ***Endoscopic ultrasound*** - **Endoscopic ultrasound (EUS)** is the gold standard for **locoregional staging**, providing the highest accuracy for determining the **depth of tumor invasion (T-stage)** and assessing **regional lymph nodes (N-stage)**. - It is critical for determining whether the tumor is **resectable** and identifying candidates for **neoadjuvant chemotherapy** or chemoradiotherapy based on the invasion depth. *Laparoscopy for peritoneal staging* - Staging laparoscopy is primarily used to detect **occult peritoneal metastases** that are not visible on CT, especially in **gastric** or Siewert type III junctional tumors. - While important, **EUS** is usually prioritized first to evaluate the primary tumor's wall invasion and local nodal status. *Repeat endoscopy with endoscopic mucosal resection* - **Endoscopic mucosal resection (EMR)** is a therapeutic and staging tool indicated for **early-stage (T1a)** lesions confined to the mucosa. - Given the **4 cm size** and suspicious appearance on initial endoscopy, this lesion is likely too advanced for EMR to be appropriate or curative. *Bronchoscopy to assess airway involvement* - Bronchoscopy is typically reserved for tumors located in the **upper or mid-oesophagus** to rule out **tracheobronchial tree** invasion. - Tumor involvement of the airway is very unlikely for an **adenocarcinoma** located at the **gastro-oesophageal junction**. *PET-CT scan* - **PET-CT** is highly effective at identifying **distant metastatic disease (M-stage)** that may have been missed on a conventional CT scan. - Although it identifies metabolic activity, it lacks the resolution of **EUS** for distinguishing the specific layers of the esophageal wall to determine the precise **T-stage**.

Question 85: A 58-year-old man with chronic pancreatitis due to alcohol excess presents with worsening abdominal pain and steatorrhoea. He has lost 8 kg over 6 months. Faecal elastase-1 is <15 μg/g stool (normal >200 μg/g). CT pancreas shows pancreatic atrophy and calcification. He is commenced on pancreatic enzyme replacement therapy. Which additional supplementation is most important to prescribe?

A. Fat-soluble vitamins (A, D, E, K) (Correct Answer)
B. Vitamin B12 injections
C. Oral iron supplementation
D. Medium-chain triglyceride supplements
E. Vitamin C and zinc

Explanation: ***Fat-soluble vitamins (A, D, E, K)*** - Chronic pancreatitis causes **pancreatic exocrine insufficiency (PEI)**, leading to fat malabsorption and significant deficiency of **vitamins A, D, E, and K**. - Supplementation is crucial to prevent serious complications such as **osteoporosis** (Vitamin D deficiency), **night blindness** (Vitamin A deficiency), and **coagulopathy** (Vitamin K deficiency). *Vitamin B12 injections* - While pancreatic enzymes facilitate the release of **vitamin B12 from R-binders**, **intrinsic factor** from the stomach is the primary determinant for B12 absorption, which is typically unaffected in chronic pancreatitis. - Clinically significant B12 deficiency is less common in PEI compared to fat-soluble vitamin deficiencies, making it a lower priority for routine initial supplementation. *Oral iron supplementation* - Iron absorption primarily occurs in the **duodenum** and is not directly dependent on pancreatic enzyme activity. - **Iron deficiency** is not a characteristic feature of pancreatic exocrine insufficiency unless there's an underlying cause like gastrointestinal bleeding. *Medium-chain triglyceride supplements* - **Medium-chain triglycerides (MCTs)** are absorbed directly into the portal circulation without requiring pancreatic lipase, making them useful for caloric supplementation in malabsorption. - However, MCTs do not address the crucial deficiency of **fat-soluble vitamins**, which is a more direct and clinically urgent consequence of severe fat malabsorption. *Vitamin C and zinc* - **Vitamin C** is a water-soluble vitamin, and its absorption is generally not impaired in pancreatic exocrine insufficiency. - While **zinc deficiency** can occur with general malabsorption, it is not the primary or most critical deficiency associated with chronic pancreatitis and fat malabsorption compared to fat-soluble vitamins.

Question 86: A 46-year-old man with alcohol-related cirrhosis and recurrent ascites undergoes large volume paracentesis with removal of 8 litres of ascitic fluid. Which intervention has been shown to reduce the risk of post-paracentesis circulatory dysfunction and improve mortality?

A. Administration of 8g of 20% human albumin solution per litre of fluid removed (Correct Answer)
B. Fluid restriction to <1 litre daily for 48 hours post-procedure
C. Infusion of gelofusine or other synthetic plasma expanders
D. Prophylactic terlipressin infusion during and after paracentesis
E. Rapid IV crystalloid replacement equal to volume removed

Explanation: ***Administration of 8g of 20% human albumin solution per litre of fluid removed*** - **Human albumin** administration is the gold standard for preventing **post-paracentesis circulatory dysfunction (PPCD)** when removing more than 5 litres of ascitic fluid. - It acts as an effective plasma expander that preserves **effective arterial blood volume**, reducing the risks of renal impairment and mortality. *Fluid restriction to <1 litre daily for 48 hours post-procedure* - Fluid restriction is commonly used to manage **dilutional hyponatremia** in cirrhosis but does not prevent the hemodynamics-driven PPCD. - Restricting fluids following a large volume removal may exacerbate **intravascular depletion** and trigger acute kidney injury. *Infusion of gelofusine or other synthetic plasma expanders* - Synthetic colloids like **gelofusine**, dextran, or polygeline are significantly less effective than **albumin** in reducing the incidence of PPCD. - Clinical trials have shown that patients receiving synthetic expanders have higher rates of **renal dysfunction** compared to those receiving albumin. *Prophylactic terlipressin infusion during and after paracentesis* - **Terlipressin** is a potent vasoconstrictor indicated for **hepatorenal syndrome** (HRS) and variceal bleeding, not as a routine replacement for large volume paracentesis. - While it addresses splanchnic vasodilation, it has not replaced **albumin** as the first-line intervention for volume expansion in this context. *Rapid IV crystalloid replacement equal to volume removed* - **Crystalloids** (like normal saline) are inefficient because they rapidly redistribute into the **interstitial space**, failing to maintain oncotic pressure. - Using crystalloids for paracentesis volumes >5L is associated with a high rate of **post-procedure complications** and does not improve mortality.

Question 87: A 39-year-old woman presents with a 14-month history of crampy abdominal pain, bloating worse after meals, and loose stools 3-4 times daily. Symptoms improve when she avoids eating and are not present at night. She has no rectal bleeding or weight loss. Physical examination is normal. Blood tests including FBC, CRP, thyroid function, and tissue transglutaminase antibodies are normal. According to NICE guidelines for IBS diagnosis, which of the following additional criteria must be present for at least 6 months?

A. Abdominal pain relieved by defecation or associated with altered bowel frequency or stool form (Correct Answer)
B. Visible or occult blood in stool samples
C. Elevated faecal calprotectin above 100 μg/g
D. Evidence of lactose intolerance on hydrogen breath testing
E. Radiological evidence of colonic dysmotility on transit studies

Explanation: ***Abdominal pain relieved by defecation or associated with altered bowel frequency or stool form***- According to **NICE guidelines**, a diagnosis of **Irritable Bowel Syndrome (IBS)** should be considered only if there is **abdominal pain** for at least 6 months that is related to defecation or bowel habit change.- This must be accompanied by at least two of the following: **bloating**, mucus passage, **strained/urgent stool passage**, or symptoms worsening with meals.*Visible or occult blood in stool samples*- The presence of **rectal bleeding** is a **red flag** symptom that suggests organic pathology like **colorectal cancer** or inflammatory bowel disease (IBD).- IBS is a functional disorder, and finding blood in the stool necessitates urgent investigation rather than a primary diagnosis of IBS.*Elevated faecal calprotectin above 100 μg/g*- **Faecal calprotectin** is a marker of **intestinal inflammation** used to differentiate IBD from IBS in primary care.- An elevated level suggests **Crohn's disease** or **Ulcerative Colitis**, whereas IBS typically presents with a normal calprotectin level.*Evidence of lactose intolerance on hydrogen breath testing*- While **lactose intolerance** can cause similar symptoms like bloating and diarrhea, it is a distinct metabolic condition and not a diagnostic criterion for IBS.- NICE guidelines recommend excluding **Coeliac disease** and IBD via blood tests, but routine **hydrogen breath testing** is not required for an IBS diagnosis.*Radiological evidence of colonic dysmotility on transit studies*- **Colonic transit studies** are specialized investigations usually reserved for severe **chronic constipation** cases to identify slow-transit issues.- They are not part of the standard **NICE clinical criteria** for IBS, which relies on symptom patterns and the exclusion of organic disease.

Question 88: A 71-year-old man is admitted with haematemesis. He has a history of ischaemic heart disease and atrial fibrillation and takes warfarin. His INR is 3.8 and Hb 82 g/L. Following resuscitation and correction of coagulopathy, he undergoes endoscopy which reveals a 2 cm gastric ulcer with a visible vessel (Forrest IIa). The bleeding is controlled with endoscopic therapy. What is the most appropriate subsequent management regarding his anticoagulation?

A. Resume warfarin immediately post-endoscopy
B. Withhold warfarin for 2 weeks then restart
C. Switch to a low molecular weight heparin bridge and restart warfarin at 7-14 days (Correct Answer)
D. Stop anticoagulation permanently and commence aspirin only
E. Resume warfarin after 90 days once ulcer healing is confirmed

Explanation: ***Switch to a low molecular weight heparin bridge and restart warfarin at 7-14 days***- For patients with a high **thromboembolic risk** (e.g., **atrial fibrillation**), anticoagulation must be resumed cautiously to prevent **stroke** after haemostasis of a **Forrest IIa** lesion.- Using **LMWH bridging** allows for shorter-acting anticoagulation before transitioning back to **warfarin** once the high-risk period for rebleeding (typically the first 7 days) has passed.*Resume warfarin immediately post-endoscopy*- Immediate resumption of full **anticoagulation** significantly increases the risk of **early rebleeding** from the visible vessel before the ulcer has begun to heal.- Guidelines recommend a window of at least several days of **haemostatic stability** before restarting Vitamin K Antagonists for high-risk ulcers.*Withhold warfarin for 2 weeks then restart*- While waiting 2 weeks reduces rebleeding risk, withholding all forms of anticoagulation for this duration significantly increases the risk of **thromboembolic stroke** in an **atrial fibrillation** patient.- A **bridging strategy** is preferred over complete cessation to balance the risks of clotting versus bleeding.*Stop anticoagulation permanently and commence aspirin only*- Permanent cessation is generally contraindicated because the **ischaemic stroke** risk from **atrial fibrillation** far outweighs the long-term GI bleeding risk.- **Aspirin** is not an adequate substitute for anticoagulation in stroke prevention for patients with high-risk **atrial fibrillation**.*Resume warfarin after 90 days once ulcer healing is confirmed*- Waiting 90 days is far too long and leaves the patient unprotected against **systemic embolism** and cardiac complications for an unsafe duration.- Ulcer healing is monitored with **PPI therapy**, but anticoagulation is typically safe to resume much sooner once the **acute bleeding** phase is resolved.

Question 89: A 34-year-old woman presents with a 5-day history of worsening bloody diarrhoea (10-12 times daily), severe abdominal cramping, and fever. She has ulcerative colitis diagnosed 3 years ago. On examination, she appears unwell with temperature 38.2°C, pulse 115 bpm, BP 110/70 mmHg. Her abdomen is distended with tenderness but no guarding. Blood tests show: Hb 98 g/L, WBC 15.8 × 10⁹/L, platelets 420 × 10⁹/L, CRP 145 mg/L, albumin 28 g/L. Abdominal X-ray shows colonic dilatation with transverse colon diameter of 6.2 cm. What is the most appropriate immediate management?

A. Commence IV hydrocortisone, IV fluids, nil by mouth, and surgical review (Correct Answer)
B. Commence IV infliximab as rescue therapy
C. Commence broad-spectrum antibiotics and arrange emergency colectomy
D. Commence oral prednisolone 40 mg daily and arrange urgent flexible sigmoidoscopy
E. Arrange urgent CT abdomen to assess for perforation

Explanation: ***Commence IV hydrocortisone, IV fluids, nil by mouth, and surgical review*** - The patient has **acute severe ulcerative colitis** complicated by **toxic megacolon** (colonic diameter >6 cm), requiring urgent resuscitation and high-dose **IV corticosteroids**. - **Surgical review** is essential as toxic megacolon carries a high risk of **perforation**, and failure of medical therapy within 72 hours often necessitates emergency surgery. *Commence IV infliximab as rescue therapy* - **Infliximab** or cyclosporine are considered **rescue therapies** if there is no response to IV steroids after 3-5 days; they are not the first-line immediate step. - Administering biologics without first stabilising the patient with **fluid resuscitation** and steroids in the face of possible toxic megacolon is premature. *Commence broad-spectrum antibiotics and arrange emergency colectomy* - **Emergency colectomy** is the definitive treatment if perforation occurs or if the patient fails to improve, but a trial of **intensive medical therapy** with steroids is usually initiated first. - While antibiotics are often used in toxic megacolon, they are an **adjunct** rather than the primary life-saving intervention over steroids and fluid resuscitation. *Commence oral prednisolone 40 mg daily and arrange urgent flexible sigmoidoscopy* - **Oral medications** are insufficient for acute severe colitis; **IV hydrocortisone** is mandated by the Truelove and Witts criteria for systemic symptoms. - Performing a **flexible sigmoidoscopy** is contraindicated in the setting of **toxic megacolon** (6.2 cm dilation) due to an extremely high risk of bowel perforation. *Arrange urgent CT abdomen to assess for perforation* - While a CT may be useful to confirm free air, the diagnosis of **toxic megacolon** is already confirmed by the **abdominal X-ray** showing 6.2 cm dilatation. - Delaying the start of **IV steroids and surgical consultation** for further imaging in a clinically unstable patient with known dilatation is inappropriate.

Question 90: A 53-year-old woman with primary biliary cholangitis (PBC) has been taking ursodeoxycholic acid for 18 months. Repeat blood tests show: bilirubin 24 μmol/L, ALP 285 U/L (previously 420 U/L at diagnosis), ALT 68 U/L, albumin 38 g/L, INR 1.1, platelets 165 × 10⁹/L. Anti-mitochondrial antibodies remain positive. Which parameter is the best predictor of long-term prognosis and transplant-free survival in PBC?

A. Improvement in serum albumin levels
B. Reduction in alkaline phosphatase to <1.67 times upper limit of normal (Correct Answer)
C. Normalization of serum bilirubin
D. Persistent positive anti-mitochondrial antibodies
E. Decline in platelet count indicating portal hypertension

Explanation: ***Reduction in alkaline phosphatase to <1.67 times upper limit of normal*** - In **Primary Biliary Cholangitis (PBC)**, the biochemical response to **Ursodeoxycholic acid (UDCA)** after 12-24 months is the strongest predictor of **transplant-free survival**. - Specifically, achieving a reduction in **Alkaline Phosphatase (ALP)** to levels below **1.67 times the upper limit of normal** (as per the Toronto or Globe criteria) is associated with a significantly better long-term prognosis. *Improvement in serum albumin levels* - While **albumin** reflects synthetic liver function, its improvement is less specific as a prognostic marker compared to the **biochemical response** of cholestatic enzymes. - Albumin levels typically stay within the reference range until the disease reaches **advanced cirrhosis**. *Normalization of serum bilirubin* - Elevated **bilirubin** is an indicator of **advanced disease** or late-stage PBC and is used as a terminal prognostic marker rather than a measure of early treatment response. - Although bilirubin remains a component of the **Paris-I criteria**, ALP reduction is recognized as the more sensitive early surrogate for long-term clinical outcome. *Persistent positive anti-mitochondrial antibodies* - **Anti-mitochondrial antibodies (AMA)** are diagnostic for PBC but their **titer or persistence** does not correlate with disease severity, progression, or response to therapy. - Changes in AMA status have no clinical utility in predicting **transplant-free survival** or treatment efficacy. *Decline in platelet count indicating portal hypertension* - A declining **platelet count** is a surrogate marker for **portal hypertension** and splenic sequestration, indicative of progressing fibrosis. - While it highlights disease progression, it is not the primary parameter used to define the **biochemical response** to UDCA that guides early treatment modifications.

Question 91: A 68-year-old man with a history of ischaemic heart disease is brought to the emergency department with coffee-ground vomiting and melaena for 12 hours. He takes aspirin 75 mg daily and clopidogrel 75 mg daily following coronary stent insertion 8 weeks ago. His pulse is 110 bpm and BP 95/60 mmHg. Hb is 78 g/L. Following initial resuscitation, what is the most appropriate management of his antiplatelet therapy?

A. Stop both aspirin and clopidogrel immediately
B. Continue both aspirin and clopidogrel (Correct Answer)
C. Stop clopidogrel but continue aspirin
D. Replace both agents with a single antiplatelet agent such as prasugrel
E. Stop aspirin but continue clopidogrel

Explanation: ***Continue both aspirin and clopidogrel***- In patients with a **coronary stent** inserted within the last 3-6 months, the risk of **stent thrombosis** (mortality 20-45%) often outweighs the risk of gastrointestinal bleeding.- Guidelines generally recommend maintaining **dual antiplatelet therapy (DAPT)** while managing the bleed with **urgent endoscopy**, haemostatic techniques, and high-dose **PPI therapy**.*Stop both aspirin and clopidogrel immediately*- Stopping both agents in a patient only 8 weeks post-stent insertion significantly increases the risk of **major adverse cardiovascular events** and sudden death.- Complete cessation is only reserved for **uncontrolled, life-threatening haemorrhage** that cannot be managed by endoscopic means.*Stop clopidogrel but continue aspirin*- While continuing **aspirin monotherapy** is standard for some secondary prevention patients with GI bleeds, it is insufficient to prevent thrombosis in the **early post-stent period**.- Clopidogrel is specifically required alongside aspirin as part of **DAPT** to ensure the patency of the newly endothelializing stent.*Replace both agents with a single antiplatelet agent such as prasugrel*- **Prasugrel** is a more potent antiplatelet agent than clopidogrel and would likely **increase the risk of bleeding** rather than mitigate it.- Switching agents does not address the acute bleeding episode and deviates from established **DAPT protocols** for post-PCI patients.*Stop aspirin but continue clopidogrel*- There is no clinical evidence to support stopping **aspirin** while continuing clopidogrel to manage a GI bleed in the context of recent stenting.- **Aspirin** is the cornerstone of antiplatelet therapy, and maintaining the synergy of both drugs is vital for **stent protection** during the first 3 months.

Question 92: A 44-year-old woman presents with a 3-day history of severe epigastric pain, nausea, and vomiting. She drinks 60 units of alcohol per week. Examination reveals epigastric tenderness and tachycardia. Blood tests show: amylase 1,450 U/L, CRP 180 mg/L, WBC 16.2 × 10⁹/L, calcium 1.95 mmol/L, glucose 12.1 mmol/L, urea 9.8 mmol/L, LDH 520 U/L, AST 180 U/L, PaO₂ 9.8 kPa on room air. According to the modified Glasgow score, what is her predicted severity of acute pancreatitis?

A. Mild pancreatitis (score 0-2)
B. Severe pancreatitis (score ≥3) (Correct Answer)
C. Moderately severe pancreatitis (score 2)
D. Cannot be assessed as scoring requires 48-hour parameters
E. Indeterminate as abdominal imaging is required for severity assessment

Explanation: ***Severe pancreatitis (score ≥3)*** - The patient scores **3 points** based on **WBC >15 × 10⁹/L** (16.2), **Glucose >10 mmol/L** (12.1), and **Calcium <2 mmol/L** (1.95), directly meeting the threshold for severe pancreatitis. - A **modified Glasgow score** of 3 or more indicates severe acute pancreatitis, which carries a higher risk of **organ failure** and **mortality**, often requiring intensive care. *Mild pancreatitis (score 0-2)* - Mild acute pancreatitis is indicated by a **Glasgow score of 0, 1, or 2**, which is lower than this patient's calculated score of 3. - Patients with mild pancreatitis typically have no **organ failure** and resolve without significant complications. *Moderately severe pancreatitis (score 2)* - This patient's score of 3 exceeds the value for **moderately severe pancreatitis** (often defined by transient organ failure in the **Atlanta classification**, not directly by a Glasgow score of 2). - A score of 2 would imply fewer severe prognostic indicators than those present in this patient, who has **leukocytosis**, **hyperglycemia**, and **hypocalcemia**. *Cannot be assessed as scoring requires 48-hour parameters* - While the **Glasgow score** can be re-evaluated at 48 hours to assess evolving severity, initial scoring is crucial for **early risk stratification** at admission. - All the necessary **biochemical and physiological parameters** required for an initial assessment were provided in the patient's presentation. *Indeterminate as abdominal imaging is required for severity assessment* - The **modified Glasgow score** is a clinical and biochemical prediction tool for severity and does not require **abdominal imaging** like CT or MRI for its calculation. - Imaging is primarily used to identify **local complications** such as necrosis or fluid collections, rather than for the initial prognostic scoring.

Question 93: A 27-year-old man with Crohn's disease affecting the ileum and colon has failed treatment with azathioprine. He is commenced on infliximab. Prior to starting therapy, which screening investigation is most important to perform?

A. Cytomegalovirus IgG and IgM
B. Varicella zoster IgG antibodies
C. Hepatitis B surface antigen and core antibodies
D. Quantiferon-TB Gold test or tuberculin skin test (Correct Answer)
E. HIV antibody testing

Explanation: ***Quantiferon-TB Gold test or tuberculin skin test*** - **Anti-TNF** therapy, such as **infliximab**, significantly increases the risk of **latent tuberculosis reactivation** into disseminated or extrapulmonary disease. - Mandatory screening via **Interferon-Gamma Release Assays (IGRAs)** or skin testing, often combined with a **chest X-ray**, must be performed prior to treatment initiation. *Cytomegalovirus IgG and IgM* - While **CMV reactivation** can occur in immunocompromised patients, it is not a routine mandatory screening requirement before starting **TNF inhibitors**. - CMV testing is more commonly reserved for patients with **steroid-refractory ulcerative colitis** to rule out opportunistic infection of the colon. *Varicella zoster IgG antibodies* - Assessment of **Varicella immunity** is recommended to determine the risk of serious primary infection, but it is not the most critical screening compared to TB. - Patients found to be seronegative may require **vaccination** with a live-attenuated vaccine before starting immunosuppression, if time allows. *Hepatitis B surface antigen and core antibodies* - Screening for **Hepatitis B (HBV)** is important because **anti-TNF** agents can trigger **viral reactivation** and potentially fatal hepatic flare. - Although important, TB screening is prioritized in clinical guidelines due to the high mortality and public health implications of **tuberculosis flare-ups**. *HIV antibody testing* - While knowing a patient's **HIV status** is clinically useful when managing chronic immunosuppression, it is not a mandatory prerequisite for **infliximab** therapy. - HIV remains a consideration for overall patient safety but does not carry the same specific reactivation risk profile as **latent tuberculosis** under TNF blockade.

Question 94: A 59-year-old man with Child-Pugh C cirrhosis due to alcohol excess is admitted with tense ascites. Diagnostic ascitic tap shows: protein 8 g/L, white cells 150 cells/μL (80% lymphocytes), serum-ascites albumin gradient (SAAG) 18 g/L. Gram stain and culture are negative. What is the most likely cause of his ascites?

A. Spontaneous bacterial peritonitis
B. Portal hypertension secondary to cirrhosis (Correct Answer)
C. Peritoneal carcinomatosis
D. Tuberculous peritonitis
E. Nephrotic syndrome

Explanation: ***Portal hypertension secondary to cirrhosis*** - A **Serum-Ascites Albumin Gradient (SAAG) ≥ 11 g/L** (18 g/L in this case) is highly indicative of **portal hypertension**, which is a direct consequence of the patient's severe liver cirrhosis. - The ascitic fluid protein of **8 g/L is low (< 25 g/L)**, consistent with a **transudative** fluid accumulation characteristic of uncomplicated ascites due to portal hypertension. *Spontaneous bacterial peritonitis* - This diagnosis requires an **ascitic neutrophil count ≥ 250 cells/μL**. The patient's total white cell count is only 150 cells/μL, making SBP highly unlikely. - While it's a complication of cirrhosis, the primary cause of the ascites as per the tap results is not an acute infection given the cell count. *Peritoneal carcinomatosis* - This condition typically presents with a **low SAAG (< 11 g/L)**, as it's an exudative process rather than a hydrostatic one. - Ascitic fluid in malignancy usually shows **high protein levels (> 25 g/L)**, contrary to the 8 g/L found here. *Tuberculous peritonitis* - Although often associated with **lymphocytic predominance**, it is an exudative process, leading to a **low SAAG (< 11 g/L)**. - It would also typically show a much higher **ascitic protein concentration** (often > 25 g/L or 30 g/L) than observed in this patient. *Nephrotic syndrome* - Ascites in nephrotic syndrome is caused by **hypoalbuminemia** leading to a **low SAAG (< 11 g/L)** due to reduced oncotic pressure. - The patient's **high SAAG (18 g/L)** definitively rules out nephrotic syndrome as the cause of ascites.

Question 95: A 36-year-old woman presents with a 9-month history of abdominal bloating, urgency, and alternating bowel habit with no nocturnal symptoms. She opens her bowels 2-4 times daily with loose stools and occasional mucus. She has lost 2 kg in weight. Examination is unremarkable. Blood tests including FBC, CRP, coeliac serology, and thyroid function are normal. Faecal calprotectin is 18 μg/g (normal <50). What is the most appropriate next step in management?

A. Reassure and commence empirical mebeverine and loperamide
B. Arrange colonoscopy to exclude inflammatory bowel disease (Correct Answer)
C. Trial of a low FODMAP diet with dietitian support
D. Arrange CT abdomen and pelvis to investigate weight loss
E. Commence empirical rifaximin for suspected small intestinal bacterial overgrowth

Explanation: ***Arrange colonoscopy to exclude inflammatory bowel disease*** - In a patient presenting with **unexplained weight loss** and altered bowel habits, a **colonoscopy** is mandatory to exclude organic pathology such as **colorectal malignancy** or **inflammatory bowel disease (IBD)**. - While a normal **faecal calprotectin** (<50 μg/g) makes IBD less likely, it is not 100% sensitive and does not rule out other structural abnormalities in the presence of **red flag symptoms** like weight loss. *Reassure and commence empirical mebeverine and loperamide* - Empirical treatment for **Irritable Bowel Syndrome (IBS)** is inappropriate before excluding organic disease, especially when **red flag features** like weight loss are present. - Mebeverine (an antispasmodic) and loperamide (an antidiarrheal) treat symptoms but would delay the diagnosis of potentially serious underlying conditions. *Trial of a low FODMAP diet with dietitian support* - A **low FODMAP diet** is an effective second-line management strategy for **IBS**, but a positive diagnosis of IBS can only be safely made after excluding organic causes. - Relying on dietary changes while the patient is losing weight may lead to further **nutritional deficiencies** and missed pathology. *Arrange CT abdomen and pelvis to investigate weight loss* - While CT can investigate weight loss and gross structural changes, it is not the primary modality for evaluating the **colonic mucosa** for conditions like IBD or early-stage malignancy. - A **colonoscopy** allows for direct visualization and **biopsy**, making it the diagnostic gold standard for the lower gastrointestinal symptoms described. *Commence empirical rifaximin for suspected small intestinal bacterial overgrowth* - **Small intestinal bacterial overgrowth (SIBO)** can present with bloating and diarrhea; however, **rifaximin** should not be used empirically without diagnostic testing like a hydrogen breath test. - More importantly, SIBO does not typically explain significant **weight loss**, which must be prioritized through more definitive investigations like endoscopy.

Question 96: A 52-year-old man presents with a 4-week history of epigastric pain that is worse at night and relieved by eating. He takes no regular medications and does not smoke. Upper GI endoscopy reveals a 1.5 cm duodenal ulcer. Urease breath test is positive for Helicobacter pylori. What is the most appropriate eradication therapy according to current UK guidelines?

A. Omeprazole, amoxicillin, and clarithromycin for 7 days
B. Omeprazole, metronidazole, clarithromycin, and bismuth for 14 days
C. Omeprazole, amoxicillin, clarithromycin, and metronidazole for 14 days (Correct Answer)
D. Omeprazole, amoxicillin, and metronidazole for 7 days
E. Omeprazole and amoxicillin for 14 days

Explanation: ***Omeprazole, amoxicillin, clarithromycin, and metronidazole for 14 days*** - Current **NICE guidelines** and the **British Society of Gastroenterology** recommend **concomitant quadruple therapy** (PPI + three antibiotics) for 14 days as a first-line treatment for *H. pylori* eradication. - This regimen is preferred due to rising **antibiotic resistance** (especially to clarithromycin), providing superior eradication rates exceeding 90%. *Omeprazole, amoxicillin, and clarithromycin for 7 days* - This was the traditional **triple therapy**; however, it is no longer the preferred first-line choice in the UK due to its declining efficacy against resistant strains. - A **7-day duration** is now considered less effective than the standard **14-day duration** for achieving complete eradication. *Omeprazole, metronidazole, clarithromycin, and bismuth for 14 days* - This is **bismuth-containing quadruple therapy**, which is typically reserved as a **second-line treatment** or for patients with a **penicillin allergy**. - Since this patient has no documented penicillin allergy, **amoxicillin-based** quadruple therapy is the standard first-line approach. *Omeprazole, amoxicillin, and metronidazole for 7 days* - This is an alternative triple therapy regimen with a short duration that does not meet the current **quadruple therapy** standards for first-line treatment. - **Triple therapy** is generally avoided as the initial empiric choice unless local resistance patterns specifically favor it or quadruple therapy is contraindicated. *Omeprazole and amoxicillin for 14 days* - **Dual therapy** is insufficient for *H. pylori* eradication and is not a recommended standard of care in clinical guidelines. - Effective eradication requires the synergistic effect of at least **two or three antibiotics** combined with acid suppression.

Question 97: A 41-year-old woman with ulcerative colitis presents with acute onset right upper quadrant pain, fever of 38.7°C, and jaundice. She has had colitis for 8 years with intermittent flares. Blood tests show: bilirubin 78 μmol/L, ALT 145 U/L, ALP 520 U/L, GGT 380 U/L. MRCP demonstrates multifocal strictures and beading of both intrahepatic and extrahepatic bile ducts with no evidence of choledocholithiasis. What is the most important long-term complication associated with this condition?

A. Hepatocellular carcinoma
B. Cholangiocarcinoma (Correct Answer)
C. Secondary biliary cirrhosis
D. Portal vein thrombosis
E. Autoimmune hepatitis overlap syndrome

Explanation: ***Cholangiocarcinoma*** - The patient's presentation with a history of **ulcerative colitis**, cholestatic liver enzymes, and **MRCP findings of multifocal strictures and beading of bile ducts** is pathognomonic for **Primary Sclerosing Cholangitis (PSC)**. - **Cholangiocarcinoma** is the most significant and feared long-term malignant complication of PSC, occurring in approximately 10-15% of patients, and surveillance for this is crucial. *Hepatocellular carcinoma* - While **cirrhosis**, which can result from advanced PSC, is a risk factor for **hepatocellular carcinoma (HCC)**, HCC is significantly less common in PSC compared to **cholangiocarcinoma**. - HCC is more typically associated with chronic viral hepatitis (B or C) or alcoholic liver disease, rather than the primary biliary pathology of PSC. *Secondary biliary cirrhosis* - **Secondary biliary cirrhosis** describes the irreversible liver damage and **fibrosis** that develops over time due to chronic bile duct obstruction and inflammation in PSC. - It represents the *progression* of the disease to end-stage liver failure rather than a distinct, specific complication like a malignancy, which is what the question implies by "most important long-term complication." *Portal vein thrombosis* - **Portal vein thrombosis** can occur as a complication of **cirrhosis** and **portal hypertension**, which can develop in advanced PSC. - However, it is a non-specific complication of end-stage liver disease and not the *most important* long-term complication directly and uniquely associated with the pathophysiology of PSC, unlike cholangiocarcinoma. *Autoimmune hepatitis overlap syndrome* - **Autoimmune hepatitis (AIH) overlap syndrome** with PSC is a recognized variant where patients exhibit features of both conditions, particularly common in younger individuals. - This is considered a **co-existing condition** or a specific presentation variant of PSC rather than a long-term complication that *develops from* established PSC.

Question 98: A 64-year-old man with known cirrhosis secondary to hepatitis B presents to the emergency department with confusion and asterixis. His wife reports he has become increasingly drowsy over the past 48 hours. Blood tests show: albumin 28 g/L, bilirubin 65 μmol/L, INR 2.1, sodium 132 mmol/L, potassium 3.2 mmol/L, urea 8.2 mmol/L, creatinine 95 μmol/L. He is not taking any regular medications. What is the most appropriate initial management?

A. Intravenous antibiotics and lactulose (Correct Answer)
B. Branched-chain amino acid supplementation
C. Protein restriction to <40g per day
D. High-dose thiamine and IV dextrose
E. Urgent liver transplant assessment

Explanation: ***Intravenous antibiotics and lactulose*** - The patient's confusion and asterixis in the setting of cirrhosis strongly suggest **hepatic encephalopathy (HE)**. **Lactulose** is the first-line treatment, reducing ammonia production and absorption by acidifying the gut lumen and promoting laxation. - **Infection**, such as **spontaneous bacterial peritonitis (SBP)**, is a common precipitant of HE in cirrhotic patients. Therefore, **empirical intravenous antibiotics** are crucial alongside lactulose to address potential underlying infection. *Branched-chain amino acid supplementation* - While **branched-chain amino acids (BCAAs)** can be considered for chronic or refractory hepatic encephalopathy, they are not the primary initial treatment for acute decompensation. - BCAAs do not address the immediate precipitants of acute encephalopathy, such as infection or gastrointestinal bleeding, as effectively as lactulose and antibiotics. *Protein restriction to <40g per day* - **Severe protein restriction** is an outdated practice that can lead to **malnutrition** and sarcopenia, worsening outcomes in cirrhotic patients. - Current recommendations advise adequate protein intake (1.2–1.5 g/kg/day) to maintain muscle mass, which plays a role in ammonia detoxification. *High-dose thiamine and IV dextrose* - This treatment is specific for **Wernicke's encephalopathy**, typically seen in **alcohol-related liver disease** due to thiamine deficiency, which is not the primary etiology in this hepatitis B patient. - While general supportive care, this regimen does not directly address the pathophysiology of ammonia accumulation or potential infection in acute hepatic encephalopathy. *Urgent liver transplant assessment* - Although the patient has decompensated cirrhosis, the immediate priority is to **stabilize the acute episode** of hepatic encephalopathy by treating its underlying precipitants. - **Urgent liver transplant assessment** is a long-term management strategy, usually pursued after acute medical issues are controlled and the patient is stable for evaluation.

Question 99: A 51-year-old woman with Child-Pugh B cirrhosis due to non-alcoholic steatohepatitis undergoes surveillance ultrasound which identifies a 2.8 cm liver lesion. Multiphase CT shows arterial hyperenhancement with washout in the portal venous phase. AFP is 45 ng/mL. She has no extrahepatic disease. ECOG performance status is 0. According to Barcelona Clinic Liver Cancer (BCLC) staging, what is the most appropriate treatment?

A. Liver transplantation assessment (Correct Answer)
B. Transarterial chemoembolisation (TACE)
C. Sorafenib therapy
D. Surgical resection
E. Radiofrequency ablation

Explanation: ***Liver transplantation assessment*** - The patient's **Hepatocellular Carcinoma (HCC)** meets the **Milan criteria** (single lesion ≤5 cm) and she has **Child-Pugh B cirrhosis**, making liver transplantation the preferred curative treatment. - This approach is optimal as it simultaneously treats the **malignancy** and the underlying **decompensated liver disease**, offering superior long-term survival compared to other options. *Transarterial chemoembolisation (TACE)* - TACE is primarily indicated for **BCLC Stage B (intermediate stage)** HCC, typically involving multinodular disease without vascular invasion or extrahepatic spread. - It is a palliative locoregional therapy and not the first-line curative option for a patient who is a candidate for liver transplantation. *Sorafenib therapy* - This systemic therapy is reserved for **BCLC Stage C (advanced stage)** HCC, characterized by **macrovascular invasion** or **extrahepatic metastases**. - The patient has localized disease without these advanced features, rendering sorafenib inappropriate as a primary treatment. *Surgical resection* - Surgical resection is generally contraindicated in patients with **Child-Pugh B or C cirrhosis** due to the significantly high risk of **postoperative liver failure**. - It is typically reserved for patients with **preserved liver function** (Child-Pugh A) and solitary tumors (**BCLC Stage 0 or A**). *Radiofrequency ablation* - RFA is a curative-intent local ablative therapy often used for **very early/early stage HCC** (lesions ≤3 cm), especially when surgery is not feasible. - While an option, in the setting of **Child-Pugh B cirrhosis** and a tumor within Milan criteria, liver transplantation offers the best long-term outcomes by treating both the tumor and the underlying liver disease.

Question 100: Which of the following is the primary mechanism by which terlipressin reduces portal pressure in variceal bleeding?

A. Inhibition of nitric oxide synthase
B. Splanchnic arterial vasoconstriction reducing portal venous inflow (Correct Answer)
C. Direct vasoconstriction of varices
D. Increased hepatic arterial resistance
E. Increased systemic vascular resistance

Explanation: ***Splanchnic arterial vasoconstriction reducing portal venous inflow*** - **Terlipressin** is a synthetic analogue of **vasopressin** that acts specifically on **V1 receptors** located on vascular smooth muscle. - By causing **splanchnic arterial vasoconstriction**, it significantly decreases the volume of blood entering the **portal venous system**, which lowers **portal pressure** and stops variceal bleeding. *Inhibition of nitric oxide synthase* - While **nitric oxide (NO)** contributes to the pathological vasodilation seen in **portal hypertension**, terlipressin does not directly inhibit the enzyme **NO synthase**. - Its therapeutic effect is mediated through **receptor-binding (V1)** rather than biochemical inhibition of vasodilatory pathways. *Direct vasoconstriction of varices* - Varices are **distended veins** that lack significant smooth muscle in their walls, making them largely unresponsive to direct pharmacological **vasoconstriction**. - The reduction in bleeding is achieved indirectly by lowering the **portal venous pressure** and the subsequent **portal-systemic pressure gradient**. *Increased hepatic arterial resistance* - Terlipressin primarily targets the **splanchnic mesenteric circulation** rather than the intrahepatic arterial system. - Increasing **hepatic arterial resistance** would be counterproductive as it could theoretically impair liver perfusion in a patient with already compromised **cirrhotic liver function**. *Increased systemic vascular resistance* - While an increase in **systemic vascular resistance (SVR)** can occur as a secondary side effect, it is not the intended **primary mechanism** for controlling variceal hemorrhage. - Excessive systemic vasoconstriction is a potential complication that can lead to **myocardial ischemia** or peripheral tissue hypoxia, not the therapeutic goal.

Question 101: A 56-year-old man presents with dyspepsia. He has been taking omeprazole 20 mg daily for 8 weeks with minimal improvement. He has no alarm features. Upper GI endoscopy shows a 4 cm hiatus hernia and grade B oesophagitis (Los Angeles classification). Helicobacter pylori rapid urease test is negative. What is the most appropriate management?

A. Continue omeprazole 20 mg daily and review in 3 months
B. Increase to omeprazole 40 mg twice daily for 8 weeks (Correct Answer)
C. Switch to ranitidine 300 mg twice daily
D. Refer for laparoscopic fundoplication
E. Arrange 24-hour pH monitoring

Explanation: ***Increase to omeprazole 40 mg twice daily for 8 weeks***- This patient has **Grade B oesophagitis** and **persistent symptoms** despite 8 weeks of standard-dose PPI, indicating the need for **dose escalation**.- A **large hiatus hernia** and **erosive oesophagitis** often require **higher-dose** and **twice-daily PPI** therapy to achieve adequate acid suppression and mucosal healing.*Continue omeprazole 20 mg daily and review in 3 months*- Continuing the current ineffective dose is inappropriate as the patient has already shown **minimal improvement** after an 8-week trial.- Failing to adequately treat **erosive oesophagitis** can lead to complications such as **strictures** or **Barrett's oesophagus**.*Switch to ranitidine 300 mg twice daily*- **H2-receptor antagonists** like ranitidine are significantly **less potent** than PPIs in suppressing gastric acid.- Switching to ranitidine would be a **step down** in therapy and is unlikely to resolve the persistent oesophagitis and symptoms.*Refer for laparoscopic fundoplication*- **Surgical intervention** like fundoplication is usually considered for patients who **fail optimized medical therapy** (high-dose PPI) or have severe complications.- It is premature to consider surgery before attempting a **maximal medical regimen**.*Arrange 24-hour pH monitoring*- **24-hour pH monitoring** is primarily used to confirm the diagnosis of GERD in patients with **atypical symptoms** or when **endoscopy is negative**.- Since the endoscopy already revealed **Grade B oesophagitis**, the diagnosis is confirmed, and pH monitoring is not required at this stage for management.

Question 102: A 29-year-old woman with ulcerative colitis limited to the rectum and sigmoid colon has been using mesalazine suppositories for 2 years with good symptom control. She now plans pregnancy. What is the most appropriate advice regarding her ulcerative colitis medication?

A. Stop mesalazine before conception due to teratogenic risk
B. Switch to oral prednisolone throughout pregnancy
C. Continue mesalazine suppositories as the benefits outweigh risks (Correct Answer)
D. Stop mesalazine and use only dietary modification during pregnancy
E. Switch to azathioprine before conception

Explanation: ***Continue mesalazine suppositories as the benefits outweigh risks*** - **Mesalazine (5-ASA)** is considered safe during pregnancy with no significant evidence of increased **congenital malformations** or adverse fetal outcomes. - Maintaining **remission** of ulcerative colitis is a priority, as active disease poses a higher risk of **preterm birth** and **low birth weight** than the medication itself. *Stop mesalazine before conception due to teratogenic risk* - Mesalazine is not classified as a **teratogen**; discontinuing it increases the risk of a disease **flare**, which is harmful to the pregnancy. - Unlike certain drugs like methotrexate, **5-aminosalicylates** do not require a washout period before conception. *Switch to oral prednisolone throughout pregnancy* - **Corticosteroids** are used to induce remission during active flares but are not recommended for **maintenance therapy** due to side effects like gestational diabetes. - Switching a well-controlled patient from a topical treatment to systemic **prednisolone** unnecessarily increases fetal and maternal exposure to steroids. *Stop mesalazine and use only dietary modification during pregnancy* - **Dietary modification** alone is insufficient to maintain remission in ulcerative colitis and lacks the evidence-based efficacy of pharmacological therapy. - Stopping effective maintenance therapy carries a high risk of **relapse**, which can negatively impact maternal and fetal health. *Switch to azathioprine before conception* - **Azathioprine** is generally safe in pregnancy, but there is no clinical indication to switch a patient whose disease is already **well-controlled** on mesalazine. - Introduction of new medications before pregnancy should be avoided if the current **lower-potency** regimen is effective.

Question 103: A 38-year-old man presents with a 12-month history of epigastric discomfort, early satiety, and bloating. He has no alarm features. He tested positive for Helicobacter pylori and completed 7-day triple therapy (PPI, clarithromycin, amoxicillin) 6 weeks ago. His symptoms have partially improved but persist. Urea breath test remains positive. What is the most appropriate next step?

A. Repeat the same triple therapy regimen for 14 days
B. Arrange urgent upper GI endoscopy
C. Switch to bismuth-based quadruple therapy (Correct Answer)
D. Switch to PPI, metronidazole, and clarithromycin for 14 days
E. Commence long-term PPI therapy without further eradication attempt

Explanation: ***Switch to bismuth-based quadruple therapy*** - After a failed first-line **H. pylori** eradication attempt, guidelines recommend using a second-line therapy that avoids antibiotics used previously, such as **clarithromycin**, due to likely resistance. - **Bismuth-based quadruple therapy** (PPI, bismuth, metronidazole, and tetracycline) for 14 days is the preferred rescue regimen to achieve higher eradication rates. *Repeat the same triple therapy regimen for 14 days* - Repeating the same antibiotics (especially **clarithromycin**) is ineffective because the initial failure strongly suggests the presence of **antibiotic-resistant** bacterial strains. - Extending the duration to 14 days does not overcome the biological resistance already established against the specific agents used. *Arrange urgent upper GI endoscopy* - This patient is young (under 55-60) and lacks **alarm features** such as weight loss, anemia, or dysphagia, making an urgent endoscopy unnecessary at this stage. - Persistent symptoms following one failed treatment round are managed by **second-line eradication** before considering invasive imaging. *Switch to PPI, metronidazole, and clarithromycin for 14 days* - This regimen is inappropriate because it reuses **clarithromycin**, which has a high risk of acquired resistance following the first treatment failure. - Effective second-line strategies must pivot to different antibiotic classes or include **bismuth** to disrupt bacterial defenses. *Commence long-term PPI therapy without further eradication attempt* - Failing to eradicate **H. pylori** increases the long-term risk of developing **peptic ulcer disease** and **gastric adenocarcinoma**. - Managing symptoms with **PPI monotherapy** alone does not address the underlying infection or the associated mucosal inflammation.

Question 104: A 42-year-old woman presents with acute severe epigastric pain radiating to the back, vomiting, and fever. CT abdomen shows pancreatic inflammation with a 6 cm peripancreatic fluid collection. Serum lipase is 2400 U/L. Despite fluid resuscitation and analgesia, she remains pyrexial at day 5. Repeat CT shows the collection has increased to 8 cm with gas locules. What is the most appropriate management?

A. Continue conservative management as collections typically resolve by 4 weeks
B. Arrange CT-guided drainage immediately (Correct Answer)
C. Commence broad-spectrum antibiotics and reassess in 48 hours
D. Arrange urgent surgical debridement
E. Arrange endoscopic cystogastrostomy

Explanation: ***Arrange CT-guided drainage immediately*** - The presence of **gas locules** within a peripancreatic collection on CT is pathognomonic for **infected pancreatic necrosis**, which carries a high mortality rate without source control. - Current guidelines advocate for a **step-up approach**, starting with minimally invasive **percutaneous drainage** as the first-line intervention to stabilize the patient and potentially avoid open surgery. *Continue conservative management as collections typically resolve by 4 weeks* - While sterile collections can be managed expectantly, the development of **persistent fever** and **intraluminal gas** indicates a life-threatening infection that requires immediate intervention. - Waiting for 4 weeks for a collection to mature into a **pseudocyst** or for resolution is dangerous in the context of active sepsis and macroscopic gas locules. *Commence broad-spectrum antibiotics and reassess in 48 hours* - Although **broad-spectrum antibiotics** are indicated for suspected infection, antibiotics alone are insufficient to treat a large, **infected necrotic collection** with gas. - Reassessment without drainage ignores the critical need for **source control**, as antibiotics have poor penetration into large areas of avascular necrotic tissue. *Arrange urgent surgical debridement* - **Open necrosectomy** was historically the standard but is now associated with higher morbidity and mortality compared to the **step-up approach** which prioritizes drainage. - Immediate surgery should be avoided in the acute phase (day 5) when the necrotic tissue is not yet well-demarcated or **walled-off**, unless minimally invasive methods fail or abdominal compartment syndrome is present. *Arrange endoscopic cystogastrostomy* - This procedure is specifically used for internal drainage of **Walled-Off Necrosis (WON)** or mature pseudocysts, which typically take **4 to 6 weeks** to form a distinct wall. - Attempting this in the acute phase (day 5) is inappropriate because the collection lacks the necessary **mature wall** for safe and effective endoscopic stent placement.

Question 105: A 62-year-old man with decompensated cirrhosis due to hepatitis C is admitted with confusion. His wife reports personality changes over the past week. Examination shows asterixis and drowsiness (West Haven grade 3). Ammonia level is elevated. He is taking lactulose 20 mL three times daily. Which additional intervention has the strongest evidence for improving outcomes in hepatic encephalopathy?

A. L-ornithine L-aspartate infusion
B. Metronidazole 400 mg three times daily
C. Rifaximin 550 mg twice daily (Correct Answer)
D. Neomycin 500 mg four times daily
E. Branched-chain amino acid supplements

Explanation: ***Rifaximin 550 mg twice daily*** - **Rifaximin** is a non-absorbable antibiotic that reduces ammonia-producing gut bacteria, making it an effective adjunct to **lactulose** for **hepatic encephalopathy (HE)**. - It has strong evidence for preventing recurrent HE and improving cognitive function, with a favorable safety profile compared to other antibiotics. *L-ornithine L-aspartate infusion* - **L-ornithine L-aspartate (LOLA)** helps detoxify ammonia by stimulating the **urea cycle** and glutamine synthesis in the muscle and liver. - While used as an adjunctive therapy, especially in acute settings, its long-term efficacy and impact on major outcomes are generally considered less robust than **rifaximin** for recurrent HE prevention. *Metronidazole 400 mg three times daily* - **Metronidazole** is an antibiotic that can reduce colonic ammonia production, but its long-term use is limited by the risk of **peripheral neuropathy** and other systemic side effects. - Its efficacy in comparison to **rifaximin** for chronic management of HE is less established and it is not the preferred choice due to safety concerns. *Neomycin 500 mg four times daily* - **Neomycin** is an aminoglycoside antibiotic that reduces gut bacteria, thus lowering ammonia production; however, it has significant systemic absorption. - Its use is largely superseded by **rifaximin** due to risks of **ototoxicity** and **nephrotoxicity**, making it unsuitable for long-term use in patients with cirrhosis. *Branched-chain amino acid supplements* - **Branched-chain amino acids (BCAAs)** are thought to improve nitrogen metabolism and may benefit patients with HE by counteracting amino acid imbalances. - While they can be used as nutritional support, especially in malnourished patients, they are not a primary therapy for managing acute, decompensated HE with elevated ammonia and grade 3 symptoms, nor do they have the same evidence base as **rifaximin** for preventing recurrence.

Question 106: A 35-year-old man with Crohn's disease affecting the terminal ileum has been in remission for 2 years on azathioprine. He now presents with a painful perianal swelling. Examination reveals a tender, fluctuant mass lateral to the anus with surrounding erythema. There is no fever. What is the most appropriate immediate management?

A. Incision and drainage under general anaesthetic with seton placement (Correct Answer)
B. Commence oral metronidazole and ciprofloxacin
C. Increase azathioprine dose
D. Commence infliximab infusion
E. MRI pelvis prior to any intervention

Explanation: ***Incision and drainage under general anaesthetic with seton placement***- The patient's presentation of a **tender, fluctuant mass** lateral to the anus is diagnostic of a **perianal abscess**, which requires urgent surgical drainage to prevent local tissue destruction and systemic sepsis.- In **Crohn's disease**, an examination under anesthesia (EUA) is preferred to ensure complete drainage and to place a **non-cutting seton** if a fistula is found, as this prevents premature closure and recurrent abscess formation.*Commence oral metronidazole and ciprofloxacin*- While **antibiotics** are useful adjuncts in managing perianal Crohn's disease, they cannot penetrate or adequately treat a localized, **walled-off abscess collection**.- Delaying surgical drainage while attempting medical therapy alone significantly increases the risk of the infection spreading and forming complex **anorectal fistulae**.*Increase azathioprine dose*- **Azathioprine** is a maintenance therapy for Crohn's disease that takes several weeks to reach therapeutic efficacy and is not indicated for the management of an **acute septic complication**.- Increasing immunosuppression in the presence of an **undrained abscess** is contraindicated as it may impair the body's ability to localize the infection.*Commence infliximab infusion*- **Anti-TNF agents** like infliximab are highly effective for healing **draining fistulae**, but they must not be started until any underlying **abscess/sepsis** has been fully drained and controlled.- Starting biologics while a collection is present can lead to **septicemia** or the worsening of the localized infection.*MRI pelvis prior to any intervention*- While **MRI pelvis** is the gold standard for mapping complex anatomy in perianal Crohn's, it should not delay the **immediate surgical management** of a clinically obvious abscess.- Imaging is typically reserved for cases where clinical findings are ambiguous or for planning **definitive fistula surgery** after the acute infection has been resolved.

Question 107: A 48-year-old woman with long-standing GORD presents with progressive dysphagia to solids over 6 months and 8 kg weight loss. Upper GI endoscopy shows a tight oesophageal stricture at 35 cm from the incisors. Multiple biopsies are taken which show intestinal metaplasia but no dysplasia or malignancy. What is the most appropriate initial management?

A. Refer for oesophagectomy
B. Arrange endoscopic mucosal resection
C. Commence high-dose PPI and arrange endoscopic dilatation (Correct Answer)
D. Arrange radiofrequency ablation of Barrett's mucosa
E. Commence oral corticosteroids for eosinophilic oesophagitis

Explanation: ***Commence high-dose PPI and arrange endoscopic dilatation*** - This patient has a **peptic stricture** due to **long-standing GORD**, indicated by progressive dysphagia and the presence of **intestinal metaplasia** without dysplasia or malignancy. - **Endoscopic dilatation** is the primary treatment for symptomatic peptic strictures, providing immediate relief from dysphagia, while **high-dose PPIs** are crucial for healing the inflammation, preventing stricture recurrence, and managing the underlying GORD. *Refer for oesophagectomy* - **Oesophagectomy** is a radical surgical procedure primarily reserved for **oesophageal carcinoma** or high-grade dysplasia refractory to endoscopic management. - Given that biopsies showed only **intestinal metaplasia** without malignancy or dysplasia, such an invasive surgery is not appropriate at this stage for a benign stricture. *Arrange endoscopic mucosal resection* - **Endoscopic mucosal resection (EMR)** is a technique used to remove **superficial neoplastic lesions**, such as visible nodules, high-grade dysplasia, or early intramucosal carcinoma in Barrett's oesophagus. - It is not indicated as a primary treatment for a **benign peptic stricture** or non-dysplastic Barrett's, as it does not address the underlying stricture effectively. *Arrange radiofrequency ablation of Barrett's mucosa* - **Radiofrequency ablation (RFA)** is an endoscopic therapy used to eradicate **dysplastic Barrett's oesophagus** to prevent its progression to adenocarcinoma. - The patient's biopsies showed **non-dysplastic intestinal metaplasia**, for which RFA is generally not recommended, and it would not mechanically open a tight oesophageal stricture. *Commence oral corticosteroids for eosinophilic oesophagitis* - **Eosinophilic oesophagitis (EoE)** is characterized by **dysphagia** and often a **"ringed" oesophagus**, with biopsy showing significant **eosinophilic infiltration**. - This patient's biopsies revealed **intestinal metaplasia**, a feature of Barrett's oesophagus, not EoE; therefore, corticosteroids specific for EoE are inappropriate.

Question 108: A 55-year-old man with alcohol-related cirrhosis presents with increasing abdominal distension. Examination reveals shifting dullness and peripheral oedema. Diagnostic ascitic tap shows: protein 8 g/L, white cells 150/mm³ (80% lymphocytes), serum-ascites albumin gradient (SAAG) 16 g/L. What is the most likely diagnosis?

A. Spontaneous bacterial peritonitis
B. Portal hypertension-related ascites (Correct Answer)
C. Malignant ascites
D. Tuberculous peritonitis
E. Pancreatic ascites

Explanation: ***Portal hypertension-related ascites*** - A **Serum-Ascites Albumin Gradient (SAAG)** of 16 g/L (≥11 g/L) is highly indicative of **portal hypertension**, which is common in patients with **alcohol-related cirrhosis**. - The ascitic fluid protein of **8 g/L** (<25 g/L) and **low total white cell count** (150/mm³) with a **low neutrophil count** (30/mm³) are consistent with uncomplicated transudative ascites. *Spontaneous bacterial peritonitis* - This diagnosis requires an ascitic fluid **polymorphonuclear (PMN) count >250/mm³**, which is not met as the patient has only 30 neutrophils/mm³. - Patients with SBP often present with **fever**, abdominal pain, or worsening encephalopathy, none of which are described here. *Malignant ascites* - Malignant ascites typically presents with a **low SAAG (<11 g/L)**, as it results from increased capillary permeability, not portal hypertension. - Ascitic fluid in malignancy usually shows a **high protein content** (>25 g/L) and may have positive cytology for malignant cells. *Tuberculous peritonitis* - While it can be **lymphocyte-predominant**, it typically has a **low SAAG (<11 g/L)** and a significantly higher protein level (>25 g/L). - The total ascitic white cell count is usually much higher, often exceeding 500/mm³, and the clinical picture includes chronic constitutional symptoms. *Pancreatic ascites* - This condition is characterized by a **low SAAG (<11 g/L)** and very high levels of **ascitic amylase**. - It typically results from a disrupted pancreatic duct or pseudocyst, occurring in the setting of acute or chronic pancreatitis.

Question 109: A 72-year-old man taking aspirin and diclofenac presents with melaena and dizziness. His pulse is 105 bpm, BP 95/60 mmHg. He receives fluid resuscitation and packed red cells. What is the most appropriate timing for upper GI endoscopy following adequate resuscitation?

A. Within 2 hours
B. Within 12 hours
C. Within 24 hours (Correct Answer)
D. Within 48 hours
E. Within 72 hours

Explanation: ***Within 24 hours***- Following adequate resuscitation, current guidelines (e.g., **NICE** or **ACG**) recommend performing upper GI endoscopy within **24 hours** for patients with acute upper GI bleeding.- This timeframe allows for optimal **hemodynamic stabilization** while providing timely diagnosis and therapeutic intervention to reduce the risk of rebleeding.*Within 2 hours*- Endoscopy within 2 hours is reserved for patients with **severe, ongoing bleeding** or those who remain **hemodynamically unstable** despite aggressive resuscitation efforts.- Given the scenario specifies

Question 110: A 28-year-old woman presents with bloody diarrhoea (8 times daily), abdominal pain, and fever (38.5°C). She was diagnosed with ulcerative colitis 3 years ago. Examination shows abdominal tenderness and tachycardia (110 bpm). Blood tests reveal: Hb 98 g/L, WCC 16 × 10⁹/L, platelets 450 × 10⁹/L, CRP 85 mg/L, albumin 25 g/L. Abdominal X-ray shows colonic dilatation of 7 cm. What is the single most important next step in management?

A. Commence intravenous ciclosporin 2 mg/kg
B. Arrange urgent surgical review and commence IV hydrocortisone (Correct Answer)
C. Increase oral mesalazine to maximum dose
D. Commence oral prednisolone 40 mg daily
E. Arrange urgent colonoscopy to assess disease severity

Explanation: ***Arrange urgent surgical review and commence IV hydrocortisone*** - The patient presents with **acute severe ulcerative colitis** (Truelove and Witts criteria) complicated by **toxic megacolon** (colonic dilatation >6 cm), which is a medical and surgical emergency. - Immediate **IV corticosteroids** are the first-line medical therapy, while an **urgent surgical review** is mandatory due to the high risk of colonic perforation and the potential need for an emergency colectomy. *Commence intravenous ciclosporin 2 mg/kg* - **Intravenous ciclosporin** or Infliximab is reserved as **rescue therapy** for patients who fail to respond to IV steroids after 3–5 days. - It is not the initial step, and surgical involvement must take precedence when **toxic megacolon** is already present. *Increase oral mesalazine to maximum dose* - Oral 5-ASA medications like **mesalazine** are used for inducing and maintaining remission in mild-to-moderate disease but are ineffective for **acute severe colitis**. - Absorption and efficacy are compromised in the setting of **severe inflammation** and colonic dilatation. *Commence oral prednisolone 40 mg daily* - **Oral prednisolone** is appropriate for moderate flare-ups, but this patient meets the criteria for **hospital admission** and requires **parenteral (IV) steroids**. - The presence of systemic features (fever, tachycardia) and **toxic megacolon** makes oral therapy insufficient and unsafe. *Arrange urgent colonoscopy to assess disease severity* - A full **colonoscopy** is strictly **contraindicated** in acute severe colitis, especially with toxic megacolon, due to the extreme risk of **iatrogenic perforation**. - A **flexible sigmoidoscopy** with minimal air insufflation might be used later to confirm the diagnosis, but it is not the next step in management for a patient with established megacolon.

Question 111: A 67-year-old man presents with sudden onset severe epigastric pain radiating to the back. He has a history of gallstones. Examination reveals epigastric tenderness and tachycardia. Serum amylase is 1850 U/L (normal <100). Which of the following is the most appropriate severity assessment tool to guide early management and predict mortality?

A. CRP level at 72 hours
B. Ranson's criteria at 48 hours
C. Modified Glasgow score at 48 hours (Correct Answer)
D. APACHE-II score at admission
E. CT severity index within 48 hours

Explanation: ***Modified Glasgow score at 48 hours*** - The **Modified Glasgow (Imrie) score** is a well-established and widely used tool for assessing the severity of **acute pancreatitis**, applicable to both **biliary and alcoholic causes**. It is most accurately prognostic when assessed at **48 hours** after admission. - This score helps predict outcomes by evaluating parameters such as age, WBC count, blood glucose, LDH, AST, albumin, and calcium. A score of **3 or more** indicates **severe pancreatitis** and is associated with increased morbidity and mortality, guiding early management decisions. *CRP level at 72 hours* - While an elevated **CRP level** (e.g., >150 mg/L) is a marker of inflammation and can indicate severe pancreatitis, its peak typically occurs at **48-72 hours**, making it less useful for immediate early management decisions. - CRP is a single inflammatory marker and does not provide a comprehensive assessment of organ dysfunction or systemic complications, unlike multi-parameter scoring systems. *Ranson's criteria at 48 hours* - **Ranson's criteria** involve parameters collected at admission and again at **48 hours**, making it somewhat cumbersome for quick, early assessment and ongoing dynamic evaluation. - This scoring system was primarily developed and validated for **alcoholic pancreatitis** and may be less accurate or universally applicable for other etiologies, such as biliary pancreatitis (as in the patient's case with gallstones). *APACHE-II score at admission* - The **APACHE-II score** is a general critical illness severity score, highly comprehensive and useful for predicting mortality in **critically ill patients** across various conditions, not just pancreatitis. However, its calculation is complex and requires numerous physiological parameters, making it time-consuming. - While it can be applied at admission, its complexity makes it less practical for routine use in guiding *early management* specifically for pancreatitis on a general ward, where a more specialized and simpler tool like the Glasgow score is preferred. *CT severity index within 48 hours* - **CT imaging** performed within the first **48-72 hours** of acute pancreatitis onset often *underestimates* the extent of pancreatic necrosis or fluid collections, as these changes may not yet be fully developed. - CT scans are primarily indicated for diagnosing complications (e.g., necrosis, pseudocyst, abscess) or when the diagnosis of pancreatitis is unclear, rather than for the initial **severity assessment** to guide medical management and predict mortality, which is better done with clinical scoring systems.

Question 112: A 45-year-old woman with known Crohn's disease presents with fever, right upper quadrant pain, and jaundice. Blood tests show: ALP 450 U/L, GGT 380 U/L, bilirubin 65 μmol/L, ALT 85 U/L. MRCP demonstrates multiple short strictures with bead-like appearance of the intrahepatic and extrahepatic bile ducts. Which complication is she at greatest long-term risk of developing?

A. Hepatocellular carcinoma
B. Cholangiocarcinoma (Correct Answer)
C. Pancreatic adenocarcinoma
D. Gallbladder carcinoma
E. Colorectal adenocarcinoma

Explanation: ***Cholangiocarcinoma*** - The clinical triad of fever, RUQ pain, and jaundice along with **MRCP findings of a beaded appearance** (multi-focal strictures) confirms a diagnosis of **Primary Sclerosing Cholangitis (PSC)**. - Patients with PSC have a significantly elevated lifetime risk (10–15%) of developing **cholangiocarcinoma**, requiring regular surveillance with **CA 19-9** and imaging. *Hepatocellular carcinoma* - Risk for primary liver cancer is generally only increased in PSC patients if the disease progresses to **cirrhosis**. - Unlike Hepatitis B or C, PSC is not primarily associated with **Hepatocellular carcinoma** in the absence of end-stage liver disease. *Pancreatic adenocarcinoma* - While there is a slight association between **IgG4-related disease** (which mimics PSC) and pancreatic issues, there is no established link with PSC. - This malignancy arises from the **exocrine pancreas**, not the biliary tree pathology seen in this patient. *Gallbladder carcinoma* - Patients with PSC do have an increased risk of **gallbladder polyps** and subsequent **gallbladder carcinoma**. - However, the risk for **cholangiocarcinoma** is statistically much higher and represents the more classic, high-weight complication of PSC. *Colorectal adenocarcinoma* - While PSC is strongly associated with **Inflammatory Bowel Disease (IBD)**, which increases colon cancer risk, the specific long-term risk of the **biliary disease** itself is cholangiocarcinoma. - The question focuses on the biliary complications following the **MRCP findings**, making the biliary tract malignancy the most specific answer.

Question 113: A 32-year-old woman presents with a 6-month history of intermittent abdominal pain, bloating, and alternating bowel habit. She reports relief after defecation. Examination is unremarkable. Blood tests including FBC, CRP, coeliac serology, and thyroid function are normal. Faecal calprotectin is 18 μg/g. What is the most appropriate next step in management?

A. Colonoscopy to exclude inflammatory bowel disease
B. CT abdomen and pelvis with contrast
C. Trial of low FODMAP diet and reassurance (Correct Answer)
D. Commence mesalazine 800 mg three times daily
E. Hydrogen breath test for lactose intolerance

Explanation: ***Trial of low FODMAP diet and reassurance*** - The patient presents with classic symptoms of **Irritable Bowel Syndrome (IBS)**, including chronic abdominal pain, bloating, and altered bowel habits with relief after defecation, in the absence of **red flag symptoms** or abnormal lab results. - Normal **FBC, CRP, coeliac serology, thyroid function**, and a very low **faecal calprotectin** (18 μg/g, well below the 50 μg/g cutoff) effectively rule out **Inflammatory Bowel Disease (IBD)** and other organic pathologies, making dietary intervention the appropriate next step. *Colonoscopy to exclude inflammatory bowel disease* - **Colonoscopy** is an invasive procedure generally not indicated in patients with classic **IBS symptoms** and a normal **faecal calprotectin**, especially without red flags like weight loss, rectal bleeding, or anemia. - The normal faecal calprotectin has a high **negative predictive value** for ruling out significant colonic inflammation, making IBD highly unlikely. *CT abdomen and pelvis with contrast* - **CT imaging** is not part of the diagnostic algorithm for suspected **IBS** and is generally reserved for situations where there is concern for structural abnormalities, **acute abdomen**, or complications of inflammatory conditions. - This investigation would expose the patient to unnecessary **ionizing radiation** without clear clinical indication given the benign presentation and normal lab results. *Commence mesalazine 800 mg three times daily* - **Mesalazine (5-ASA)** is an anti-inflammatory drug primarily used in the management of **Ulcerative Colitis** and sometimes Crohn's disease to induce and maintain remission. - It has no proven efficacy or role in the treatment of **Irritable BowSowel Syndrome (IBS)**, and prescribing it would be inappropriate given the lack of evidence for IBD. *Hydrogen breath test for lactose intolerance* - While **lactose intolerance** can contribute to IBS-like symptoms, a **low FODMAP diet** is a broader dietary intervention that includes restriction of lactose, fructose, and other fermentable carbohydrates. - The **hydrogen breath test** is specific for lactose malabsorption, but a trial of the comprehensive low FODMAP diet often provides better overall symptom relief for IBS patients and is a more practical initial approach before specific testing.

Question 114: A 58-year-old man with a history of heavy alcohol use presents with haematemesis. He is haemodynamically stable. Upper GI endoscopy reveals bleeding oesophageal varices which are successfully banded. His blood tests show: Hb 92 g/L, platelets 78 × 10⁹/L, albumin 28 g/L, bilirubin 45 μmol/L, INR 1.6. What is the most appropriate prophylactic measure to reduce the risk of rebleeding in the first five days?

A. Propranolol 40 mg twice daily
B. Terlipressin 2 mg four times daily for 5 days (Correct Answer)
C. Ciprofloxacin 500 mg twice daily for 7 days
D. Pantoprazole 40 mg twice daily
E. Sengstaken-Blakemore tube insertion

Explanation: ***Terlipressin 2 mg four times daily for 5 days***- **Terlipressin** is a vasopressin analogue that causes **splanchnic vasoconstriction**, which effectively reduces **portal venous pressure** and the risk of early variceal rebleeding.- International guidelines (like Baveno) recommend continuing vasoactive drugs for up to **5 days** after successful endoscopic haemostasis to stabilize the patient during the highest-risk period.*Propranolol 40 mg twice daily*- **Non-selective beta-blockers** are vital for **long-term secondary prophylaxis**, but they are contraindicated in the acute phase due to the risk of **hypotension** and masking tachycardia.- These agents should only be initiated once the patient is stable, typically several days after the bleeding has been controlled.*Ciprofloxacin 500 mg twice daily for 7 days*- While **antibiotic prophylaxis** is mandatory in patients with variceal hemorrhage to prevent **spontaneous bacterial peritonitis**, it does not provide the vasoactive control needed to prevent rebleeding.- Though it reduces mortality and infection rates, it functions as an **adjunct therapy** rather than a direct mechanical or physiological preventative for variceal pressure.*Pantoprazole 40 mg twice daily*- **Proton pump inhibitors (PPIs)** are used for **peptic ulcer disease** bleeding but have no physiological effect on reducing **portal hypertension** or variceal bleeding.- They may be used briefly to promote healing of **post-banding ulcers**, but they are not a primary prophylactic measure for varices.*Sengstaken-Blakemore tube insertion*- This is a **rescue therapy** used for **uncontrolled or massive bleeding** that cannot be managed by endoscopy alone.- It is not indicated for a patient who is **haemodynamically stable** and has already undergone successful **endoscopic band ligation**.

Practice by Chapter

Acute pancreatitis

Practice Questions

Cirrhosis and complications

Practice Questions

Dyspepsia and GORD

Practice Questions

Inflammatory bowel disease

Practice Questions

Irritable bowel syndrome

Practice Questions

Upper GI bleeding

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free